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ý'  9üý19/. Abstract 
Wnt  signalling  is  active  both  in  development  and  the  progression  of  certain  disease 
processes,  most  notably  cancer.  Glycogen  Synthase  Kinase-3  (GSK-3)  and  ß-catenin  both 
define  the  canonical  Wnt  pathway,  where  GSK-3  negatively  regulates  ß-catenin,  which,  in 
turn,  regulates  gene  expression.  Mutations  to  ß-catenin  that  prevent  GSK-3  phosphorylation 
are  associated  with  the  progression  of  many  different  tumour  types.  In  addition  to  its 
signalling  function,  ß-catenin  is  required  structurally  at  adherens  junctions,  linking  cadherin 
molecules  to  the  actin  cytoskeleton  via  its  interaction  with  a-catenin.  Loss  of  1-catenin 
from  adherens  junctions  is  associated  with  the  increased  invasiveness  and  metastasis  of 
tumour  cells. 
Homologues  of  GSK-3  (GskA)  and  ß-catenin  (Aardvark)  have  been  cloned  in  the  cellular 
slime  mould  Dictyostelium  discoideum.  Aardvark  is  required  for  both  the  expression  of  the 
pre-sprore  marker  gene  pspA  and  the  formation  of  adherens  junctions  in  Dictyostelium. 
This  thesis  describes  the  characterisation  of  Aardvark,  with  particular  regard  to  its  function 
and  interaction  with  GskA. 
This  work  shows  that  distinct  regions  of  Aar  are  required  for  its  signalling  and  adhesion 
functions  and  suggests  that  two  distinct  proteins  may  bind  to  it  to  mediate  the  formation  of 
adherens  junctions.  A  novel  protein  kinase  has  been  identified  that  may  phosphorylate  the 
N-terminus  of  Aar  to  regulate  the  expression  of  the  pre-spore  marker  gene  pspA.  Full- 
length  Aar  is  unstable  and  a  `destabilisation'  region  has  been  identified  within  the  core  of 
the  protein.  A  novel  derepression  mechanism  is  used  to  explain  GskA  and  Aar  function  in 
the  expression  of  pspA.  The  characterisation  of  non-canonical  Wnt  signalling  will  enhance 
the  understanding  of  the  evolution  and  function  of  the  core  components  of  the  pathway, 
giving  greater  insight  into  their  roles  in  both  development  and  disease  processes. 
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12 1.1  Introduction 
1.1.1  Genes,  development  and  disease 
The  human  genome  contains  30,000-40,000  protein-coding  genes  (Lander  et  at.,  2001).  It  is 
the  differential  expression  of  these  genes  that  underlies  the  differences  in  cell  types  seen  in 
an  adult  human.  Gene  expression  controls  both  growth  and  development  to  produce  a  new- 
born  baby  from  a  fertilised  egg.  This  growth  and  differentiation  also  needs  to  be  coupled 
with  morphogenesis;  that  is,  the  movement  of  cells  into  the  required  pattern  to  determine 
the  correct  final  body  plan.  During  morphogenesis,  cells  must  communicate  with  one 
another  (cell  signalling)  and  also  stick  to  one  another  (cell-cell  adhesion).  It  is  this  coupling 
of  growth  and  differentiation  with  morphogenesis  that  defines  `development'.  Defects  in 
development  can  often  lead  to  the  onset  of  disease  process;  cancer  being  a  common 
example.  Both  cell  signalling  and  cell  adhesion  processes  are  active  in  cancer.  These  cells 
continuously  perceive  the  signal  to  grow  and  divide,  with  the  reduced  adhesion  of  cells 
leading  to  the  metastasis  of  tumours. 
1.1.2  The  Wnt  Pathway 
One  of  the  major  pathways  contributing  to  both  development  and  cancer  is  the  Wnt 
pathway.  Genetic  experiments  in  the  fruit  fly,  Drosophila  melanogaster,  gave  the  first 
glimpse  of  the  pathway.  The  Wingless  protein  (Wg)  controls  cell  fate;  for  example, 
instructing  cells  of  the  wing  that  they  should  be  posterior  cells.  Later,  Int-1  was  shown  to 
be  the  human  homologue  of  Wg,  and  the  amalgamation  of  the  two  names  produced  the 
name  `Wnt'.  The  pathway  has  since  been  shown  to  control  many  developmental  processes 
-  including  cell  fate  specification,  embryonic  axis  formation,  and  cell  proliferation  -  across 
a  wide  spectrum  of  vertebrate  and  invertebrate  organisms  (Cadigan  and  Nusse,  1997;  Moon 
et  al.,  1997).  Mutations  to  many  of  the  genes  of  this  pathway  have  been  shown  to  be 
coincidental  with  a  large  number  of  tumour  types  (Polakis,  2000). 
13 Signals  mediated  by  Wnt  ligands  have  been  shown  to  branch  into  four  intracellular 
pathways:  (1)  a  canonical  Writ  pathway,  which  signals  through  TCF/LEF-1  transcription 
factors  via  GSK-3  and  ß-catenin  (see  Cadigan  and  Nusse,  1997);  (2)  a  planar  cell  polarity 
pathway,  which  utilises  Rho-kinase  and  JNK  to  cause  cytoskeletal  rearrangements  (see 
Sokol,  2000);  (3)  a  Wnt/Ca2+  pathway  that  controls  PKC  and  CamKII  to  regulate  cell 
adhesion  and  motility  (see  Kuhl  et  al.,  2000);  and  (4)  a  novel  pathway  that  regulates  spindle 
orientation  and  asymmetric  cell  division,  through  GSK-3  and  APC  (see  Huelsken  and 
Birchmeier,  2001).  Whilst  Wnt  is  common  to  all  of  these  pathways,  many  of  the  other 
components  differ  greatly.  Dishevelled  is  a  protein  that  may  act  as  the  switch  between  the 
different  pathways  (figure  1.1). 
Wnt  signalling  via  the  canonical  pathway  requires  the  accumulation  of  (3-catenin  within  the 
cell.  ß-catenin  complexes  with  HMG-box  transcription  factors  of  the  TCF/LEF-1  family  to 
induce  expression  of  downstream  genes  (Huber  et  al.,  1996b).  However,  (3-catenin  is 
normally  targeted  for  breakdown  via  the  proteasome,  following  phosphorylation  by  a 
complex  containing  Axin,  APC,  GSK-3  and  Casein  Kinase  1.  The  Wnt  signal  inhibits 
GSK-3,  via  a  process  that  is  known  to  require  Dishevelled. 
1.1.3  ß-catenin  and  GSK-3:  central  components  of  the  Canonical  Wnt  Pathway 
Canonical  Wnt  signalling  in  cancer  is  typified  by  tumorigenesis  in  the  epithelial  lining  of 
the  colon.  Wnt  regulates  cell  proliferation.  A  critical  balance  exists  between  the  rate  of 
proliferation  and  the  rate  of  death  of  cells  due  to  attrition.  Mutations  to  single  components 
of  the  pathway  can  tip  the  balance  in  the  favour  of  proliferation,  with  unregulated  division 
leading  to  the  onset  of  carcinogenesis. 
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Figure  1.1  Wnt  signalling  diversifies  into  at  least  4  branches 
Writ  signalling  via  Dishevelled  has  been  shown  to  regulate  both  canonical  Writ  signalling 
and  planar  cell  polarity.  Recent  evidence  suggests  that  PLC  activation  by  Wnt  signalling  in 
the  Ca  2+  pathway  may  involve  G-proteins,  whilst  a  pathway  utilising  GSK-3  and  APC  has 
been  shown  to  regulate  asymmetric  cell  division  in  C.  elegans.  Figure  adapted  from 
Polakis,  2001. 
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15 (3-catenin  plays  a  vital  role  in  both  the  proliferation  of  epithelial  cells  and  the  metastasis  of 
tumours.  It  is  required  in  a  signalling  capacity,  as  a  downstream  effector  of  Wnt.  It  is  also  a 
major  component  of  the  adherens  junctions.  These  junctions  connect  cells  in  a  single 
epithelial  sheet  by  interconnecting  the  actin  filaments  of  adjacent  cells  and  forming  a  tight 
belt  between  them.  The  mis-regulation  of  ß-catenin,  either  through  mutation  to  the  protein 
itself,  or  its  regulatory  protein  APC  (Adenomatous  Polyposis  Coli),  is  found  associated 
with  over  80%  of  inherited  and  sporadic  colon  carcinomas  (Polakis,  2000).  In  addition  to 
the  mis-regulation  of  1-catenin  signalling,  loss  of  the  protein  from  the  adherens  junctions 
reduces  adhesion  and  leads  to  increased  metastasis  of  tumours  (Kawanishi  et  al.,  1995). 
GSK-3  is  absolutely  required  for  ß-catenin  regulation.  Phosphorylation  by  GSK-3  leads  to 
the  ubiquitin-dependent  proteasomal  degradation  of  (3-catenin. 
Genetic  studies  in  the  mouse  Mus  musculus,  and  Drosophila,  as  well  as  cell  biological  and 
biochemical  studies  in  cultured  mammalian  cells  and  the  frog  Xenopus  laevis,  established 
the  canonical  pathway.  More  recently,  components  of  the  pathway  have  been  found  in 
hydra  (Hobmayer  et  al.,  2000)  and  the  cellular  slime  mould  Dictyostelium  discoideum 
(Grimson  et  al.,  2000;  Harwood  et  al.,  1995).  Dictyostelium  exist  as  free-living  amoebae, 
but  following  starvation  form  a  multicellular  fruiting  body  composed  primarily  of  two  cell 
types:  stalk  and  spore.  This  morphogenesis  requires  Dictyostelium  to  undergo 
differentiation,  along  with  regulated  cell-cell  adhesion,  in  a  process  which  requires  at  least 
two  Wnt  pathway  homologues  (see  Coates  and  Harwood,  2001).  Like  mammalian  cells,  a 
(3-catenin  homologue,  Aardvark,  is  required  for  cell  signalling  and  the  formation  of 
adherens  junctions  in  Dictyostelium  (Grimson  et  al.,  2000).  The  further  characterisation  of 
Aar  is  described  in  this  thesis. 
16 1.2  Wnt  ligands  and  receptors 
1.2.1  Wnts 
In  1982,  Roel  Nusse  and  Harold  Varmus  discovered  that  int-1  (later  renamed  Wnt-1  due  to 
its  homology  with  the  Drosophila  protein  Wingless)  was  responsible  for  the  majority  of 
tumours  in  mice  infected  with  the  mouse  mammary  tumour  virus  (Nusse  and  Varmus, 
1982).  To  date,  18  human  and  four  Drosophila  Writ  genes  have  been  identified  (Huelsken 
and  Birchmeier,  2001).  Writs  are  cysteine-rich  secreted  proteins  that  act  as  intercellular 
signalling  molecules.  Purification  is  made  difficult  by  the  high  level  of  hydrophobicity  and 
the  formation  of  aggregates  by  secreted  Writs. 
1.2.2  Frizzleds  and  LRPs 
For  many  years  the  inability  to  purify  Wnt  proteins  made  identification  of  their  cognate 
receptors  difficult.  More  recently,  genetic,  cell  biological  and  biochemical  approaches  have 
suggested  that  the  frizzled  (Fz)  cell-surface  receptors  act  as  receptors  for  Wnt  proteins. 
Fzs  are  seven-pass  transmembrane  proteins.  They  contain  a  putative  N-terminal  signal 
sequence,  and  C-terminal  to  this  is  a  sequence  of  120  amino  acids,  which  contains  10 
highly  conserved  cysteine  residues.  A  highly  divergent  region  of  40-100  amino  acids  are 
predicted  to  form  a  flexible  linker  and  seven  transmembrane  segments  are  separated  by 
short  extracellular  and  cytoplasmic  loops  before  the  protein  ends  with  a  C-terminal 
cytoplasmic  tail  (Wang  et  al.,  1996). 
The  overall  structure  of  Fzs  resembles  that  of  G-protein  coupled  receptors  (GPCRs),  but 
whether  Wnt  signalling  proceeds  via  G-proteins  remains  controversial.  Little  evidence 
exists,  but  one  group  has  recently  tried  to  answer  this  question  using  a  chimaeric  receptor 
with  the  ligand-binding  and  transmembrane  segments  from  the  32-adrenergic  receptor 
17 ((32AR)  and  the  cytoplasmic  domains  from  rat  Frizzled-1  (Rfz  1)  (Liu  et  al.,  2001  b).  They 
show  that  treatment  with  the  (3-adrenergic  agonist  isoproterenol  leads  to  the  stabilisation  of 
(3-catenin  in  mouse  cells  transformed  with  the  chimaeric  receptor.  Furthermore,  G-protein 
inactivation  or  depletion  of  Gaq  and  Gao  blocked  the  response. 
Ten  human  and  four  Drosophila  Fzs  have  been  identified  to  date.  The  first  mutation  in  afz 
(fzl)  was  discovered  by  genetic  screens  in  Drosophila  and  exhibits  a  tissue  polarity  defect 
(Vinson  and  Adler,  1987).  The  epithelial  cells  that  make  up  the  wing  blade  are  usually 
aligned  such  that  the  single  hairs  on  each  cell  all  point  in  a  distal  direction  (Adler,  1992).  In 
fzl  mutants,  hairs  point  in  every  direction.  In  addition,  fzl  mutants  display  a  mis-orientation 
of  the  ommatidia  comprising  the  compound  eye  (Zheng  et  al.,  1995),  something  which  is 
also  seen  with  mutants  of  Dsh,  a  protein  which  is  required  for  transduction  of  the  Wg  signal 
-  see  section  1.3  (Theisen  et  at.,  1994).  The  endogenous  ligand  of  Fz1  has  not  been 
established,  however  the  role  of  Dsh  suggested  that  the  Fz  family  may  transduce  Wnt 
signals. 
Subsequent  analysis  showed  that  the  fz-related  gene  in  Drosophila,  Dfz2  is  a  Wg  receptor. 
Stable  transfection  of  Dfz2  into  cell  lines  in  which  it  would  not  normally  be  expressed,  turn 
them  from  Wg  non-responsive  to  Wg-responsive  (Bhanot  et  al.,  1996).  Wg  protein, 
however,  does  not  bind  uniquely  to  Dfz2,  and  in  fact  will  also  bind  the  original  Fz.  Some 
redundancy  appears  to  exist  between  the  Fz  receptors,  but  the  identification  of  a  Wnt  co- 
receptor  has  shed  more  light  onto  the  subject. 
LRP5  and  LRP6  (arrow  in  Drosophila),  members  of  the  low-density  lipoprotein-related 
proteins  (LRPs),  are  coreceptors  of  Wnt.  Arrow  is  essential  for  the  transduction  of 
Wingless  in  Drosophila  (Wehrli  et  al.,  2000),  whilst  LRP6  is  essential  for  Wnt  transduction 
18 in  Xenopus,  and  the  extracellular  domain  of  LRP6  has  been  shown  to  interact  with  Frizzled 
in  a  Wnt-dependent  manner  (Tamai  et  al.,  2000).  The  intracellular  domain  of  LRP5  binds 
Axin,  and  this  is  enhanced  by  the  addition  of  Wnt  (Mao  et  al.,  2001).  In  addition,  binding  to 
LRP5  induces  degradation  of  Axin,  which  can  trigger  LEF-1-mediated  gene  transcription. 
1.2.3  Wnt  antagonists 
Several  classes  of  protein  have  been  discovered  that  will  block  Wnt  signalling  at  the  cell 
surface.  They  do  this  by  directly  binding  Wnt  proteins,  or  by  competing  for  binding  with 
either  the  Fz  receptors,  or  the  LRP  receptors. 
Wnt-inhibitory  factor-1  (WIF-1)  is  a  secretory  protein  that  binds  Writs  and  inhibits  their 
function;  presumably  by  preventing  them  from  binding  to  the  Fz  receptors  (Hsieh  et  al., 
1999).  Highly  conserved  orthologues  are  found  in  mice,  Xenopus  and  zebrafish. 
Cerberus  encodes  a  secreted  protein  that  is  expressed  in  the  anterior  endomesoderm  of 
Xenopus  (Bouwmeester  et  at.,  1996).  Cerberus  has  been  shown  to  directly  bind  XWnt8, 
with  microinjection  of  cerberus  mRNA  into  Xenopus  embryos  inducing  ectopic  heads. 
Independent  of  Wnt  binding,  Cerberus  also  possesses  two  further  sites  required  for  nodal- 
related  and  bone  morphogenic  protein  (BMP)  signalling  -  two  pathways  required  for  head 
formation  in  Xenopus.  A  murine  homologue,  mCer-1,  has  also  been  isolated  (Biben  et  at., 
1998). 
sFRPs  (secreted  frizzled-related  proteins)  are  a  family  of  secreted  proteins,  all 
approximately  30kDa  in  size,  which  contain  a  cysteine-rich  domain  (CRD)  similar  to  that 
of  Fzs.  C-terminal  to  the  CRD  is  a  stretch  of  charged  residues  with  homology  to  nectrins;  a 
family  of  secreted  proteins  involved  in  axon  guidance  (Finch  et  al.,  1997;  Rattner  et  al., 
19 1997).  The  first  sFRP  to  be  cloned,  Frizzled  in  bone,  Fzb  (also  known  as  sFRP-3)  was 
discovered  in  rats,  where  it  is  required  for  skeletal  development  (Hoang  et  al.,  1996).  sFRPs 
have  been  shown  to  bind  Wg  and  inhibit  downstream  signalling,  with  the  CRD  both 
necessary  and  sufficient  for  this  (Wang  et  al.,  1997;  Xu  et  al.,  1998).  More  recently, 
evidence  of  an  activating  role  for  sFRP-1  in  Wg  signalling  has  been  shown  (Uren  et  al., 
2000),  raising  the  possibility  that  these  proteins  may  act  as  inhibitors  or  activators  of  Wg 
signalling,  depending  on  their  cellular  context. 
Dikkopf-1  (Dkk-1),  the  first  Dkk  to  be  discovered  (four  have  been  found  to  date),  was 
isolated  as  a  secreted  protein  that  induces  the  Spemann's  organiser  (an  embryonic  region 
with  potent  head-inducing  activity)  in  Xenopus  (Glinka  et  al.,  1998).  Injection  of  mRNA 
showed  that  Dkk-1  is  both  necessary  and  sufficient  to  cause  head  induction  in  Xenopus. 
Dkks  are  composed  of  two  CRDs  separated  by  a  spacer  region  of  variable  length.  The 
domains  are  well  conserved  across  all  four  Dkk  family  members  (Krupnik  et  al.,  1999). 
Both  Dkk-1  and  Dkk-2  have  been  shown  to  interact  with  the  Fz  co-receptor  LRP6/Arrow  to 
antagonise  Wg  signalling  (Bafico  et  al.,  2001;  Glinka  et  al.,  1998;  Li  et  al.,  2002); 
presumably,  by  competing  for  binding  with  Wg.  This  interaction  occurs  in  a  Dsh- 
independent  manner.  Dkk-4  is  also  a  Wg  antagonist,  but  there  is  no  evidence  that  Dkk-3 
modulates  Wnt  signalling. 
The  individual  domains  of  Dkk-1  and  Dkk-2  possess  distinct  functional  activities.  Both 
1't  pit 
Dkks  !  D*f  Wnt8  and  cooperate  in  the  induction  of  head  structures,  but  only  Dkk-2 
synergises  with  the  Wnt  co-receptor  LRP6  to  activate  0-catenin  signalling  (Brott  and  Sokol, 
2002).  These  differences  have  been  attributed  to  variations  in  the  N-terminal  domains  of  the 
proteins. 
20 1.3  Dishevelled 
1.3.1  Dishevelled  and  the  Canonical  Wnt  Pathway 
The  dishevelled  gene  (dsh)  of  Drosophila  encodes  a  cytoplasmic  phosphoprotein  with  no 
known  biochemical  function.  Genetic  epistasis  experiments  placed  Dsh  downstream  of  Wg 
and  upstream  of  Zw-3  (figure  1.1). 
Dsh  becomes  hyperphosphorylated  following  Wg  stimulation  and  this  form  of  the  protein  is 
found  enriched  at  the  plasma  membrane  (Yanagawa  et  al.,  1995).  This  suggests  that  Wg 
signalling  recruits  Dsh  to  the  membrane.  Casein  Kinase  2  (CK2)  has  been  implicated  as  the 
kinase  which  phosphorylates  Dsh,  following  the  discovery  that  Dsh  is  found  in  a  complex 
with  CK2  and  CK2  will  phosphorylate  Dsh  at  high  levels  in  vitro  (Willert  et  al.,  1997).  The 
CK2  inhibitor  apigenin  blocks  proliferation  in  Wnt-1  transfected  cell  lines,  abolishes  ß- 
catenin  phosphorylation,  and  reduces  ß-catenin  and  Dvl  (the  mammalian  homologue  of 
Dsh)  protein  levels  (Song  et  al.,  2000).  This  implies  that  both  Dsh  and  CK2  are  part  of  the 
Wg  signalling  pathway  and  both  are  positive  regulators  of  the  signal.  However,  over- 
expression  of  one  of  the  Wg  receptors,  Dfz2,  leads  to  phosphorylation  of  Dsh,  but  not 
accumulation  of  the  ß-catenin  homologue  Armadillo  (Arm)  (Willert  et  al.,  1997).  Therefore 
Dsh  phosphorylation  is  insufficient  for  the  transduction  of  the  Wg  signal  to  Arm. 
Dsh  has  highly  conserved  homologues  in  Xenopus  and  mice.  Over-expression  of  Dsh  in 
Drosophila  and  Xenopus  can  mimic  Wnt  signalling,  (Rothbacher  et  al.,  1995;  Yanagawa  et 
al.,  1995),  but  a  knockout  of  the  dsh  homologue  dvll  in  mice  fails  to  display  any  of  the 
drastic  Wnt  phenotypes  (Lijam  et  al.,  1997).  However,  this  may  reflect  a  redundancy 
amongst  the  3  mice  homologues  of  Dsh  (Dvll/2/3). 
21 At  least  three  conserved  domains  have  been  identified  in  Dsh,  the  N-terminal  DIX 
(dishevelled,  axin  interaction)  domain,  a  central  PDZ  (Postsynaptic  density  95,  discs  large, 
zonula  occludens-1)  domain  and  a  C-terminal  DEP  (dishevelled,  1-10,  Pleckstrin 
homology)  domain  (Boutros  and  Mlodzik,  1999).  The  DIX  domain  binds  to  the  C-terminus 
of  Axin,  which  also  possesses  a  DIX  domain,  whilst  the  PDZ  domain  appears  to  bind  Frati 
(frequently  rearranged  in  advanced  T-cell  lymphomas  1),  one  of  the  two  human 
homologues  of  GBP  (GSK-3  binding  protein)  (Li  et  al.,  1999).  The  DEP  domain  is  required 
for  planar  cell  polarity  (see  below),  but  not  Wg  signalling  (Axelrod  et  al.,  1998).  This 
supports  the  idea  that  Dsh  may  act  as  the  switch  between  Fz-mediated  cell  fate  and  Fz- 
mediated  planar  cell  polarity. 
1.3.2  Dishevelled  and  planar  cell  polarity 
Epithelial  cells  are  polarised  in  two  ways.  Apical-basal  polarity  distinguishes  the  top  and 
bottom  surfaces  of  the  epithelial  sheet,  and  planar  polarity  allows  cells  to  determine 
directions  in  the  plane  of  the  sheet.  Wnt  signalling  regulates  planar  cell  polarity  (or  PCP). 
Each  of  the  hexagonal  cells  that  comprise  the  Drosophila  wing  secrete  a  single  hair,  an 
actin-rich  plasma  membrane  projection.  Each  and  every  one  of  the  hairs  points  distally 
from  the  distal  cell  vertex.  Mutations,  which  disrupt  PCP,  orientate  the  polymerised  actin  in 
random  locations,  and  hence  the  hairs  point  in  all  directions. 
A  non-canonical  Wnt  pathway  appears  to  control  PCP  (Boutros  and  Mlodzik,  1999). 
Genetic  epistasis  experiments  have  suggested  the  involvement  of  the  small  GTPase  RhoA 
and  c-Jun  NH2-terminal  kinase  (JNK)  downstream  of  Fz  in  the  PCP  pathway.  Dsh  can 
activate  JNK  (Boutros  et  al.,  1998),  suggesting  that  Dsh  may  act  at  the  branch  point 
between  Wnt-mediated  cell  fate  and  Wnt-mediated  PCP.  In  addition,  Axin  has  been  shown 
to  interact  with  MEKK1,  dimerising  to  activate  JNK  signalling  (Zhang  et  al.,  1999).  The 
22 involvement  of  both  Dsh  and  Axin  raises  the  possibility  that  an  interaction  between  the  two 
may  be  required  for  Dsh-mediated  control  of  PCP. 
1.3.3  Dishevelled  and  Notch 
Mutations  in  presenilin  (PS)  genes  are  associated  with  Alzheimer's  disease  (see  De  Ferrari 
and  Inestrosa,  2000).  PS  proteins  mediate  cleavage  of  the  C-terminal  domain  of  Notch. 
Notch  subsequently  enters  the  nucleus  to  regulate  transcription.  Genetic  epistasis 
experiments  have  suggested  that  Dsh  interacts  antagonistically  with  Notch  and  Dsh  has 
been  shown  to  bind  the  cytoplasmic  tail  of  Notch  in  a  yeast  two-hybrid  system  (Axelrod  et 
al.,  1996). 
1.4  ß-catenin  and  TCF/LEF-1 
Along  with  GSK-3,  these  two  proteins  define  the  canonical  Wnt  pathway.  It  is  the 
interaction  of  (3-catenin  with  HMG-box  transcription  factors  of  the  TCF/LEF-1  family  that 
leads  to  the  activation  of  Wnt  target  genes  such  as  cyclin  D  and  c-myc  (Huber  et  al., 
1996b).  Co-expression  of  ß-catenin  and  these  transcription  factors  leads  to  the 
accumulation  of  ß-catenin  in  the  nucleus.  Mutations  to  Pangolin  (Pan)  -  the  Drosophila 
LEF  homologue  -  that  block  binding  to  Armadillo,  reduce  Wg  signalling  in  vivo  (Brunner 
et  al.,  1997).  In  Xenopus,  injection  of  RNA  encoding  a  mutant  form  of  XTcf-3  (the  LEF-1 
homologue)  that  cannot  bind  f3-catenin  acts  as  a  dominant  negative  (Molenaar  et  al.,  1996). 
This,  along  with  the  finding  that  ß-catenin  accumulates  in  the  nucleus  upon  Wnt 
stimulation,  led  to  the  idea  that  Wnts  induce  the  accumulation  of  a  ß-catenin/TCF  complex 
in  the  nucleus  (Huber  et  al.,  1996a).  Further  extrapolation  of  these  findings  led  to  the 
hypothesis  that  the  ß-catenin/TCF  complex  acts  as  a  composite  transcription  factor,  where 
TCF  provides  the  site-specific  DNA  binding  and  ß-catenin  activates  the  transcription  of 
target  genes  bound  by  the  complex  (van  de  Wetering  et  al.,  1997). 
23 In  addition  to  ß-catenin,  a  second  protein,  Pygopus  (Pygo),  that  is  required  for  TCF- 
mediated  transcription  has  recently  been  discovered  in  Drosophila;  and  possesses  two 
homologues  in  humans  and  one  in  Xenopus  (Belenkaya  et  al.,  2002;  Kramps  et  al.,  2002; 
Parker  et  al.,  2002;  Thompson  et  al.,  2002).  Mutations  to  Pygo  carry  the  Wg  phenotype, 
and  the  protein  is  required  for  TCF-mediated  transcription  but  not  the  stabilisation  of  ß- 
catenin.  Pygo  is  a  nuclear  protein  that  is  found  complexed  with  the  ß-catenin  homologue 
Armadillo,  in  Drosophila.  The  amino  acid  sequence  identifies  a  PHD  domain,  suggesting  a 
function  in  chromatin  remodelling.  In  addition,  the  Drosophila  BCL9  homologue  Legless 
(Lgs)  appears  to  be  required  for  the  recruitment  of  Pygo  to  the  0-catenin-TCF  complex 
(Kramps  et  al.,  2002).  An  alternative  hypothesis  to  the  widely-accepted  ß-catenin/TCF 
transcription  factor  model  has  recently  emerged  (Chan  and  Struhl,  2002).  This  new  model 
suggests  that  ß-catenin  may  transduce  Wnt  signals  by  exporting  TCF  from  the  nucleus  or 
by  activating  it  in  the  cytoplasm. 
In  the  absence  of  a  Wnt  signal,  ß-catenin  is  phosphorylated  in  a  complex  with  Axin,  GSK- 
3,  CKW  and  APC.  Mutations  at  four  Ser  and  Thr  residues  in  the  N-terminus  of  ß-catenin, 
are  prevalent  in  several  types  of  human  carcinoma  (Korinek  et  al.,  1997;  Morin  et  al.,  1997; 
Rubinfeld  et  at.,  1997).  It  is  the  phosphorylation  of  Ser-33  and  Ser-37  by  GSK-3  that 
targets  ß-catenin  for  ubiquitination,  facilitating  the  binding  of  the  F-box  protein  3Trcp,  and 
leading  to  proteosome-mediated  degradation  (Orford  et  al.,  1997;  Aberle  et  al.,  1997;  Liu  et 
at.,  1999). 
The  Dropsohila  gene  slimb,  which  contains  and  F-box  and  WD-40  repeats,  negatively 
regulates  Wg  signalling  (Jiang  and  Struhl,  1998).  Proteins  containing  F-boxes  are  thought 
to  serve  as  adaptor  molecules,  with  the  F-box  binding  to  the  E3  ubiquitin  ligase.  Studies  in 
Xenopus  revealed  that  the  F-box/WD40-repeat  protein  ß-Trcp  bridges  phosphorylated  ß- 
24 catenin  and  the  E3  ubiquitin  ligase  Skpl,  targeting  it  for  breakdown  via  the  proteasome 
(Liu  et  al.,  1999). 
More  recently,  Siah-1,  the  human  homologue  of  Drosophila  seven  in  absentia  has  been 
shown  to  mediate  a  novel  ß-catenin  degradation  pathway  (Liu  et  al.,  2001a).  Siah  proteins 
have  a  short  half-life  and  are  normally  kept  at  a  low  level  within  the  cell  (Hu  and  Fearon, 
1999).  Activation  of  the  tumour  suppressor  protein  p53  is  thought  to  stabilise  Siah-1. 
Breakdown  of  ß-catenin  following  p53  activation  has  previously  been  reported  (Sadot  et 
al.,  2001).  Siah-1  binds  the  C-terminus  of  APC  and  a  second  protein  SIP  which,  like  3Trcp, 
is  able  to  bind  Skpl,  along  with  the  F-box  protein  Ebi  (Matsuzawa  and  Reed,  2001).  Ebi  is 
able  to  bind  to  (3-catenin,  in  a  non  phosphorylation-dependent  manner  and  APC  binds  to 
both  Siah-1  and  ß-catenin,  bridging  the  two  (Matsuzawa  and  Reed,  2001).  Figure  1.2 
highlights  these  two  ß-catenin  degradation  pathways. 
This  proposes  a  two-tiered  mechanism  for  the  destruction  of  ß-catenin.  In  the  canonical 
Wnt  Pathway,  ß-catenin  is  targeted  for  breakdown  following  phosphorylation  within  the  N- 
terminus  and  the  binding  of  the  F-box  protein  (3-Trcp.  Mutations  to  the  phosphate-accepting 
residues  in  the  N-terminus  of  ß-catenin  are  only  associated  with  a  small  number  of 
incidences  of  colon  cancer.  This  low  incidence  could  be  explained  by  the  discovery  of  this 
second,  p53-mediated,  ß-catenin  degradation  pathway.  Forms  of  ß-catenin  which  have 
escaped  recognition  by  (3Trcp  become  bound  by  the  F-box  protein  Ebi,  again  at  the  N- 
terminus,  in  a  non-phosphorylation-dependent  manner  (for  a  review  of  both  (3Trcp  and  Ebi- 
mediated  ß-catenin  degradation,  see  Polakis,  2001). 
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Figure  1.2  Protein  interactions  in  the  degradation  of  ß-catenin 
R=  ring  domain,  F=  F-box,  MCR  =  mutation  cluster  region.  See  text  for  details. 
1.5  GSK-3 
The  Zeste-White-3/Shaggy  (Zw3/Shg)  serine/threonine  protein  kinase  of  Drosophila 
possesses  two  highly  homologous  mammalian  paralogues,  glycogen  synthase  kinase  3-a 
(GSK-3(x)  and  glycogen  synthase  kinase  3-0  (GSK-30).  The  two  kinases  were  named  due 
to  their  ability  to  phosphorylate  and  inactivate  glycogen  synthase,  although  roles  in  many 
other  signalling  pathways  have  now  been  shown  (Grimes  and  Jope,  2001;  Harwood,  2001). 
26 The  expression  pattern  of  the  two  are  highly  similar  (Woodgett,  1990),  but  only  GSK-30 
will  substitute  for  Shaggy  in  the  Wg  pathway  (Ruel  et  al.,  1993).  However,  GSK-3ß  knock- 
out  mice  develop  normally  up  until  birth,  suggesting  that  GSK-3a  can  partially  compensate 
for  the  loss  of  GSK-3ß.  (Hoeflich  et  al.,  2000).  All  future  reference  to  GSK-3  shall  refer  to 
the  ß  isoform,  as  it  remains  the  better  studied  with  reference  to  Wnt  signalling. 
Drosophila  genetics  has  established  that  Wg  acts  positively  on  Dsh  which  is  upstream  of 
Shaggy,  with  the  net  result  being  the  accumulation  of  Armadillo  (Arm),  the  Drosophila 
homologue  of  ß-catenin  (Cadigan  and  Nusse,  1997).  In  the  absence  of  Wg  signalling,  GSK- 
3  phosphorylates  Arm,  targeting  it  for  breakdown  via  the  3'proteasome. 
Efficient  phosphorylation  of  many  GSK-3  substrates  requires  the  presence  of  another 
phosphorylated  residue,  optimally  located  four  amino  acids  C-terminal  to  the  GSK-3  target 
site  (Frame  and  Cohen,  2001).  The  newly  phosphorylated  residue  may  then  prime  a  further 
GSK-3  phosphorylation  event  and  this  may  continue  until  there  ceases  to  be  an 
appropriately  positioned  serine  or  threonine  residue.  This  type  of  phosphorylation  cascade 
is  thought  to  be  the  mechanism  by  which  GSK-3  regulates  0-catenin  via  phosphorylation  at 
its  N-terminus.  In  addition  to  phosphorylating  0-catenin,  GSK-3  also  phosphorylates  and 
stabilises  Axin  and  also  phosphorylates  APC,  which  promotes  its  binding  with  ß-catenin 
(Rubinfeld  et  al.,  1996;  Yamamoto  et  al.,  1999). 
A  >50%  reduction  in  activity  is  seen  in  GSK-3  purified  from  cells  treated  with  Wg- 
conditioned  medium  (Cook  et  al.,  1996),  but  the  exact  mechanism  of  GSK-3  inhibition  in 
the  Wnt  pathway  is  not  entirely  clear.  Several  mechanisms  of  GSK-3  regulation  have  been 
demonstrated.  Phosphorylation  at  Tyr-216  is  thought  to  be  essential  for  GSK-30  function, 
27 and  so  the  action  of  a  phosphatase  would  reduce  GSK-3  activity.  However,  there  is  no 
evidence  to  suggest  that  a  phosphatase  inactivates  GSK-3  in  the  Wnt  pathway. 
GSK-3  is  also  inactivated  via  phosphorylation  at  Ser-9  and  several  kinases  have  been 
shown  to  phosphorylate  GSK-3  at  this  position.  These  include;  cAMP-dependent  protein 
kinase  (PKA);  PKB/Akt,  protein  kinase  C  (PKC);  and  p70  S6  kinase  and  p90Rsk  (Cross  et 
al.,  1995;  Eldar-Finkelman  et  al.,  1995;  Fang  et  al.,  2000;  Goode  et  al.,  1992;  Sutherland  et 
al.,  1993).  GSK-3  is  central  to  the  insulin  signalling  pathway,  where  it  is  inactivated 
following  phosphorylation  at  Ser-9  by  PKB/Akt  (Cross  et  al.,  1995).  However,  PKB 
activity  is  insufficient  to  significantly  increase  TCF-dependent  transcription  (Ding  et  al., 
2000).  Wg-induced  inactivation  of  GSK-3  is  sensitive  to  the  PKC  inhibitor  Ro31-8220 
(Cook  et  al.,  1996).  This  could,  of  course,  be  via  phosphorylation  of  a  second  protein;  for 
example,  Dvl,  although  the  in  vitro  data  supports  a  more  direct  interaction.  Dvl  does 
however,  have  a  putative  PKC  binding  site  in  its  DEP  domain.  (Mudher  et  al.,  2001). 
It  may  be  that  a  change  in  the  subcellular  localisation  of  GSK-3  is  responsible  for  the  loss 
of  ß-catenin  phosphorylation  following  Writ  signalling,  or  maybe  it  is  a  combination  of  this 
and  direct  inactivation.  It  has  already  been  established  that  Dvl  binds  both  Axin  and  Fratl. 
Axin  and  Fratl  also  bind  GSK-3  (Li  et  al.,  1999;  Yost  et  al.,  1996).  Dvl,  Axin  and  GSK-3 
can  form  a  ternary  complex,  where  Axin  acts  as  a  bridge  for  the  other  two  proteins.  Fratl 
can  be  recruited  to  the  complex,  probably  by  Dvl.  The  finding  that  the  Dvl  binding  domain 
of  either  Fratl  or  Axin  will  inhibit  Wnt  induction  of  downstream  target  genes  suggests  that 
their  interactions  with  GSK-3  may  be  an  important  step  in  the  pathway  (Li  et  al.,  1999). 
Exactly  how  Fratl,  Axin  and  Dvl  bring  about  Wg-induced  inactivation  of  GSK-3  remains 
unclear.  The  Dvl  binding  site  of  Axin  overlaps  with  the  ß-catenin  binding  site  (Julius  et  al., 
2000),  which  suggests  a  mechanism  whereby  Dvl  competes  with  3-catenin  for  binding  to 
28 Axin  following  Wnt  stimulation.  GSK-3  would  become  separated  from  ß-catenin,  allowing 
levels  of  the  latter  to  rise. 
In  addition  to  Dishevelled  and  Axin,  GBP  (GSK-3  Binding  Protein)/Frat  (frequently 
rearranged  in  advanced  T-cell  lymphomas)  also  binds  GSK-3.  A  role  for  GBP/Frat  in  the 
Wnt  pathway  was  proposed  following  the  discovery  that  in  addition  to  binding  GSK-3,  the 
protein  also  interacts  with  Dishevelled  (Li  et  al.,  1999).  A  role  for  GBP/Frat  in  the  nuclear 
export  of  GSK-3  has  recently  been  proposed,  following  the  finding  that  Frat-binding 
mutants  of  GSK-3  accumulate  in  the  nucleus  and  a  peptide  of  Frat  that  competes  for 
binding  with  GSK-3  causes  endogenous  GSK-3  to  accumulate  in  the  nucleus  (Franca-Koh 
et  al.,  2002). 
The  current  model  for  Frat  action  proposes  that  Dishevelled  recruits  Frat  to  the  Axin 
complex  following  Wnt  stimulation.  Frat  then  titrates  GSK-3  from  Axin,  inhibiting  GSK-3 
dependent  phosphorylation  of  ß-catenin,  allowing  levels  of  the  latter  to  rise  (Li  et  al.,  1999; 
Salic  et  al.,  2000).  To  date,  no  change  in  the  localisation  of  Frat  or  GSK-3  has  been 
observed  following  stimulation  of  cells  with  either  Wnt  or  insulin. 
1.6  Protein  Phosphatase  2A  (PP2A) 
The  association  of  PP2A  with  the  Wnt  pathway  arose  from  the  observation  that  it  will  bind 
the  C-terminus  of  Axin  in  vitro  (Hsu  et  al.,  1999).  This  suggested  that  PP2A  may  interact 
with  the  Axin/APC/GSK-3/0-catenin  complex  to  modulate  the  effect  of  GSK-3 
phosphorylation  of  ß-catenin  and/or  other  proteins. 
29 The  PR61  subunit  of  PP2A  has  been  shown  to  inhibit  ß-catenin-dependent  TCF  activation 
and  Xenopus  axis  duplication,  without  dephosphorylation  of  Axin  or  ß-catenin  degradation 
(Yamamoto  et  al.,  2001).  The  exact  target  of  PP2A  in  the  Writ  pathway  remains  unclear. 
1.7  Casein  Kinase  1 
Two  Casein  Kinase  1  family  members  appear  to  be  active  in  the  Wnt  pathway.  Casein 
Kinase  lE  (CK1c)  is  a  positive  regulator  of  Wnt  signalling.  Overexpression  of  CK1E 
mimics  Wnt  signalling,  inducing  a  secondary  axis  in  Xenopus,  stabilising  ß-catenin  and 
stimulating  gene  expression  (Sakanaka  et  al.,  1999).  Both  kinase-dead  CK1E  and  anti-sense 
CK1E  inhibit  Wnt  signalling.  Furthermore,  CK1c  has  been  found  in  a  complex  with  Axin 
and  Dishevelled  (Sakanaka  et  al.,  1999).  The  kinase  is  brought  into  the  complex  by  the 
ankyrin  repeat  protein  Diversin  (Schwarz-Romond  et  al.,  2002). 
Phosphorylation  of  Ser-33  and  Ser-37  of  ß-catenin  is  dependent  on  prior  phosphorylation  of 
residues  Thr-41  and  Ser-45  (van  Noort  et  al.,  2002).  Despite  Ser-45  being  the  most  frequent 
tumour  mutation  spot  (Polakis,  2000),  GSK-3  is  unable  to  phosphorylate  this  residue  in 
vitro  (Hagen  and  Vidal-Puig,  2002).  CK1a  can  phosphorylate  ß-catenin  in  vitro  at  Ser-45, 
in  an  Axin-dependent  manner  (Liu  et  al.,  2002;  Amit  et  al.,  2002).  CK1a  phosphorylation 
of  Ser-45  is  both  necessary  and  sufficient  to  prime  the  GSK-3-mediated  phosphorylation  of 
Thr-41.  Furthermore,  CKla  phosphorylation  of  ß-catenin  has  been  shown  to  be  inhibited 
by  Wnt.  This  suggests  a  mechanism  where  in  the  absence  of  Wnt  stimulation,  Axin 
facilitates  CK1a  phosphorylation  of  ß-catenin  at  Ser-45,  initiating  a  GSK-3 
phosphorylation  cascade  ending  at  Ser-33.3Trcp  is  then  able  to  bind  ubiquitinated 
catenin,  targeting  it  for  breakdown  via  the  proteosome. 
30 1.8  Axin  and  APC 
Axin  is  the  product  of  the  fused  locus.  Mutations  have  pleiotropic  effects  on  development, 
including  the  formation  of  axial  duplications  in  homozygous  vertebrate  embryos  (Zeng  et 
al.,  1997).  Axin  shows  similarity  to  RGS  (regulators  of  G-protein  signalling)  proteins  and 
to  the  N-teminus  of  Dsh  proteins.  Injection  of  Axin  mRNA  inhibits  dorsal  axis  formation  in 
Xenopus  embryos  by  interfering  with  Writ  signalling  (Zeng  et  al.,  1997).  Ectopic  expression 
in  dorsal  blastomeres  of  Xenopus  embryos  causes  ventralisation,  indicating  an  inhibitory 
function  in  normal  axis  formation.  Conversely,  ventral  injection  of  RNA  encoding  a  mutant 
Axin  lacking  the  RGS  domain  leads  to  axis  duplication,  suggesting  that  this  mutant  is  a 
dominant-negative.  Co-injection  of  Axin  RNA  with  the  RNA  of  Writ  pathway  components 
reveals  that  it  acts  downsteam  of  Wnt,  Dsh,  and  GSK-3  but  upstream  of  ß-catenin  (Fagotto 
et  al.,  1999). 
What  is  the  mechanism  by  which  Axin  inhibits  axis  duplication?  The  Axin  protein  contains 
binding  sites  for  both  GSK-3  and  ß-catenin,  with  all  three  forming  a  ternary  complex  when 
co-expressed  in  COS  cells  (Ikeda  et  al.,  1998).  GSK-3  does  not  significantly  phosphorylate 
ß-catenin  in  vitro  (Rubinfeld  et  al.,  1996).  However,  the  addition  of  Axin  significantly 
increases  GSK-3  phosphorylation  of  (3-catenin  in  vitro  (Ikeda  et  al.,  1998),  suggesting  that 
at  least  one  of  the  roles  of  Axin  is  to  enhance  GSK-3  phosphorylation  of  ß-catenin.  This 
could  be  through  bringing  GSK-3,  CKlet  and  0-catenin  together. 
Conductin  is  a  paralogue  of  Axin,  sharing  45%  amino  acid  identity  (Behrens  et  al.,  1998). 
Biochemically  it  behaves  like  Axin,  promoting  the  degradation  of  J  -catenin.  Unlike  Axin 
though,  Conductin  is  selectively  expressed  in  the  mouse  embryo  (Behrens  et  al.,  1998). 
Conductin  is  upregulated  in  colonic  and  hepatocellular  carcinomas  (Lustig  et  al.,  2002). 
Furthermore,  Conductin  expression  in  colorectal  tumour  cells  can  be  blocked  through  the 
31 expression  of  dominant-negative  TCF,  and  is  upregulated  following  Wnt-1  stimulation  of 
cultured  cells  or  in  Min  mice  (mice  null  for  APC)  (Lustig  et  al.,  2002).  The  evidence  to  date 
therefore  suggests  that  Conductin  itself  is  a  target  of  Wnt  signalling,  acting  in  a  negative 
feedback  loop.  In  a  normal  cell,  Conductin  can  scaffold  ß-catenin  into  the  degradation 
complex  containing  GSK-3,  promoting  ß-catenin  breakdown.  Wnt-1  stimulation  stabilises 
ß-catenin,  allowing  it  to  complex  with  TCF  and  activate  target  genes,  one  of  which  is 
Conductin,  a  negative  regulator  of  ß-catenin. 
Mutations  in  the  APC  (adenomatous  Polyposis  coli)  gene  are  responsible  for  up  to  80%  of 
both  inherited  and  sporadic  forms  of  colon  cancer  (Miyoshi  et  al.,  1992).  The  APC  gene 
encodes  a  large  (approximately  310kDa)  protein  with  several  distinct  motifs;  namely,  an  N- 
terminal  oligomerisation  domain,  seven  armadillo  repeats,  three  repeats  of  15  amino  acids, 
seven  repeats  of  20  amino  acids,  and  a  basic  domain  (see  Polakis,  1999).  The  first  three  of 
the  20  amino  acid  repeats  of  APC  encompass  what  has  been  termed  the  mutation  cluster 
region  (MCR)  and  contains  the  majority  of  somatic  APC  mutations  seen  in  colon  cancer 
(Miyoshi  et  al.,  1992).  The  oligomerisation  domain  is  required  for  the  homodimerisation  of 
APC  molecules,  whilst  the  C-terminal  basic  domain  binds  microtubules.  It  is  the  15  amino 
acid  and  20  amino  acid  repeats  that  are  of  greatest  relevance  to  cancer.  The  three  15  amino 
acids  repeats  each  bind  ß-catenin  independently,  whilst  the  seven  20  amino  acid  repeats 
each  bind  ß-catenin  in  a  phosphorylation-dependent  manner.  It  is  the  deletion  of  four  or 
five  of  the  20  amino  acid  repeats  that  is  most  commonly  associated  with  incidents  of  colon 
cancer  (Polakis,  1997).  Experimental  deletions  to  APC,  showed  that  loss  of  ß-catenin 
regulation  occurred  as  the  3'  boundary  of  the  MCR  was  crossed.  However,  these  deletions 
also  represent  a  loss  of  2  of  the  3  binding  sites  for  Axin  (Behrens  et  al.,  1998),  suggesting 
another  route  to  ß-catenin  mis-regulation. 
32 The  over-expression  of  Axin  in  APC-mutant  cancer  cells  is  sufficient  to  downregulate  ß- 
catenin  (Hart  et  al.,  1998).  So  what  is  the  precise  role  that  APC  plays  in  the  downregulation 
of  (3-catenin?  Several  theories  exist  and  one  attractive  idea  has  resulted  from  the  in  vitro 
reconstruction  of  Axin-mediated  ß-catenin  degradation  (Salic  et  al.,  2000).  APC  may  be 
required  to  sequester  ß-catenin  throughout  the  cytoplasm,  or  may  bind  nuclear  ß-catenin 
and  transport  it  to  the  Axin  complex  (Bienz,  1999).  Two  pieces  of  evidence  support  this 
theory.  Firstly,  the  finding  that  APC  contains  nuclear  export  sequences  (Rosin-Arbesfeld  et 
al.,  2000)  and,  secondly,  APC  has  been  shown  to  move  along  microtubules  and  concentrate 
at  their  growing  ends  in  epithelial  cells  (Mimori-Kiyosue  et  al.,  2000). 
1.9  Wnt  signalling  in  Caenorhabditis  elegans 
Three  highly  divergent  ß-catenin  homologues  with  different  functions  have  been  identified 
in  C.  elegans:  WRM-1,  BAR-1  and  HMP-2.  (Korswagen  et  al.,  2000).  BAR-1  is  the  only 
one  that  interacts  with  the  TCF-like  transcription  factor  POP-1  to  activate  expression  of 
Wnt  target  genes.  WRM-1  activates  the  kinase  LIT-1/Nemo-like  kinase,  which  participates 
in  MAP  kinase  signalling  and  opposes  signalling  by  POP-1.  HMP-2  interacts  with  the  C. 
elegans  cadherin,  HMR-1  to  regulate  adhesion. 
A  non-canonical  Wnt  pathway  in  C.  elegans  is  required  for  the  control  of  asymmetric  cell 
divisions  (for  a  review,  see  Thorpe  et  al.,  2000).  The  Wnt  homologue  MOM-2  (more 
mesoderm-2)  binds  to  the  Fz  homologue  MOM-5,  to  activate  a  signalling  cascade  which  is 
required  for  the  induction  of  endoderm  in  the  early  embryo  (Rocheleau  et  al.,  1997;  Thorpe 
et  al.,  1997),  and  the  specification  of  several  asymmetric  cell  divisions  during  larval 
development  (Herman  and  Horvitz,  1994;  Herman  et  al.,  1995). 
33 A  mitogen-activated  protein  kinase  (MAPK)  pathway,  consisting  of  MOM-4/TAK1  and 
LIT-1/NLK,  acts  in  parallel  to  the  MOM-2/Wnt  pathway  to  downregulate  POP-1  levels 
(Kaletta  et  al.,  1997;  Meneghini  et  al.,  1999;  Rocheleau  et  al.,  1999).  The  reduction  in  POP- 
1  levels  leads  to  derepression  of  end-1  and  the  induction  of  endoderm  development  (Lin  et 
al.,  1995).  Therefore,  instead  of  turning  POP-1/TCF  into  a  transcritional  activator,  the 
MOM-2IWnt/MAPK  pathway  blocks  the  repressive  function  of  POP-1.  Figure  1.3 
illustrates  this  non-canonical  Wnt  pathway. 
BAR-1  has  been  shown  to  bind  PRY-1,  the  C.  elegans  Axin  homologue,  and  regulate  a 
second  and  more  canonical  Wnt  pathway  (Korswagen  et  al.,  2002).  This  suggests  that  two 
parallel  pathways,  one  canonical  and  one  non-canonical,  transduce  Wnt  signals  in  worms 
(see  Korswagen,  2002). 
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Figure  1.3  Non-canonical  Wnt  signalling  in  C.  elegans 
MOM-2/Wnt  signalling,  in  combination  with  a  MAPK  pathway,  leads  to  depression  of  end- 
1.  WRM-1  and  LIT-1/NLK  form  a  complex  that  is  activated  by  MOM-4/TAK1  to 
phosphorylate  and  inactivate  POP-1.  Both  the  GSK-3  homologue  SGG-1  and  the  APC 
related  protein  APR-1  appear  to  function  as  positive  regulators  of  the  pathway. 
35 1.10  ß-catenin  and  cell-cell  adhesion 
1.10.1  Adhesion  defects  associated  with  the  loss  of  ß-catenin  or  E-cadherin 
The  loss  of  zygotic  DE-cadherin  (the  Drosophila  homologue  of  E-cadherin)  is  associated 
with  the  reduction  of  morhogenetic  movements,  the  disintegration  of  the  malpighian  tube 
into  small  spherical  structures  and  the  blocking  of  the  tracheal  network  (Cox  et  al.,  1996; 
Uemura  et  al.,  1996). 
In  Drosophila,  mutations  to  germ  line  arm  lead  to  the  production  of  small  eggs,  which  is 
presumed  to  be  from  a  lack  of  resistance  to  the  pressure  exerted  by  the  muscular 
contractions  of  the  egg  chamber,  associated  with  a  loss  of  adhesion  (Peifer  et  al.,  1993).  In 
addition,  mutations  to  arm  leads  to  the  loss  of  adhesion  between  the  germ  cells,  but  not  the 
follicle  cells,  which  leads  to  an  incorrectly  positioned  oocyte  (Peifer  et  al.,  1993). 
ß-catenin  knock-out  mice  show  defects  in  the  development  of  the  embryonic  ectoderm. 
Cells  detach  from  the  ectodermal  layer  and  become  dispersed  into  the  proamniotic  cavity 
(Haegel  et  al.,  1995).  In  addition,  knock-out  mice  fail  to  form  mesoderm. 
1.10.2  ß-catenin  and  adherens  junctions 
Regulated  cell-cell  adhesion  is  crucial  in  the  development  of  a  multicellular  organism. 
Intercellular  junctions  usually  form  at  sites  of  cell-cell  contact  between  neighbouring  cells; 
epithelial  cells  are  connected  by  a  combination  of  different  adhesive  structures  (see  figure 
1.4).  Near  to  the  apical  surface,  tight  junctions  create  a  seal  between  adjacent  cells 
restricting  the  movement  of  molecules  between  them.  Below  the  tight  junctions  are  the 
adherens  junctions,  which  join  the  actin  cytoskeleton  of  adjacent  cells,  forming  an  adhesion 
belt,  also  known  as  the  zonula  adherens.  Nearer  to  the  basal  surface  are  the  desmosomes 
and  the  gap  junctions.  The  desmosomes  join  the  intermediate  filaments  of  adjacent  cells, 
36 whilst  the  gap  junctions  contain  channels  that  allow  small  molecules  and  ions  to  pass  from 
one  cell  to  another,  rather  like  the  plasmodesmata  of  plants.  The  hemidesmosomes  anchor 
the  intermediate  filaments  inside  the  cell  to  the  basal  lamina. 
Cadherin  molecules  play  essential  roles  in  development,  cell  polarity  and  tissue 
morphology  (Takeichi,  1991).  E-cadherin  has  an  extracellular  domain  of  five  cadherin-type 
repeats.  It  is  these  repeats  that  interact  in  a  calcium-dependent  fashion  with  the  cadherin 
molecules  on  opposing  cell  surfaces  to  regulate  cell  adhesion  (Nagar  et  al.,  1996).  The 
cytoplasmic  domain  of  E-cadherin  was  found  to  associate  with  a-,  0-  and  y-catenin  (Ozawa 
et  al.,  1989). 
The  binding  of  ß-catenin  to  the  cytoplasmic  tail  of  E-cadherin  introduces  a-catenin  to  the 
adherens  junction  complex  (for  a  review,  see  Nagafuchi,  2001).  a-catenin,  in  turn,  links 
with  the  actin  cytoskeleton.  y-catenin,  or  plakoglobin,  is  a  paralogue  of  (3-catenin,  sharing 
high  sequence  similarity  (Cowin  et  al,  1986).  Plakoglobin  is  mainly  found  localised  at 
desmosomes,  where  it  binds  the  desmosomal  cadherin  proteins,  desmogleins  and 
desmocollins.  Plakoglobin  is  also  able  to  bind  to  E-cadherin,  but  with  weaker  affinity  than 
ß-catenin  (Knudsen  and  Wheelok,  1992;  Peifer  et  al,  1992). 
The  importance  of  ß-catenin  localisation  at  the  adherens  junctions  is  two-fold;  (1)  It  is 
required  for  maintaining  the  integrity  of  the  adherens  junctions:  loss  of  ß-catenin  from 
adherens  junctions  leads  to  reduced  adhesion  and  thus  increased  invasiveness  and 
metastasis  of  tumour  cells  (Birchmeier  et  al.,  1993);  (2)  When  not  bound  to  E-cadherin,  13- 
catenin  can  move  to  the  nucleus  and  activate  target  genes  of  the  Wnt  pathway,  another 
possible  factor  in  the  progression  of  certain  types  of  tumour. 
37 Figure  1.4  Schematic  of  epithelial  cell  junctions,  highlighting  the  major  protein 
components 
E-cadherin  cell  adhesion  molecules  bind  homophilically  to  one  another,  to  connect  adjacent 
cells.  ß-catenin  links  the  cadherin  molecules  with  the  actin  cytoskeleton  via  a-catenin,  to 
provide  a  continuous  belt  of  actin  across  the  epithelium. 
1.10.3  Tyrosine  phosphorylation  of  ß-catenin 
There  is  no  evidence  that  phosphorylation  of  ß-catenin  by  GSK-3  plays  a  role  in  its  binding 
at  adherens  junctions.  However,  tyrosine  phosphorylation  (at  Tyr-654)  has  been  shown  to 
decrease  the  interaction  of  ß-catenin  with  E-cadherin  in  vivo  (Kinch  and  Burridge,  1995; 
Roura  et  al.,  1999).  Elucidation  of  the  crystal  structure  of  the  ß-catenin/E-cadherin  complex 
demonstrated  that  Tyr-654  is  a  key  residue  in  this  interaction  (Huber  and  Weis,  2001). 
p120-catenin  is  a  further  catenin  molecule  often  found  associated  with  the  adherens 
junctions,  and  was  originally  identified  as  a  substrate  for  the  pp60src  Tyr  kinase  (Kanner  et 
38 al.,  1991).  In  addition,  pp60`-"  Tyr  kinase,  or  its  viral  homologue  pp60v-$`°,  has  been. 
reported  to  promote  the  dissociation  of  the  adherens  junction  complex  and  will 
phosphorylate  ß-catenin  in  vitro  (Roura  et  al.,  1999).  However,  this  does  not  exclude  the 
possibility  that  pp60`-"c  could  activate  another  Tyr  kinase  responsible  for  the 
phosphorylation  of  ß-catenin.  For  example,  the  Fer  kinase  and  the  EGF  receptor,  which  are 
both  Tyr  kinases  associated  with  ß-catenin  (Rosato  et  al.,  1998;  Shibamoto  et  al.,  1994). 
The  implication  of  src  Tyr  kinases  and  EGF  signalling  in  the  dissociation  of  ß-catenin  from 
adherens  junctions  would  propose  further  ways  in  which  (3-catenin  can  promote 
oncogenesis. 
1.11  Dictyostelium  discoideum 
The  cellular  slime  mould  Dictyostelium  discoideum  is  a  simple  eukaryote  that  undergoes  a 
programme  of  multicellular  development  with  similarities  to  that  of  animal  development. 
Cells  grow  as  unicellular  amoebae  and  divide  with  a  short  generation  time,  making  it 
simple  to  obtain  large  numbers  for  use  in  biochemical  assays.  A  34Mb  haploid  genome 
makes  Diclyostelium  genetically  tractable  and  a  cDNA  sequencing  project  has,  to  date, 
yielded  6,400  independent  sequences,  which  represents  70-80%  of  all  of  the  expected  genes 
(Urushihara,  2002). 
1.11.1  Dictyostelium  development 
It  is  the  starvation  of  Dictyostelium  that  initiates  the  developmental  programme,  leading  to 
multicellularity.  Hemispherical  mounds  of  approximately  100,000  amoebae  form  following 
cAMP-induced  chemotaxis.  From  the  mound,  a  small  tip  appears  which  extends  until  a 
finger-like  structure,  the  slug,  is  produced.  The  slug  then  falls  over  and,  guided  by  photo- 
and  thermotaxis,  migrates  to  the  soil  surface  in  order  to  produce  a  fruiting  body.  See  figure 
1.5  for  the  timing  of  events. 
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Figure  1.5  Dictyostelium  development 
In  the  presence  of  a  plentiful  food  source,  amoebae  grow  and  divide.  Upon  starvation, 
cells  coalesce  into  adherent  cell  'streams'  which  tighten  to  form  the  mound.  The  'tip'  then 
develops  from  the  mound  and  extends  to  make  a  slug,  which  will  either  culminate,  or 
migrate  until  conditions  are  more  favourable  for  making  a  fruiting  body.  (Figure 
reproduced  with  permission  from  A.  J.  Harwood). 
40 The  natural  habitat  of  Dictyostelium  discoideum  is  the  forest  floor;  they  were  first  isolated 
from  decaying  leaves  in  North  America  by  Kenneth  Raper  in  1935  (Raper,  1935). 
Dictyostelium  amoebae  usually  feed  on  bacteria.  They  sense  the  onset  of  starvation  via  the 
secreted  factor  PSF  (prestarvation  factor).  PSF  is  required  for  the  expression  of  early 
starvation  genes  (Rathi  and  Clarke,  1992).  Amoebae  synthesise  PSF  during  the  growth 
phase  and  it  accumulates  in  the  surrounding  microenvironment.  However,  the  gene 
inductive  effect  of  PSF  is  inhibited  by  the  presence  of  bacteria.  In  the  absence  of  a  food 
source  PSF  accumulates,  which  results  in  the  upregulation  of  the  cAMP-dependent  protein 
kinase  (PKA).  PKA  activity  is  required  for  the  upregulation  of  several  genes,  including 
adenylyl  cyclase  A  (aca)  and  the  cAMP  receptor  cAR1  (Schulkes  and  Schaap,  1995).  The 
activation  of  adenylyl  cyclase  leads  to  the  secretion  of  cAMP  in  the  nanomolar  range.  ACA 
becomes  activated  via  cAR1,  which  becomes  adapted  following  exposure  to  CAMP. 
Consequently,  ACA  becomes  inactive  until  extracellular  cAMP  is  removed  by 
phosphodiesterase  (PDE)  (see  Kimmel  and  Firtel,  1991).  This  leads  to  the  relay  of  cAMP 
pulses  across  the  field  of  aggregating  cells  (Van  Haastert,  1995).  In  addition  to  emitting 
cAMP  pulses,  cells  respond  to  cAMP  by  chemotaxing  towards  the  source,  hence  the  field 
of  developing  cells  move  towards  the  aggregation  centre. 
In  addition  to  the  cAMP  relay,  cells  also  need  to  sense  the  accumulation  of  a  secreted  factor 
called  CMF  (conditioned  medium  factor).  When  the  number  of  starving  cells  within  a 
10mm  proximity  reaches  the  required  density,  the  concentration  of  CMF  will  reach  a  level 
that  induces  cells  to  aggregate.  Once  an  aggregate  is  formed,  micromolar  levels  of  cAMP, 
in  combination  with  CMF,  induce  the  expression  of  prespore  and  prestalk  genes  (Gomer  et 
al.,  1991;  Mehdy  and  Firtel,  1985).  Within  the  slug,  the  posterior  two  thirds  are  composed 
of  prespore  cells,  whilst  the  anterior  third  is  composed  of  prestalk  cells.  These  two  cell 
types  will  subsequently  give  rise  to  the  spore  and  stalk  cells,  respectively,  of  the  mature 
41 fruiting  body  (MacWilliams  and  Bonner,  1979).  Once  the  slug  begins  to  culminate,  prestalk 
cells  in  the  tip  move  down  through  the  developing  prespore  mass  and  embed  into  the  basal 
disc  (see  Dormann  et  al.,  1996).  As  the  stalk  develops,  it  becomes  enclosed  in  a  protein- 
and  cellulose-containing  tube  (Grimson  et  al.,  1996).  As  the  prestalk  cells  enter  the  tube, 
they  become  terminally  differentiated,  forming  vacuolated  stalk  cells.  The  stalk  grows  by 
elongation,  via  the  addition  of  stalk  cells  to  its  top,  which  raises  the  spore  head  up  to  the  top 
of  the  stalk. 
Conditions  have  been  established  whereby,  in  the  absence  of  multicellularity,  spore  and 
stalk  cells  can  be  formed  in  monolayers  (Berks  and  Kay,  1988;  Town  et  al.,  1976).  This 
approach  has  led  to  the  discovery  of  further  factors  required  for  cell  differentiation  in 
Dictyostelium.  Differentiation-inducing  factor-1  (DIF-1)  is  a  small  chlorinated  alkyl 
phenone  required  for  the  determination  of  pre-stalk  cell  fate  (Kopachik  et  al.,  1983;  Morris 
et  al.,  1987).  DIF-1  promotes  the  differentiation  of  pre-stalk  cells,  whilst  repressing  the 
differentiation  of  pre-spore  cells  (Early  and  Williams,  1988). 
SDF-1  and  SDF-2  (spore  differentiation  factor  1&  2)  are  peptides  that  promote  terminal 
spore  differentiation  under  submerged  conditions  (Anjard  et  al.,  1997).  The  two  SDF 
peptides  appear  to  regulate  independent  pathways,  but  both  may  require  phosphorylation  by 
PKA  (Anjard  et  al.,  1997).  SDF-1  and  SDF-2  are  produced  and  secreted  at  different  times 
in  development  and  are  released  in  single  bursts,  which  may  represent  an  irreversible  step 
in  cell  differentiation  (Anjard  et  al.,  1998). 
Ore  sent-10,601) 
Ammonia  and  adenosine  both  affect  de  iatan.  Ammonia  accumulates  as  cells  develop, 
and  if  sufficient  levels  do  not  evaporate,  aggregation  is  delayed  and  slugs  will  migrate 
(Anjard  et  al.,  1997).  The  addition  of  well-buffered  substrates  leads  to  the  immediate 
42 production  of  a  fruiting  body,  thought  to  be  due  to  the  neutralisation  of  ammonia. 
Adenosine  is  thought  to  bind  cells  on  the  cARI  receptor  (Newell,  1982).  Binding  of 
adenosine  inhibits  the  cAMP  relay  and  blocks  adaptation  in  perfusion  experiments 
(Theibert  and  Devreotes,  1984).  Some  evidence  also  exists  for  a  role  in  later  development 
(Schaap  and  Wang,  1986). 
1.11.2  GSK-3  signalling  in  Dictyostelium 
The  Dictyostelium  GSK-3  homologue,  GskA,  has  been  shown  to  be  crucial  for  the  early 
prespore/prestalk  cell  patterning  event,  although  not  essential  for  cell  differentiation 
(Harwood  et  al.,  1995).  In  the  gskA  null  mutant,  the  prestalk  cell  population  is  grossly 
expanded  at  the  expense  of  the  prespore  cell  population  and  cAMP  repression  of  both  ecmB 
expression  (a  marker  of  pre-stalk  cells)  and  stalk  formation  is  lost  in  monolayer  culture 
(Harwood  et  al.,  1995).  A  rise  in  GskA  activity  is  seen  at  the  onset  of  multicellular 
development,  when  ecmB  and  pspA  (a  marker  of  pre-spore  cells)  are  first  expressed.  This 
increase  in  activity  is  mediated  by  the  cAMP  receptor  cAR3;  cAR3  null  mutants  have  many 
features  common  to  the  loss  of  gskA  (Plyte  et  at.,  1999).  The  Dictyostelium  tyrosine  kinase 
Zak-1  has  been  shown  to  increase  GSK-3  activity  in  vitro  and  is  required  for  the  increase  in 
GskA  activity  seen  in  development  (Kim  et  al.,  1999).  It  is  regulated  by  cAMP  via  cAR3 
and  mutants  also  have  effects  similar  to  loss  of  gskA.  Conversely,  loss  of  the  lower-affinity 
cAMP  receptor,  cAR4,  leads  to  greater  activity  of  GskA  and  prolonged  tyrosine 
phosphorylation  when  treated  with  cAMP  (Ginsburg  and  Kimmel,  1997;  Kim  et  al.,  2002). 
This  suggests  that  a  tyrosine  phosphatase  may  be  downstream  of  cAR4.  Figure  1.6 
illustrates  this  dual  regulation  of  GskA  by  cAMP. 
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Figure  1.6  cAMP  regulation  of  GskA 
cAMP  binding  at  the  cAR3  receptor  activates  GskA  via  the  tyrosine  kinase  ZAK-1.  GskA 
induces  pre-spore  gene  expression  whilst  at  the  same  time  inhibiting  pre-stalk  gene 
expression.  cAMP  binding  at  the  cAR4  receptor  inhibits  GskA  via  a  tyrosine  phosphatase. 
44 The  Axin  binding  motif  of  GSK-3  is  conserved  in  GskA  and  mutation  leads  to  a  reduction 
in  the  expression  of  the  prespore  gene  pspA  (Fraser  et  at.,  2002).  This  apparent  Axin- 
dependent  GSK-3-mediated  gene  expression  suggests  that  Axin  and  other  downstream 
components  of  the  Wnt  pathway  may  be  present  in  Dictyostelium. 
A  ß-catenin  homologue,  Aardvark  (Aar),  has  been  cloned  in  Dictyostelium  (Grimson  et  al., 
2000).  An  examination  of  the  Aar  sequence  reveals  the  presence  of  ten  armadillo  repeats 
(ß-catenin  has  12).  It  also  has  a  putative  ct-catenin  binding  site,  which  aligns  with  that  of  ß- 
catenin,  as  well  as  potential  GSK-3  phosphorylation  sites.  Aar  possesses  additional  N- 
terminal  sequence  compared  with  ß-catenin  and  lacks  the  C-terminal  trans-activation 
domain. 
Aar  is  required  for  pspA  expression  in  cell  suspension,  where  there  is  an  absence  of  cell 
contacts  (Grimson  et  al.,  2000).  This  shows  that  Aar,  like  ß-catenin,  is  a  signal  transduction 
molecule.  In  addition,  expression  of  pspA  is  both  delayed  and  reduced  during  development 
in  the  aar  null  mutant  and  aar  mutants  produce  50%  less  spores  than  wild  type  cells. 
Overexpression  of  Aar  in  the  gskA  null  mutant  fails  to  restore  high  pspA  expression, 
suggesting  that  the  GSK-3/ß-catenin  relationship  is  positive  in  Dictyostelium  (Grimson  et 
al.,  2000).  This  appears  similar  to  the  non-canonical  Wnt  pathway  of  C.  elegans  where 
GSK-3  acts  positively  on  WRM-1,  the  ß-catenin  homologue,  for  endoderm  induction 
(Korswagen,  2002). 
1.11.3  Aar  and  cell  adhesion 
As  with  ß-catenin,  in  addition  to  a  cell  signalling  function,  Aar  also  has  a  structural 
function  (Grimson  et  al.,  2000).  Aar  localises  to  cell-cell  contacts,  which  have  the 
morphology  of  adherens  junctions.  aar  mutants  develop,  but  fruiting  bodies  are 
45 mechanically  weak,  and  the  majority  collapse  onto  the  substratum.  Transmission  electron 
microscopy  of  longitudinal  sections  of  the  stalk  tube  reveal  a  loss  of  actin  from  the 
adherens  junctions  in  aar  mutant  fruiting  bodies,  further  supporting  a  role  for  Aar  in  the 
formation  of  Dictyostelium  adherens  junctions  (Grimson  et  al.,  2000).  Conversely, 
overexpression  of  aar  in  wild  type  cells  leads  to  the  mis-localisation  of  large  amounts  of 
actin  at  the  adherens  junctions,  causing  the  membrane  to  buckle.  This  results  in  the 
instability  of  fruiting  bodies,  but  the  phenotype  is  not  as  severe  as  the  aar  mutant. 
The  fruiting  body  of  wild  type  Dictyostelium  contains  just  one  single  stalk,  positioned  in 
the  centre  of  the  stalk  tube.  Stalk  cells  only  normally  differentiate  inside  the  stalk  tube,  but 
in  aar  mutant  fruiting  bodies  stalk  cells  can  differentiate  outside  of  the  stalk  tube  (Coates  et 
al.,  2002).  This  can  lead  to  the  formation  of  additional  stalks.  The  exact  mechanism  behind 
ectopic  stalk  formation  is  unclear.  One  possibility  is  that  the  loss  of  adherens  junctions 
associated  with  the  aar  mutant  disrupts  the  integrity  of  the  stalk  tube.  This  would  allow  the 
stalk-inducing  factor  to  escape,  giving  rise  to  the  formation  of  ectopic  stalks.  This 
illustrates  how  changes  in  structure  can  lead  to  effects  on  signalling. 
1.12  Aims  of  thesis 
The  observation  that  the  GskA-Aar  interaction  appears  to  mimic  that  of  the  GSK-3-WRM-1 
interaction  in  C.  elegans  was  an  interesting  one.  Further  analysis  of  the  Dictyostelium,  and 
other,  non-canonical  Wnt-like  signalling  pathways  may  reveal  important  findings  about 
both  the  evolution  and  function  of  these  pathways  in  mammalian  development. 
Whilst  the  structure  of  Aar  has  been  examined  at  the  sequence  level,  no  physiological 
relevance  has  been  attributed  to  features  such  as  the  putative  a-catenin  binding  and  GSK-3 
46 phosphorylation  sites.  At  the  outset  of  this  project,  the  following  questions  were  to  be 
addressed: 
9  Does  GskA  directly  phosphorylate  Aar? 
"  What  physiological  roles  can  be  assigned  to  the  various  features  of  the  Aar  sequence? 
"  What  does  the  subcellular  localisation  of  Aar  reveal  about  Aar  protein  function? 
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48 2.1  List  of  abbreviations  used 
aar,  Aar,  aar  Aardvark  gene,  protein  product  and  knock-out 
AEBSF  4-(2-Aminoethyl)benzenesulphonyl  Fluoride 
Ala  Alanine 
ampR  Ampicillin  resistant 
APS  Ammonium  persulphate 
Arg  Arginine 
bp  base  pairs 
BSA  Bovine  serum  albumin  (Fraction  V) 
°C  degrees  Celsius 
cAMP  Adenosine  3':  5'-cyclic  monophosphate 
cDNA  complementary  DNA 
Ci  Curie 
Cys  Cysteine 
dATP  2'-Deoxyadenosine  5'-triphosphate 
dCTP  2'-Deoxycytosine  5'-triphoshate 
ddHZO  Double  distilled  water  (Millipore) 
DEAE  Diethylaminoethanol 
DEPC  Diethyl  pyrocarbonate 
dGTP  2'-Deoxyguanosine  5'-triphosphate 
DIF  Differentiation  Inducing  Factor 
DMSO  Dimethyl  sulphoxide 
DNA  Deoxyribonucleic  acid 
DTT  DL-Dithiothreitol 
dTTP  Thymidine  5'-triphosphate 
ECL  Enhanced  chemiluminescence 
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W EDTA  Disodium  Ethylenediaminetetra-acetic  acid 
EGTA  Ethylene  Glycol-bis(B-aminoethylether)-N,  N,  N'N'-tetraacetic  acid 
g  gram 
Glu  Glutamic  acid 
Gly  Glycine 
His  Histidine 
His-tag  6x  histidine  epitope  tag 
hrp  Horseradish  peroxidase 
IgG  Immunoglobulin 
kb  kilobase 
kDa  kiloDalton 
I  litre 
Leu  Leucine 
M  molar 
MBq  Mega  bequerels 
m  metre 
m  (prefix)  milli  (10.3) 
µ  micro  (10-6) 
Met  Methionine 
min  minutes 
mol  moles 
MOPS  3-(N-Morpholino)propanesulphonid  acid 
mRNA  Messenger  RNA 
n  nano  (109) 
ODx  Optical  density  at  x  nm 
p  Pico  (10'12) 
50 32P  Radioactive  phosphorous 
PBS  Phosphate-buffered  saline 
PBST  PBS/0.1%  Tween-20 
pfu  Plaque-forming  units 
Phe  Phenylalanine 
Pro  Proline 
RNA  Ribonucleic  acid 
rpm  Revolutions  per  minute 
s  seconds 
SDS  Sodium  dodecyl  sulphate 
SDS-PAGE  SDS-polyacrylamide  gel  electrophoresis 
Ser  Serine 
SSC  Standard  sodium  citrate 
TBE  Tris/Borate/EDTA 
TE  Tris/EDTA 
TEM  Transmission  electron  microscopy 
TEMED  N'N'N'N'Tetramethylethylenediamine 
Thr  Threonine 
Tris  Tris  (hydroxymethyl)  methylamine 
TRITC  Tetramethylrhodamine  B  Isothiocyanate 
Tyr  Tyrosine 
UV  Ultraviolet 
V  Volt 
Val  Valine 
v/v  volume  for  volume 
w/v  weight  for  volume 
51 2.2  Dictyostelium  culture  and  transformation 
2.2.1  Cell  culture 
Vegetative  cells  were  grown  at  22°C,  either  on  lawns  of  Klebsiella  aerogenes  plated  on 
Sussman's  medium,  or  in  shaking  culture  in  axenic  medium  containing  0.1mg/ml 
streptomycin  (and  20.  tg/ml  G418  or  10  tg/ml  if  selecting  for  overexpressors  or  knock-outs, 
respectively).  Ax2  was  used  as  the  wild  type  strain  throughout  this  thesis. 
For  long  term  storage,  107  cells  or  more  were  resuspended  in  lml  horse  serum  containing 
5%  DMSO  in  a  2m1  cryovial  (Nunc)  and  slowly  frozen  at  -80°C,  before  being  transferred 
to  liquid  nitrogen  stores. 
2.2.2  Transformation  of  Dictyostelium  by  electroporation 
107  log  phase  (1-2x  106/ml)  cells  were  spun  out  of  axenic  medium  at  700g  for  4min  and 
washed  once  in  sterile  electroporation  buffer  (50mM  sucrose  in  KK2)  before  resuspension 
in  800gl  of  the  same  buffer.  The  cell  suspension  was  then  incubated  on  ice  for  10  min  and 
electroporated  in  50x4mm  electroporation  cuvettes  using  a  BioRad  Gene  Pulser  (at  1.6KV 
with  a  capacitance  of  3µF).  Cells  were  then  incubated  on  ice  for  10  min,  before  the  addition 
of  8µl  of  1mM  MgC12/lmM  CaC12  and  further  incubation  for  15  min  at  room  temperature 
(RT).  The  contents  of  each  cuvette  were  split  between  two  axenic  plates.  Media  containing 
20µg/ml  streptomycin  was  added.  After  24  hours,  the  media  was  replaced  with  media 
containing  20gg/ml  strep,  20µg/ml  G418  and  1%  (v/v)  heat-killed  E.  coli  (strain  B/R). 
2.3  Molecular  biology 
2.3.1  Agarose  gel  electrophoresis  of  DNA 
Agarose  gels  were  prepared  in  0.5xTBE  (see  section  2.6  for  recipe)  as  described  previously 
(Sambrook,  1989).  The  percentage  of  the  gel  was  determined  by  the  size  of  DNA  fragments 
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DNA  under  UV  light.  DNA  was  loaded  in  10%  (v/v)  DNA  loading  buffer.  1µg  of  size 
markers  was  also  loaded  (1kb  A.  digest,  Gibco). 
2.3.2  Amplification  of  DNA  by  Polymerase  Chain  Reaction  (PCR) 
5014  reactions  were  set  up  in  thin-walled  200µ1  tubes  (Radleys)  or  multiwell  plates  (Perkin 
Elmer),  as  follows: 
"  0.1µg  aar  plasmid  DNA  (or  ddHZO  control) 
"  0.2µl  of  lOOpmol4tl  5'  primer  (or  ddH2O  control) 
"  0.2µl  of  lOOpmol/gl  3'  primer  (or  ddH2O  control) 
"  5µl  of  dNTPs  (200µM  dATP,  dCTP,  dTTP  and  dGTP  -  Amersham  Pharmacia  Biotech), 
"  5µl  lx  Pfu  buffer  (Stratagene) 
"  2.5  units  of  Taq  polymerase  and  2.5  units  of  recombinant  Pfu  polymerase  (Stratagene) 
Volume  made  up  to  50µl  using  ddH2O 
For  a  standard  amplification  of  aar  DNA  up  to  2.5Kb  in  length,  the  DNA  was  denatured  at 
95°C  for  30s  then  subjected  to  28  cycles  of  95°C  for  30s,  55°C  for  30s,  65°C  for  5  min 
followed  by  a  final  extension  step  at  65°C  for  10  min  before  storage  at  4°C.  For 
amplification  of  larger  PCR  products,  extension  times  of  10  min  were  used  in  the  cycles. 
2.3.3  TOPO  Cloning  reactions 
All  PCR  products  were  cloned  into  the  pCRII-TOPO  vector  (Invitrogen)  and  subsequently 
transformed  into  TOP10  chemically  competent  E.  coli  (see  below).  The  TOPO  cloning 
reaction  utilises  the  3'  deoxyadenosine  overhang  of  Taq  amplified  PCR  products.  The 
linearised  pCR-II  vector  contains  overhanging  3'  deoxythymidine.  These  overhangs  ligate 
efficiently  with  the  PCR  products  due  to  the  activity  of  topoisomerase  which  is  covalently 
53 bound  to  the  vector.  Resulting  colonies  were  analysed  by  miniprep  and  digest  analysis  (see 
sections  2.3.6  and  2.3.7). 
2.3.4  Bacterial  permanents 
Glycerol  stocks  of  positive  colonies  were  made  by  the  addition  of  0.5m1  50:  50  (v/v)  L- 
broth/glycerol  to  0.5m1  of  the  overnight  culture;  stocks  were  stored  at  -80°C.  The  pCRII 
vector  contains  the  M13  and  T7  promoter  sites,  facilitating  the  sequencing  of  the  PCR 
insert. 
2.3.5  Plasmid  DNA  preparations  -  maxiprep 
For  large-scale  plasmid  DNA  preps,  QIAGEN  Plasmid  Maxi  kits  (Qiagen  Ltd)  were  used, 
which  employ  a  variation  on  the  alkaline  lysis  method  of  DNA  preparation.  These  kits 
utilise  columns  containing  anion-exchange  resin  to  covalently  bind  plasmid  DNA  to 
immobilised  diethylaminoethanol  (DEAE)  groups  over  a  wide  range  of  salt  conditions. 
In  brief,  plasmid-containing  E.  coli  cells  were  grown  overnight  in  a  250m1  L-broth  culture, 
supplemented  with  100µg/ml  ampicillin.  Cells  were  lysed  with  SDS  and  the  lysate  passed 
through  the  columns  by  gravity  flow.  Protein,  carbohydrates  and  small  metabolites  were 
washed  from  the  column  with  low-salt  buffers,  while  the  plasmid  DNA  remained  tightly 
bound.  Plasmid  DNA  was  then  eluted  with  a  high-salt  buffer.  Up  to  500µg  plasmid  DNA 
per  column  may  be  isolated  by  this  method.  (Glycerol  stocks  were  made  as  per  section 
2.3.4  and  stored  at  -80°C). 
2.3.6  Plasmid  DNA  preparations  -  miniprep 
For  smaller  scale  plasmid  preps,  requiring  sequencing  quality  DNA,  spin  miniprep  kits 
(MoBio  Laboratories  Inc.  )  were  used.  These  utilise  the  same  principle  as  the  QIAGEN 
54 Plasmid  Maxi  kits  to  purify  plasmid  DNA.  A  typical  yield  from  an  individual  prep  is  5- 
10µg  plasmid  DNA  from  a  1.5m1  bacterial  culture. 
Small-scale  DNA  plasmid  preps  for  all  applications  other  than  sequencing  were  carried  out 
via  the  rapid  boiling  method  (Harwood,  1996).  1.5m1  of  plasmid-containing  E.  coli  were 
spun  out  of  medium  by  centrifugation  for  lmin  at  12,000g  in  a  benchtop  centrifuge.  Pellets 
were  resuspended  in  l00µ1  of  lmg/ml  lysozyme/STET  mix  (see  section  2.6  for  STET 
recipe),  and  vortexed  to  break  up  the  pellet.  Samples  were  boiled  for  45s  and  centrifuged 
for  10  min  at  12,000g.  The  resulting  pellet  containing  the  cell  debris  (including  the  bacterial 
chromosome)  was  removed  and  the  plasmid  DNA  was  precipitated  by  the  addition  of  200µl 
of  isopropanol  and  centrifugation  for  5  min  at  12,000g.  The  pellet  was  then  washed  in  70% 
ethanol,  air-dried  for  10  min  and  resuspended  in  l00µ1  TE  buffer.  Typical  yields  of  1-5µg 
plasmid  DNA  are  obtained  via  this  method. 
2.3.7  Restriction  enzyme  digestion  analysis  of  plasmid  DNA 
0.1-1µg  of  DNA  was  usually  digested  with  lgl  of  appropriate  restriction  enzyme,  according 
to  the  manufacturers  instructions.  All  restriction  enzymes  were  obtained  commercially  from 
New  England  Biolabs  and  digests  were  performed  in  a  2Oµ1  volume  of  lx  appropriate 
manufacturer's  enzyme  buffer  for  lh  at  37°C.  For  analysis,  half  the  digest  was  added  to  1µl 
10x  DNA  loading  buffer  and  DNA  fragments  separated  on  TBE  agarose  gels. 
2.3.8  Gel  purification  of  DNA  fragments 
DNA  fragments  were  separated  on  0.8%  TBE/agarose  gels  and  the  relevant  bands  excised. 
DNA  was  purified  from  the  gel  bands  using  the  QlAquick  Gel  Extraction  Kit  (Qiagen  Ltd). 
In  brief,  gel  slices  were  melted  in  a  buffer  containing  guanidine  thiocyanate.  This  chelates 
55 the  water,  forcing  the  DNA  to  bind  to  a  silica  resin  contained  in  a  gravity-flow  column. 
Columns  were  then  ethanol  washed  before  elution  with  TE  buffer. 
2.3.9  Ligations  -  oligonucleotide  insertion 
For  the  creation  of  double  stranded  oligonucleotides,  0.1µg  of  each  strand  of  the 
oligonucleotides  were  annealed  at  60°C  for  Ih  in  a  volume  of  20µl  of  lx  T4  DNA  ligase 
buffer  (New  England  Biolabs). 
For  the  insertion  of  the  double-stranded  oligonucleotide  into  the  vector,  the  following 
ligation  reactions  were  set  up: 
Vector  (V)  Oligo  (0)  lOx  ligase  buffer  ddHZO  Molar  Ratio  (O:  V) 
1.5µ1  -  lµl  6.8µl  - 
1.5µ1  3µl  lµl  3.5µ1  approx.  50:  1 
1.5µl  6µl  1  tI  0.5µl  approx.  100:  1 
0.2µl  of  T4  DNA  ligase  (New  England  Biolabs)  was  added  to  each  ligation  reaction,  and 
incubated  at  room  temperature  for  2h. 
2.3.10  Ligations  -  standard  reaction 
For  ligation  of  larger  fragments  of  DNA  into  vectors,  20  µl  reactions  were  set  up  as  for 
oligonucleotide  insertion,  but  with  molar  ratios  of  2:  1  and  10:  1  (insert:  vector)  used  instead. 
2.3.11  Transformation  of  bacteria 
TOP1OTM  chemically  competent  Escherichia  coli  (Invitrogen)  were  transformed  as  per  the 
manufacturer's  instructions.  50µl  of  transformed  cells  were  spread  onto  LB  agar  plates 
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otherwise).  Single  transformed  colonies  were  picked  using  a  sterile  loop  and  inoculated 
into  L-Broth  with  appropriate  selection.  Cultures  were  shaken  at  37°C,  250rpm,  in  a  tube 
or  flask  at  least  4  times  the  volume  of  the  culture  to  ensure  good  aeration. 
2.3.12  Sequencing  and  analysis  of  DNA 
PCR  fragments  were  purified  away  from  the  PCR  reaction  using  spin  columns  (S400, 
Amersham  Pharmacia  Biotech),  according  to  the  manufacturer's  instructions.  1µg  plasmid 
DNA  or  5µg  PCR  product  was  sent  to  MWG  Biotech  Ltd  for  sequencing.  The  resulting 
sequencing  data  was  analysed  using  Lasergene  software  (DNAStar). 
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The  following  oligonucleotides  were  used  in  this  thesis: 
Oligo  Name  Use  Sequence  (5'-3') 
Xhol  5'  GFP  Primer  for  the  amplification  of  GFP  GGA  CGG  AGA  AGA 
from  pDNeoGFP,  adds  a  5'  XhoI  TGC  TCG  AGC  TTG 
site  for  insertion  into  pDXA-3C-aar  CAT  GCC  CAT  GAG 
XbaI  3'  GFP  Primer  for  the  amplification  of  GFP  CGA  GCT  CGA  GAT 
from  pDNeoGFP,  adds  a  3'  XbaI  CTA  GAT  ATC  GAT 
site  for  insertion  into  pDXA-3C-aar  GAA  TTC  GAG 
aar  5'  KpnI  ýN201  5'  primer  for  the  creation  of  Aar  GGT  ACC  TTA  GAA 
AN201,  used  with  `aar  3'  Xho1'.  GGT  ATA  GAA  GAT 
Adds  5'  KpnI  site  for  insertion  into  CAA  AAC  G 
DXA-3C. 
aar  5'  ATG  KpnI  AN258  5'  primer  for  the  creation  of  Aar  GGG  TAC  CAA  AAA 
AN258,  used  with  `aar  3'  XhoI'.  TGG  GTA  GCA  CTA 
Adds  5'  KpnI  site,  (followed  by  ATA  ACC  ACA  ACA 
ATG  for  insertion  into  pDXA-3C.  AC 
aar  5'  ATG  KpnI  i  N371  5'  primer  for  the  creation  of  Aar  GGG  TAC  CAA  AAA 
AN371,  used  with  `aar  3'  XhoI'.  TGT  CAA  GAT  GGT 
Adds  5'  KpnI  site,  (followed  by  CAA  ATC  CAA  C 
ATG)  for  insertion  into  pDXA-3C. 
aar  5'  ATG  KpnI  AN587  5'  primer  for  the  creation  of  Aar  GGG  TAC  CAA  AAA 
AN587,  used  with  `aar  3'  XhoI'.  TGA  GTG  CAA  AAG 
Adds  5'  KpnI  site,  (followed  by  AAG  GTG 
ATG)  for  insertion  into  pDXA-3C. 
aar  3'  XhoI  3'  primer  used  with  5'  Aar,  &N  ATA  ACT  CGA  GTT 
primers.  Adds  3'  Xhol  site  for  CCA  TCT  TCT  AAT 
insertion  into  DXA-3C-aar  GCT  ACT  TG 
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aar  5'  KpnI  5'  primer  used  with  3'  Aar  AC  GTC  CTA  ATG  GTA 
primers.  Adds  5'  KpnI  site  for  CCT  ACC  ACA  CCA 
insertion  into  pDXA-3C-aar  CAC  ACC  C 
aar  3'  Xhol  AC210  3'  primer  for  the  creation  of  Aar  CTG  ACT  CGA  GCA 
AC210,  used  with  `aar  5'  Kpnl'.  TCG  TTT  TGA  TCT 
Adds  3'  XhoI  site,  for  insertion  into  TCT  ATA  CCT  TC 
DXA-3C. 
aar  3'  XhoI  AC288  3'  primer  for  the  creation  of  Aar  GAT  TCT  CGA  GCA 
AC288,  used  with  `aar  5'  KpnI'.  TTA  TTA  CTA  CTT 
Adds  3'  XhoI  site,  for  insertion  into  TCA  ATT  AAA  TTA 
pDXA-3C.  C 
aar  AC623  up  Upper  strand  oligo  of  a  pair.  AAT  TCA  AAC  ACA 
Annealed  with  `aar  AC623  down'  AGG  TTG  TGG  TGC 
to  make  a  double-stranded  CCT  AAG  AAA  TTT 
oligonucleotide,  used  to  replace  the  AGG  TTG  TAG 
sequence  between  the  EcoRI  and 
XhoI  sites  of  pDXA-3C-aar  to 
create  Aar  AC623. 
aar  AC623  down  See  `aar  AC623  up'.  TCG  ACT  ACA  ACC 
TAA  ATT  TCT  TAG 
GGC  ACC  ACA  ACC 
TTG  TGT  TTG 
aar  V5His  up  Upper  strand  oligo  of  a  pair.  TCG  AGA  TGC  ATT 
Annealed  with  `aar  V5His  down'  to  AGG  TAA  ACC  AAT 
make  a  double-stranded  TCC  AAA  TCC  ACT 
oligonucleotide  with  a  5'  XhoI  site  TCT  TGG  TCT  TGA 
and  a  3'  XbaI  site.  Inserted  into  TTC  AAC  TCA  TCA 
pDXA-3C-aar  to  create  pDXA-aar-  TCA  TCA  TCA  TCA 
V5-his.  TTA  AT 
aar  V5His  down  See  `aar  V5His  up'.  CTA  GAT  TAA  TGA 
TGA  TGA  TGA  TGA 
TGA  GTT  GAA  TCA 
AGA  CCA  AGA  AGT 
GGA  TTT  GGA  ATT 
GGT  TTA  CCT  AAT 
GCA  TC 
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2-5x10'  Dictyostelium  cells  were  placed  on  dry  ice.  They  were  lysed  immediately  by 
adding  500µl  of  RNA  buffer  containing  1%  SDS  (v/v)  and  500µ1  of  phenol  and  then 
vortexing.  In  addition,  the  lysate  was  shaken  for  15  min  at  room  temperature.  The  mixture 
was  cooled  on  ice  before  spinning  at  20,000g,  15  min,  4°C  to  separate  aqueous  and  phenol 
layers.  350µ1  of  the  aqueous  layer  was  removed  and  transferred  to  500µ1  chloroform,  the 
mixture  was  vortexed,  spun  as  above  and  the  upper  aqueous  layer  transferred  to  lml 
ethanol.  RNA  was  precipitated  for  1  hour  at  -20°C  before  spinning  at  20,000g  for  10  min, 
4°C.  The  pellet  was  washed  in  70%  ethanol,  left  to  air  dry  on  ice,  and  dissolved  in  20µl 
sterile  ddHZO.  RNA  concentration  was  determined  by  measuring  the  OD  at  A260  on  a 
spectrophotometer.  RNA  was  prepared  for  electrophoresis  in  1x  MOPS  buffer,  0.2M 
formaldehyde,  50%  (v/v)  formamide  and  10%  (v/v)  sterile  RNA  loading  dye,  denatured  at 
60°C  for  15  min  and  cooled  on  ice.  5µg  RNA  per  lane  was  loaded  on  a  1%  (w/v)  agarose 
gel  containing  lx  MOPS  buffer,  0.65M  formaldehyde  and  ethidium  bromide  to  a  final 
concentration  of  0.25pg/ml. 
The  gel  was  run  in  lx  MOPS  buffer  at  120V  for  3.5  hours.  After  electrophoresis,  RNA  was 
visualised  under  UV  light  and  photographed  before  equilibrating  in  10xSSC  (see  section 
2.6  for  recipe)  and  blotting  onto  Hybond  N  nylon  membrane  (Amersham  Pharmacia 
Biotech)  by  capillary  transfer  in  1OxSSC.  The  RNA  was  UV-crosslinked  to  the  membrane 
(Stratalinker,  Stratagene). 
Filters  were  prehybridised  at  42°C  for  5  hours  in  RNA  hybridisation  buffer  and  then 
hybridised  in  denatured  probe.  Aar,  D19,  or  Ig7  PCR  products,  were  labelled  with  [a-32P1 
dATP  using  the  Megaprime  DNA  labelling  kit  (Amersham  Pharmacia  Biotech). 
Unicorporated  nucleotides  were  removed  by  purifying  the  probe  on  MicroSpinTM  S-400  HR 
60 columns  (Amersham  Pharmacia  Biotech).  The  purified  probes  were  denatured  by  boiling 
for  5  mins,  before  being  added  to  RNA  hybridisation  buffer,  and  incubated  with  filters 
overnight  at  42°C.  Unbound  probe  was  removed  with  2xSSC/0.1%SDS  washes  (2x  15 
minutes),  followed  by  0.5xSSC/0.1%SDS  (2x  15  minutes).  Filters  were  sealed  in  plastic 
and  exposed  against  a  phosphorimaging  screen  (K-Screen,  Kodak),  before  imaging  in 
BioRad  phosphorimager.  Band  intensities  were  quantified,  where  desired,  using  the 
Quantity  OneTM  software  (BioRad). 
2.4  Biochemistry 
2.4.1  Protein  separation  and  western  blotting  of  whole  cell  extracts 
Approximately  lx  107  logarithmically  growing  cells  were  pelleted  at  2,000g  for  2  min. 
Sodium  dodecyl  sulphate-polyacrylamide  gel  electrophersis  (SDS-PAGE)  was  used  to 
separate  proteins  for  western  blotting.  Cells  were  lysed  by  boiling  for  5  min  in  Laemmli 
buffer  and  debris  pelleted  at  20,000g  for  5  min  before  loading  on  a  polyacrylamide  gel. 
Between  105  and  106  cell  equivalents  per  lane  were  loaded  on  to  a  discontinuous  gel 
composed  of  a  4%  polyacrylamide  stacking  gel,  on  top  of  either  a  8.0%  or  10% 
polyacrylamide  resolving  gel  (Protogel,  National  Diagnostics  Corporation),  according  to 
the  range  of  size  separation  required. 
Electrophoresis  was  at  150V  for  1.5  hours,  and  coloured  molecular  weight  standards 
(Rainbow  markers,  Amersham  Pharmacia  Biotech)  were  run  alongside  samples  for  size 
determination.  After  electrophoresis,  some  gels  were  stained  with  Coomassie  Blue 
overnight  and  destained  over  several  hours  with  4-5  changes  of  destain  to  visualise  total 
protein.  All  other  gels  were  equilibrated  in  western  transfer  buffer  for  10  minutes. 
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membrane  (Amersham  Pharmacia  Biotech)  by  semi-dry  blotting  in  a  BioRad  transfer  cell 
according  to  the  manufacturer's  instructions.  The  membrane  was  rinsed  in  phosphate 
buffered  saline  (PBS)  and  proteins  were  visualised  using  2%  PonceauS  (w/v)  in  I%  acetic 
acid  (v/v)  to  ensure  even  transfer  and  loading.  Membranes  were  blocked  for  1  hour  at  room 
temperature  or  overnight  at  4°C  in  5%  dried  skimmed  milk  (w/v),  0.1%  Tween-20  (v/v)  in 
PBS.  After  five  5  minute  washes  in  PBS/0.1%  Tween-20  (v/v)  (PBST)  membranes  were 
incubated  in  primary  antibody  diluted  in  PBST  for  1-2  hours  at  room  temperature.  (Anti-V5 
was  HRP  tagged.  All  other  antibodies  required  incubation  with  an  HRP-conjugated 
secondary  antibody.  )  After  incubation  with  primary  antibody,  filters  were  washed 
extensively  in  a  large  volume  of  PBST  and  incubated  in  secondary  antibody  diluted  in 
PBST  for  a  further  hour.  After  further  washes,  the  secondary  antibody  was  detected  using 
enhanced  chemoiluminescence  reagent  (ECL,  Pierce)  according  to  the  manufacturer's 
instructions.  Protein  bands  were  detected  in  a  BioRad  FluorSMax  fluorimager. 
2.4.2  Antisera  :  The  following  antibodies  were  used  during  the  course  of  this  work: 
Primary 
"  Aar:  Rabbit  polyclonal  IgG,  raised  to  a  synthetic  Aar  peptide  representing  the  final  5 
armadillo  repeats  of  the  protein.  Used  at  1:  1,000  for  immunofluorescent  cell  staining, 
following  testing  of  both  the  preimmune  and  immune  sera  at  1:  50,1:  100,1:  500  and 
1:  1,000  (the  titration  of  the  antisera  was  performed  previously  by  Juliet  Coates,  in  the 
lab  -  see  also  Coates,  1999). 
"  GFP:  Rabbit  polyclonal  IgG  which  recognises  the  epitope  corresponding  to  amino 
acids  1-238  of  green  fluorescent  protein  (GFP)  of  Aequorea  victoria.  Used  at  1:  1,000 
for  western  blotting.  (Santa  Cruz). 
9  V5:  Mouse  monoclonal  IgG,  which  recognises  the  V5  epitope  (GKPIPNPLLGLDST). 
Used  at  1:  5,000  for  western  blotting.  (Invitrogen). 
62 "  Ubiquitin:  Rabbit  polyclonal  IgG.  Used  at  1:  100  for  western  blotting.  (Sigma-Aldrich). 
Secondary 
9  Anti-Rabbit  IgG  (H+L).  Horseradish  peroxidase-conjugated  antibody,  raised  in  goats. 
Used  at  1:  10,000  for  western  bloating.  Vector  Laboratories. 
2.4.3  Fast  Protein  Liquid  Chromatography  -  FPLC 
An  Amersham  Pharmacia  Biotech  FPLC  system  was  used  for  the  size  separation  of  protein 
samples.  0.25-0.5m1  of  sample  was  loaded  onto  a  SuperoseTM  12  column  (Amersham 
Pharmacia  Biotech)  and  washed  with  a  solution  of  50mM  Tris/lOOmM  NaCI  (pH8.0). 
Samples  were  eluted  with  a  flow  rate  of  0.25ml/min,  and  collected  into  50µ1  of  kinase 
protection  buffer  (see  section  2.6).  The  apparent  molecular  weight  of  the  proteins  contained 
in  each  fraction  was  established  from  the  standard  curve  previously  generated  in  our 
laboratory  by  W.  J.  Ryves. 
2.4.4  Purification  of  peptides 
All  peptides  were  synthesised  commercially  by  Zinser  Analytic  and  purified  as  follows. 
C  18  Sep-Pak  Cartridges@  (Waters)  were  washed  with  5m1  of  acetonitrile,  followed  by  5ml 
ddH2O.  Peptides  were  resuspended  in  5m1  ddH2O  before  loading  on  the  cartridges. 
Cartridges  were  then  washed  with  5ml  ddH2O,  before  elution  of  peptide  in  5ml  60%  MeOH 
(v/v).  Peptides  were  then  dried  down  in  a  speed  vac  and  re-suspended  in  the  desired  volume 
of  ddH2O. 
2.4.5  In  Vitro  kinase  assays 
In  vitro  kinase  assays  were  performed  as  described  before  (Ryves  et  al.,  1998).  5mUnits  of 
recombinant  GSK-30  (Upstate),  40  units  of  recombinant  casein  kinase  18  (New  England 
Biolabs),  or  FPLC-purified  Aark  (as  stated  in  the  text)  were  added  to  each  assay.  In 
63 addition,  where  indicated,  lithium  chloride  was  used  at  50mM,  and  the  casein  kinase  1 
inhibitor  CKI-7  (Seikagaku  Corporation)  was  used  at  10µM. 
Each  assay  was  initiated  by  the  addition  of  an  ATP/Mg2+  mix  (100µM  final  concentration), 
containing  4.625MBq/ml  [y-32P]  ATP.  After  10  minutes  had  elapsed,  the  peptide  was 
immobilised  on  P81  cellulose  phosphate  paper  (Whatman),  by  spotting  2Oµ1  of  each  assay 
onto  squares  of  the  paper.  The  P81  squares  were  then  washed  3  times  in  100mM 
phosphoric  acid  to  remove  the  unincorporated  radioactive  phosphate.  The  papers  were 
washed  for  a  total  of  lhour,  and  the  activity  of  each  square  counted  in  a  beta  counter  (Tri- 
Carb  1900  TR,  Packard).  In  addition  to  counting  the  activity  of  each  individual  assay,  an 
equivalent  quantity  of  ATP/Mg2+/['y-32P]  ATP  as  was  used  in  the  assay  was  also  counted  to 
enable  the  determination  of  the  amount  of  phosphate  transferred  as  a  ratio  of  the  amount 
added. 
2.5  Cell  biology 
2.5.1  Development  of  Dictyostelium 
Cells  were  spun  down  from  logarithmically  growing  culture  (1-2x106  cells/ml)  and  washed 
four  times  in  KK2.  Cells  were  resuspended  in  300µl  of  KK2  and  spread  evenly  across  black, 
nitrocellulose  filters  (4.7cm  diameter,  0.45µm  pore  size,  Millipore)  on  a  KK2  -soaked  pre- 
filter.  Filters  were  incubated  at  22°C  in  a  humid  atmosphere  for  the  required  length  of  time. 
2.5.2  Immunofuorescent  cell  staining 
Vegetative  cells  were  allowed  to  settle  on  glass  coverslips  (BDH).  To  fix  cells,  the  media 
was  removed  and  replaced  with  200µl  0.1%  paraformaldehyde  (w/v)  in  picric  acid  (pH6.5) 
for  30  minutes.  Cells  were  then  washed  in  the  following  sequence:  10mM  PIPES, 
PBS/glycin  (twice),  70%  ethanol,  and  100mM  PBS/glycin  (three  times).  Cells  were 
64 blocked  against  non-specific  binding  in  PBG  (see  section  2.6  for  recipe),  for  15  minutes. 
Antibodies  were  diluted  as  above,  in  blocking  reagent.  After  incubation  with  primary 
antibody  for  2-3hours  at  room  temperature,  cells  were  washed  7  times  in  blocking  solution, 
before  incubation  with  secondary  antibody  for  1-2  hours  at  room  temperature.  Cells  were 
then  washed  in  the  following  sequence  PBG,  100mM  PBS/glycin  (three  times),  and  finally 
once  in  ddHZO  before  mounting  with  mowial  mountant.  Slides  were  viewed  on  a  Bio-Rad 
MRC1024  confocal  microscope. 
2.5.3  Live  cell  imaging  of  GFP  transformants 
`Hanging  drop'  slides  were  made  as  follows:  a  rubber  `0'  ring,  approximately  2cm  in 
diameter,  was  greased  and  placed  on  a  glass  coverslip.  0.5ml  of  log  phase  culture  was  spun 
out  of  media  and  washed  once  in  KK2  buffer,  before  resuspension  in  5%Ll  of  KK2  +/- 
inhibitor:  10mM  LiCL,  or  10µM  of  the  specific  IMPase  inhibitor  L-690,330  (Tocris 
Cookson).  Cells  were  then  pippetted  into  the  middle  of  the  `0'  ring  and  allowed  to  settle 
before  25µ1  of  the  liquid  was  removed.  A  glass  slide  was  placed  on  top  of  the  `0'  ring  with 
sufficient  pressure  as  to  create  a  seal  between  the  coverslip,  `0'  ring  and  slide.  The  slide 
was  then  inverted,  thus  producing  a  `hanging  drop',  ready  for  viewing  on  a  Bio-Rad 
MRC1024  confocal  microscope. 
65 2.6  Inhibitors 
The  following  inhibitors  were  used  during  the  course  of  this  work: 
"  CKI-7  (casein  kinase  1  inhibitor):  purchased  from  Seikagaku  Corporation;  10mM 
stock  solution  (in  DMSO);  added  as  1/4  part  to  in  vitro  kinase  assays  (see  section  2.4.5) 
at  10µM  final  concentration  (the  manufacturers  quote  an  IC50  value  of  9.54M). 
"  L-690,330  (IMPase  inhibitor):  purchased  from  Tocris  Cookson;  100mM  stock 
solution  (in  ddH2O);  used  at  10µM.  L-690,330  has  an  IC50  value  of  1µM  (Klein  and 
Melton,  1996).  L-690,330  was  used  at  10µM  (following  titration  experiments 
performed  previously  by  R.  Williams  in  the  lab).  The  inhibitor  was  added  to  the  KK2 
cell  suspension  during  live  cell  imaging  of  GFP  transformants. 
"  SB-415286  (GSK-3  inhibitor):  a  kind  gift  from  GlaxoSmithkline;  2mM  stock  solution 
(in  DMSO);  added  as  1/4  part  to  in  vitro  kinase  assays  (see  section  2.4.5)  at  1µM  final 
concentration.  The  inhibitor  has  a  K;  value  of  31  nM,  but  was  titrated  into  a  standard 
assay  to  determine  the  optimum  concentration  for  the  level  of  ATP  used  in  these  assays, 
since  it  is  a  direct  competitor  of  ATP  (this  was  previously  performed  by  W.  J.  Ryves). 
b5a 2.6  Recipes  and  reagents 
Standard  laboratory  chemicals  were  from  BDH.  Other  chemicals  were  from  Sigma 
Chemical  Company  unless  otherwise  stated.  All  chemicals  were  reagent  grade  or  better. 
Media 
Axenic  medium 
"  1.43%  peptone  (w/v)  (Oxoid,  L34) 
"  0.72%  yeast  extract  (w/v)  (Oxoid  L21) 
"  3.6mM  Na2HPO4,3mM  KH2PO4 
"  30%  glucose  (w/v) 
"  0.5mg/ml  vitamin  B  12,1mg/ml  folic  acid  pH9.0 
Final  pH  6.4  (sterile) 
KIEZ 
"  15.5mM  KH2PO4 
"  3.8mM  K2BPO4 
"  Final  pH  6.2 
L-Broth 
9  1%  bactotryptone  (w/v)  (Difco) 
"  0.5%  bacto-yeast  extract  (w/v)  (Difco) 
"  17mM  NaCl 
Final  pH  7.0  (sterile) 
66 LB  agar 
"  L-broth 
"  1.5%  Bactoagar  (w/v)  (Difco) 
SM  (Sussman's  medium) 
"1%  glucose  (w/v) 
"  1%  peptone  (w/v)  (Oxoid  L34) 
"  0.1%  yeast  extract  (w/v)  (Oxoid  L21) 
"  2%  agar  (w/v)  (Difco) 
"  4mM  MgSO4,4mM  KH2PO4,6mM  K2HPO4 
Molecular  Biology 
50x  Denhardt's  solution 
"  1%  BSA  (w/v)  (FractionV) 
91%  Ficoll  (w/v) 
"  1%  Polyvinylpyrollidine  (w/v) 
DNA  loading  buffer 
"  0.25%  bromophenol  blue  (w/v) 
"  0.5%  xylene  cyanol  (w/v) 
"  15%  Ficoll-400  (w/v) 
67 MOPS  buffer 
9  20mM  MOPS  pH7.0 
"  5mM  Na  Acetate 
"1  mM  EDTA 
RNA  buffer 
"  100mM  Tris-HC1,  pH  7.4 
9  200mM  NaCl, 
"  20mM  EDTA 
RNA  hybridisation  buffer 
"  43%  formamide  (v/v) 
"  5x  SSC 
"  lOx  Denhardt's  solution 
"  10mM  Na2HPO4/NaH2PO4  pH  6.8 
"  200mg/ml  denatured,  sheared  salmon  testis  DNA 
"  0.1  %  SDS  (v/v) 
RNA  loading  dye 
"  50%  glycerol  (v/v) 
"  1mM  EDTA 
"  0.4%  bromophenol  blue  (w/v) 
"  0.4%  xylene  cyanol  (w/v) 
68 ssc 
9  150mM  NaCl 
9  15mM  Na3citrate 
STET 
"  50mM  Tris-HC1  pH8 
9  50mM  EDTA 
"  8%  sucrose  (w/v) 
0  5%  Triton-X  100  (v/v) 
0.5x  TBE 
"  45mM  Tris-HC1 
"  45mM  Boric  acid 
0  1mM  EDTA 
TE 
9  10mM  Tris-HCI  pH  7.4 
"1  mM  EDTA 
69 Biochemistry 
Coomassie  destain 
1  25%  methanol  (v/v) 
2  16%  acetic  acid  (v/v) 
Coomassie  stain 
"  0.25%  Coomassie  Brilliant  Blue  (v/v) 
"  10%  acetic  acid  (v/v) 
"  45%  methanol  (v/v) 
6x  Kinase  Protection  Buffer 
"  50mM  Tris  (pH7.4) 
"  100µM  EGTA 
"  5OmM  NaC1 
"  50%  glycerol  (v/v) 
"  1mM  AEBSF 
"  1mM  benzamidine 
"  1OmM  DTT 
Laemmli  buffer 
"  10%  glycerol  (v/v) 
"  100mM  DTT 
"  2%  SDS  (v/v) 
"  50mM  Tris-HC1  pH6.8 
"  0.1  %  bromophenol  blue  (w/v) 
70 PBS 
"  137mM  NaCl 
"  2.68mM  KCl 
9  7.98mM  Na2HPO4 
9  1.47mM  KH2PO4 
Final  pH  7.2 
Tris  Kinase  Buffer  (TKB) 
"  20mM  Tris 
"  2mM  DTT 
"  pH  7.5 
"  Western  transfer  buffer 
"  48mM  Tris 
"  39mM  glycine 
"  20%  methanol 
71 Cell Biology 
Mowial  mountant 
"  2.4g  MOWIAL 
"  6g  glycerol 
Add  6m1  ddH2O  and  stir  for  several  h  at  RT. 
Add  12m1  0.2M  Tris,  pH8.5  and  heat  to  50°C 
Add  2.5%  DABCO  (w/v) 
PBG 
In  1L  PBS: 
"  5g  BSA 
"  Ig  fish  gelatin 
Sterile  filter. 
PBS/Glycin 
"  500m1  PBS 
"  3.75g  glycin 
Sterile  filter. 
Picric  acid 
"  0.4g  paraformaldehyde 
"  5ml  ddH2O 
"3  drops  1M  NaOH,  heat  to  40°C  and  make  up  to  7m1  before  adding: 
"  10m120mM  PIPES 
"  3m1  saturated  picric  acid  solution 
Final  pH  6.5 
72 Chapter  3 
Phosphorylation  of  Aardvark 
73 3.1  Introduction 
Aardvark  (Aar)  possesses  signalling  functions  known  to  be  dependent  on  the  activity  of  the 
Dictyostelium  GSK-3  homologue,  GskA  (Grimson  et  al.,  2000;  Fraser  et  al.,  2002).  GSK-3 
phosphorylation  of  ß-catenin  targets  the  protein  for  breakdown  following  the  binding  of  the 
F-box  protein  1  Trcp.  In  C.  elegans  however,  the  relationship  between  GSK-3  and  the  (3- 
catenin  homologue  WRM-1  appears  to  be  a  positive  one  (Korswagen  et  al.,  2000).  This 
also  appears  to  be  the  case  in  Dictyostelium  (Grimson  et  al.,  2000),  but  it  has  yet  to  be 
established  whether  the  interaction  between  GskA  and  Aar  is  a  direct  one.  Therefore,  one  of 
the  aims  at  the  outset  of  this  project  was  to  determine  whether  GskA  phosphorylates  Aar. 
3.2  Establishing  an  in  vitro  kinase  assay  for  GSK-3  phosphorylation  of  ß-catenin 
peptides 
The  study  of  (3-catenin  phosphorylation  in  vivo  is  complex:  it  requires  either  the  over- 
expression  of  a  dominant  negative  form  of  ßTrcp,  or  the  addition  of  proteosome  inhibitors 
(Amit  et  al.,  2002).  GSK-3  will  only  phosphorylate  f3-catenin  at  low  levels  in  vitro  (Yost  et 
al.,  1996).  Both  priming  phosphorylation  by  Casein  Kinase  la  (CK1a)  and  the  addition  of 
other  protein  factors  such  as  Axin,  are  required  (Hagen  and  Vidal-Puig,  2002;  Amit  et  al., 
2002;  Liu  et  al.,  2002). 
In  vitro  GSK-3  kinase  assays  utilising  peptide  substrates  have  previously  been  reported 
(Wang  et  al.,  1994;  Ryves  et  al.,  1998;  Ginger  et  al.,  2000).  To  establish  whether  this 
approach  would  work  for  a  known  GSK-3/0-catenin  interaction,  peptides  based  upon  the 
N-terminal  GSK-3  target  sites  of  ß-catenin,  encompassing  Ser-33,  Ser-37,  Thr-41  and  Ser- 
45,  were  commercially  synthesised.  Two  peptides  were  made,  corresponding  to  amino 
acids  24  to  49  of  ß-catenin.  One  peptide  was  synthesised  with  the  priming  phosphate  on 
Ser-45.  Both  peptides  (and  all  future  peptides)  had  the  addition  of  two  N-terminal  and  three 
74 C-terminal  Arg  residues.  This  was  to  facilitate  the  binding  of  the  peptides  to  P81  cation 
exchange  cellulose  phosphate  paper,  in  the  in  vitro  kinase  assays  (see  section  2.4.5).  Figure 
3.1  outlines  the  sequence  of  the  two  peptides  and  also  shows  the  site  at  the  N-terminus  of 
the  protein  from  where  the  peptides  were  derived. 
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Peptide  name  Sequence 
n-UP  RRHWQQQSYLDSGIHSGATTTAPSLSGKRRR 
ß-P1  RRHWQQQSYLDSGIHSGATTTA  SGKRRR 
Aar-UP  RRSNYSSPNTLIPSVSKTYISPFRRR 
Aar-P1  RRSNYSSPNTLIPSVS  ISPFRRR 
Aar-P2  CRRSNYSSPNTLI  SKTYISPFRRR 
Figure  3.1  Comparison  of  ß-catenin  and  Aar  proteins  and  peptide  substrates 
(a)  Alignment  of  ß-catenin  and  Aardvark  proteins,  based  upon  the  shared  homology  of  their 
Arm  domains,  GSK-3  phosphorylation  sites  (black  oval)  and  a-catenin  binding  sites  (red 
star).  The  GSK-3  sites  and  a-catenin  binding  site  of  Aardvark  are  putative.  Residues  in  red 
represent  the  known/putative  phosphate-accepting  residues  and  the  priming  sites  are  boxed 
and  marked  P1  or  P2. 
(b)  Sequences  of  Aardvark  and  ß-catenin  peptides.  All  peptides  possess  two  N-terminal  and 
three  C-terminal  Arg  residues  to  facilitate  binding  to  the  cellulose  phosphate  paper  in  the  in 
vitro  kinase  assay.  Red  residues  represent  the  Ser/Thr  residues  to  receive  the  phosphate.  UP 
=  unprimed;  P1  =  primed,  position  1;  P2  =  primed,  position  2. 
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SNYSSPNTLIPIJSK  [ISPF 3.3  GSK-30  phosphorylates  a  phosphate-primed  ß-catenin  peptide  in  vitro 
Recombinant  GSK-30  was  unable  to  phosphorylate  the  un-primed  ß-catenin  peptide  (ß-UP) 
in  the  in  vitro  kinase  assay  (see  section  2.4.5).  However,  the  addition  of  the  priming 
phosphate  at  Ser-45  (producing  1-P1)  created  a  GSK-3  substrate  (figure  3.2).  Furthermore, 
the  addition  of  50mM  lithium  chloride  (LiCI),  to  inhibit  the  kinase  activity  of  GSK-30, 
reduced  activity  towards  the  peptide  by  almost  90%. 
The  Michaelis  constant,  K. 
￿  of  an  enzyme  is  calculated  by  measuring  the  activity  from  a 
range  of  substrate  concentrations,  and  creating  a  double  reciprocal  plot  of  velocity  versus 
substrate  concentration,  known  as  the  Lineweaver-Burke  plot.  The  intercept  on  the 
horizontal  axis  represents  -1/Km. 
To  calculate  the  K.  value  for  the  interaction  between  GSK-30  and  ß-P1,  an  in  vitro  kinase 
assay  was  performed  with  GSK-30  and  serial  dilutions  of  200µM  ß-P1.  Figure  3.3  (a)  and 
(b)  show  the  activity  of  GSK-30  towards  each  dilution  of  ß-P1,  and  the  resultant 
Lineweaver-Burk  plot  is  shown  in  (c).  The  K.  value  was  calculated  from  the  plot,  using 
Excel  software  (Microsoft),  to  be  85µM.  This  value  falls  within  the  range  of  Km  values  for 
known  GSK-30  peptide  substrates,  for  example  CREB,  200µM  (Wang  et  al.,  1994);  the 
modified  glycogen  synthase  peptide  GSM,  75µM  (Ryves  et  al.,  1998);  and  DdSTATa, 
25µM  (Ginger  et  al.,  2000). 
77 Figure  3.2  GSK-3(3  phosphorylation  of  P-catenin  peptides 
Activity  of  recombinant  GSK-3(3  towards  (3-catenin-UP  (n-UP),  and  (3-catenin-PI 
((3-PI  )  peptides  in  an  in  vitro  kinase  assay.  Lithium  chloride  was  added  to  the  assay, 
as  indicated,  at  50mM  to  inhibit  the  kinase  activity  of  GSK-3(3.  The  ist  columns  (grey) 
represent  peptides  at  400µM;  the  2nd  columns  (black)  represent  peptides  at  800µM. 
The  assay  was  performed  in  triplicate,  and  the  results  are  shown  +/-  SEM. 
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Figure  3.3  Calculating  the  Km  value  for  GSK-3p  phosphorylation  of  ß-P1 
a)  Phosphorylation  of  200µM  13-P  1  by  GSK-30 
b)  Serial  dilutions  of  (3-P  l  from  200µM  to  3.  l  25µM 
c)  Double-reciprocal  plot  of  GSK-3ß  activity  against  ß-P1.  Km  value  =  85µM 
0=  BP  =  linear  BP.  The  assay  was  performed  in  triplicate.  Results 
are  shown  +/-  SEM. 
79 3.4  Aar  peptide  substrates  and  GSK-30 
When  the  Arm  repeat  domains  of  Aar  and  ß-catenin  are  aligned,  a  site  in  the  N-terminal 
region  of  Aar  containing  four  Ser/Thr  residues,  conforming  to  the  GSK-3  consensus 
phosphorylation  site,  aligns  with  the  N-terminal  GSK-3  sites  of  (3-catenin  (figure  3.1  & 
Grimson  et  al.,  2000).  Furthermore,  at  no  other  point  along  the  length  of  the  Aar  protein  are 
there  4  consecutive  sites  conforming  to  the  GSK-3  consensus  site.  Peptides  that  spanned 
these  putative  GSK-3  sites  of  Aar  (amino  acids  233-253)  were  synthesised  commercially, 
with  or  without  a  priming  phosphate  on  a  Thr  residue  at  +4  to  the  start  of  the  putative  sites 
(Aar-P1  and  Aar-UP,  respectively;  figure  3.1).  In  addition,  a  third  peptide  (Aar-P2)  was 
synthesised  which  had  the  priming  phosphate  positioned  on  a  Ser  at  -4  to  the 
phosphorylated  Thr  in  Aar-P1,  to  mimic  phosphorylation  by  GSK-3. 
Recombinant  GSK-30  did  not  phosphorylate  any  of  the  three  Aardvark  peptides  in  vitro 
(figure  3.4).  To  validate  the  experimental  approach,  assays  were  repeated,  including  the 
GSK-3  substrate,  GSM,  and  electrophoresed  on  a  16%  tricine  gel.  Whilst  phosphorylation 
of  GSM  was  detected,  phosphorylation  of  the  Aar  peptides  remained  undetectable  (figure 
3.4). 
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Figure  3.4  GSK-30  kinase  activity  towards  Aar  peptides 
(A)  Recombinant  GSK-3(3  was  tested  for  activity  towards  the  modified  GSK-3 
peptide  substrate,  GSM,  and  towards  all  three  Aar  peptides  in  an  in  vitro  kinase 
assay.  No  phosphorylation  of  the  unprimed  Aar  peptide  (Aar-UP)  or  the  two 
primed  peptides  (Aar-PI  and  Aar-P2)  was  detectable.  GSK-3(3  activity  was 
inhibited  with  50mM  LiCI.  The  results  of  one  triplicate  assay  are  shown  +/-  SEM. 
(B)  The  assays  in  (a)  were  repeated,  but  stopped  by  the  addition  of  SDS  before 
separation  of  samples  on  a  16%  tricine  gel.  Phosphorylation  was  detected  by 
phosphorimaging.  Whilst  phosphorylation  of  GSM  could  be  detected,  there  was 
no  detectable  phosphorylation  of  any  of  the  Aar  peptides.  GSK-3(3  activity  was 
inhibited  with  50mM  lithium  chloride.  The  assay  was  repeated  and  the  same 
results  obtained. 
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GSM  GSK-3  GSM  GSM  UP  P1  P2 3.5  Phosphorylation  of  Aar  peptides  by  MC-purified  Dictyostelium  cell  extracts 
GskA  and  GSK-30  share  71%  sequence  homology  in  their  catalytic  domain  (Harwood  et 
al.,  1995)  and  GskA  phosphorylates  all  tested  GSK-30  substrates  in  vitro;  for  example, 
CREB,  GS-1  and  GSM  (W.  J.  Ryves,  pers.  commun.  ).  Further,  GSK-3(3  phosphorylates  the 
GskA  substrate  DdSTATa  in  vitro.  However,  this  does  not  preclude  that  Aar  is  a  substrate 
for  GskA  but  not  GSK-30  in  vitro.  The  availability  of  a  gskA  null  Dictyostelium  strain  aids 
the  determination  of  whether  any  activity  towards  Aar  comes  from  GskA  or  another  kinase. 
GskA  is  active  throughout  growth  and  development  (Plyte  et  al.,  1999).  A  Dictyostelium 
growth  phase  cell  extract  was  separated  by  FPLC  on  the  basis  of  charge  and  the  fraction 
exhibiting  peak  GskA  activity  was  determined  by  its  activity  towards  GSM  (this  work  was 
previously  performed  by  W.  J.  Ryves  in  the  lab).  This  peak  fraction  was  used  to  determine 
whether  GskA  exhibited  kinase  activity  towards  any  of  the  three  Aar  peptides.  As  cell 
extracts  and  not  purified  kinases  were  being  used,  the  use  of  lithium  to  inhibit  GSK  activity 
was  inappropriate  due  to  a  second  lithium  target,  IMPase,  being  present.  Therefore,  the 
GSK-3  inhibitor,  SB-415286,  was  added  at  lp.  M  to  specifically  inhibit  GskA  activity. 
Figure  3.5  shows  the  levels  of  GskA  phosphorylation  of  the  three  Aar  peptides.  Partly- 
purified  GskA  phosphorylated  Aar-P1  to  a  level  four-fold  higher  than  with  the  unprimed 
peptide,  which  itself  was  higher  than  the  Aar-P2  phosphorylation.  This  phosphorylation  of 
Aar  is  therefore  dependent  on  priming  and,  in  addition,  the  positioning  of  the  priming 
phosphate  is  critical.  However,  the  addition  of  SB-415286  reduced  the  observed  activity 
towards  Aar-P1  by  20%,  whereas  it  reduced  phosphorylation  of  GSM  by  59%.  This 
suggested  that  a  kinase  other  than  GskA  (later  termed  Aark  for  `Aar  kinase')  was 
responsible  for  phosphorylation  of  Aar-Pl.  Further  investigation  of  the  biochemical 
characteristics  and  identity  of  Aark  were  subsequently  initiated. 
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Figure  3.5  GskA  phosphorylation  of  Aar  peptides 
Activity  of  a  FPLC-purified  sample,  containing  peak  kinase  activity  for  GskA, 
against  Aar-UP  (UP),  Aar-P1  (P1),  Aar-P2  (P2)  and  GSM.  All  peptides  were 
added  at  400µM  and  SB-415286  (SB)  was  added  at  1pM,  where  indicated. 
Although  assayed  alongside  the  Aar  peptides,  the  GSM  activity  is  shown 
separately  for  greater  clarity.  The  assay  was  performed  in  triplicate  and  results 
are  shown  +/-  SEM. 
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SB 3.6  Further  purification  of  Aark 
In  order  to  separate  Aark  from  GskA,  a  range  of  FPLC-purified  gskA  null  cell  extracts 
(provided  by  W.  J.  Ryves  in  the  lab)  were  tested  for  activity  towards  the  three  Aar  peptides 
(figure  3.6).  The  peak  of  Aark  activity  was  detected  in  fraction  number  15.  This  activity 
was  priming-dependent,  as  the  Aar-P1  peptide  was  phosphorylated  to  a  three-fold  higher 
level  than  Aar-UP.  Furthermore,  the  precise  site  of  the  priming  phosphate  is  critical,  as  a 
peptide  with  the  priming  phosphate  moved  to  a  position  -4  from  that  of  the  original  peptide 
was  no  longer  a  substrate. 
3.7  Determing  the  size  of  Aark  and  the  K.  value  for  its  interaction  with  Aar-P1 
The  peak  gskA  null  fraction  for  Aark  activity  was  subjected  to  further  FPLC  separation  both 
to  estimate  the  size  of  Aark  and  determine  the  K.  value  for  its  interaction  with  Aar-P1.  The 
peak  Aark  fraction  was  passed  through  a  size  gradient  column  (see  section  2.4.3).  Prior 
calibration  of  the  system  with  molecular  weight  standards  allowed  the  determination  of  the 
approximate  molecular  weight  of  each  resulting  fraction.  Figure  3.7  shows  the  activity  of 
the  resulting  fractions  towards  Aar-P1.  The  peak  of  Aark  activity  is  in  the  apparent  size 
range  of  30-35kDa. 
To  calculate  the  K.  value  for  the  interaction  between  Aark  and  Aar-P1,  serial  dilutions  of 
3.2mM  Aar-P1  were  made  and  an  in  vitro  kinase  assay  performed  with  the  newly-purified 
Aark.  Figures  3.8  (a)  and  (b)  show  the  activity  of  Aark  towards  each  dilution  of  Aar-P1, 
and  the  Lineweaver-Burk  plot  is  shown  in  (c).  The  K.  value  was  calculated  from  the  plot  to 
be  365µM. 
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Figure  3.6  Activity  of  purified  gskA  null  fractions  against  Aar  peptides 
Proteins  from  a  gskA  null  Dictyostelium  cell  extract  were  separated  by  FPLC,  on 
the  basis  of  ion  exchange  and  interaction  with  phosphocellulose.  This  separation 
was  via  aP  11  phosphocellulose  exchange  column  (Whatman),  across  a  0-500mM 
NaCl  gradient  (this  purification  was  performed  by  W.  J.  Ryves  in  the  lab).  The 
resulting  fractions  were  assayed  for  activity  towards  each  of  the  Aar  peptides  by 
in  vitro  kinase  assay. 
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Figure  3.7  Activity  of  size-separated  FPLC  gskA  null  fractions  against  Aar-P1 
Proteins  from  a  Dictyostelium  gskA  null  cell  extract  were  separated  by  FPLC,  on  the 
basis  of  size,  through  a  Superose  12  column.  The  system  was  previously  calibrated 
with  molecular  weight  markers,  which  allowed  an  estimate  of  the  size  of  Aark  to  be 
made.  The  fraction  which  corresponded  to  30-35kDa  showed  peak  Aark  activity,  as 
determined  by  activity  towards  Aar-P1  in  an  in  vitro  kinase  assay. 
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Figure  3.8  Calculating  the  Km  value  for  Aark  phosphorylation  of  Aar-P1 
a)  Phosphorylation  of  3.2mM  Aar-P  I  by  Aark 
b)  Serial  dilutions  of  Aar-PI  from  3.2mM  down  to  200µM 
C)  Double-reciprocal  plot  of  Aark  activity  against  [Aar-P  I  I.  Km  value  =  305µM 
 =  Aar-PI  =  linear  Aar-P1.  The  assay  was  performed  in  triplicate. 
Results  are  shown  +/-  SEM. 
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[Aar-P1]  µM 3.8  Aark  shows  specific  activity  towards  Aar 
Having  shown  that  recombinant  GSK-3ß  shows  specific  activity  towards  the  phosphate- 
primed  ß-catenin  peptide  but  not  to  either  of  the  phosphate-primed  Aar  peptides,  it  was 
important  to  determine  whether  the  reverse  was  true  for  Aark.  Aark  shows  no  activity 
towards  either  the  un-primed  or  primed  ß-catenin  peptides  (figure  3.9).  This  shows  that 
Aark  phosphorylation  of  Aar-P1  is  specific  for  this  phosphopeptide. 
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3.9  Determining  the  identity  of  Aark 
It  has  already  been  established  that  Aark  requires  Aar  to  be  phosphate-primed.  Besides  the 
GSK-3  family  of  Ser/Thr  protein  kinases,  the  Casein  Kinase  1  (CK1)  family  are  the  only 
other  group  of  protein  kinases  known  to  show  a  preference  for  primed  substrates.  CK1 
recognises  the  sequence  S/T(Phos)-X-X-SIT,  putting  the  phosphate  onto  a  Ser  or  Thr 
residue  at  +3  to  the  priming  phosphate. 
CKI-7,  N-(2-aminoethyl)-5-chloroisoquinoline  8-sulfonamide,  exerts  potent  inhibition  of 
CK1  with  an  IC50  value  of  9.5µM  (Seikagaku  Corporation).  CKI-7  causes  only  weak 
inhibition  of  protein  kinase  C  at  1mM,  and  has  an  IC50  value  of  550µM  for  cAMP- 
dependent  protein  kinase.  The  high  specificity  of  CKI-7  inhibition  of  CK1,  along  with  the 
commercially  available  recombinant  CK1  and  its  cognate  peptide  substrate  provide 
excellent  tools  to  determine  whether  Aark  is  a  CK1  family  member. 
The  ability  of  CKI-7  to  inhibit  Aark  phosphorylation  of  Aar-P1  and  the  ability  of 
recombinant  CK1  to  phosphorylate  Aar-P1  were  tested  (figure  3.10).  Aark  was  unable  to 
phosphorylate  the  CK1  peptide  substrate  (CK1-P),  but  CKI-7  (10µM)  reduced  the  activity 
of  Aark  towards  Aar-P1  by  45%.  However,  CKI  was  unable  to  phosphorylate  Aar-P1, 
whilst  CKI-7  reduced  CK1  activity  towards  the  CK1  peptide  by  almost  80%. 
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Figure  3.9  Comparison  of  Aark  activity  towards  Aar  and  (3-catenin  peptides 
400µM  Aar-PI  (P1),  ß-catenin-UP  ((3-UP)  and  ß-catenin-PI  (ß-P1)  were  all  added 
alone  or  with  Aark  in  an  in  vitro  kinase  assay.  The  results  shown  are  from  one  assay 
performed  in  triplicate,  +/-  SEM.  The  assay  was  repeated,  with  the  same  trend  seen. 
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Figure  3.10  Aark  and  CKI  phosphorylation  of  Aar  and  CKIP  peptides 
All  peptides  were  added  at  400µM  in  the  in  vitro  kinase  assay.  UP  =  Aar-UP;  Pl  =  Aar-P1; 
CKIP  =  Casein  Kinase  1  peptide  substrate.  The  CK  I  inhibitor,  CKI-7,  was  used  at  10µM, 
where  indicated.  The  results  of  one  assay,  performed  in  triplicate,  are  shown  +/-  SEM. 
The  assay  was  repeated  and  the  same  trends  seen. 
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3.10  Determining  the  recognition  site  for  Aark 
Aark  is  a  Dictyostelium  protein  kinase  that  requires  some,  or  all,  of  its  substrate  to  be 
phosphate-primed.  To  aid  in  the  identification  of  Aark,  the  substrate  recognition  sequence 
was  determined.  This  would  also  determine  whether  Aark  is  a  tyrosine  or  a  serine/threonine 
specific  protein  kinase. 
Shortened  Aar-P1  peptides  (with  the  prefix  `S')  were  designed,  and  substitutions  of  each  of 
the  serine,  threonine  or  tyrosine  candidates  for  phosphate-acceptors,  were  made  (Table  3.1). 
Alanine  and  serine  are  two  structurally  similar  amino  acids.  They  differ  in  the  fact  that 
alanine  posseses  a  methyl  group  instead  of  the  phosphate-accepting  hydroxyl  group  of 
serine  on  one  of  its  side  chains.  Likewise,  phenylalanine  and  tyrosine  are  structurally 
related,  with  the  only  difference  being  the  absence  of  the  phosphate-accepting  hydroxyl 
group  on  the  carbon  ring  of  phenylalanine.  Therefore  the  substitution  of  serine/threonine 
residues  with  alanine,  or  tyrosine  residues  with  phenylalanine  produces  non- 
phosphorylatable  residues  that  conserve  the  structure  of  the  peptide  and  allows  the 
comparison  of  phosphorylation  efficiencies. 
Peptide  Name  Sequence 
Aar-P1  RRRSNYSSPNTLIPSVSKT(Phos)YISPFRR 
Aar-SP1  RRRLIPSVSKT(Phos)YISPFRR 
Aar-S2  RRRLIPAVSKT(Phos)YISPFRR 
Aar-S3  RRRLIPSVAKT(Phos)YISPFRR 
Aar-S4  RRRLIPSVSKT(Phos)FISPFRR 
Aar-S5  RRRLIPSVSKT(Phos)YIAPFRR 
Table  3.1  Sequences  of  new,  shortened  Aar  peptides 
Sequences  of  the  shorter  Aar  peptides  compared  with  the  original  Aar-P1.  Residues  in  red 
highlight  the  non-phosphorylatable  substitutions.  The  sequence  of  the  original  Aar-P1  is 
included  for  comparison. 
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Y  , ý:  -,  r:  ý:..,. The  ability  of  Aark  to  phosphorylate  the  new,  shortened,  peptides  was  tested  (figure  3.11). 
A  high  degree  of  activity  towards  Aar-SP1  was  seen,  which  showed  that  shortening  the 
peptide  by  removing  the  first  eight  amino  acids  had  no  effect  on  the  ability  of  Aark  to 
phosphorylate  it.  At  400µM,  Aar-S4  and  Aar-S5  were  phosphorylated  to  an  equal  level  as 
Aar-SP1.  This  meant  that  the  sites  of  their  substitutions  could  not  be  the  phosphate- 
accepting  residues.  This  also  confirms  that  Aark  is  a  Ser/Thr  kinase  and  not  a  tyrosine 
kinase,  as  the  substitution  contained  in  Aar-S4  has  replaced  the  only  tyrosine  in  the  peptide. 
Aark  showed  low  activity  towards  both  Aar-S2  and  Aar-S3,  meaning  that  at  least  one  (or 
both)  of  the  substituted  residues  represents  the  phosphate-accepting  residue(s).  One 
explanation  could  be  that  one  of  the  residues  is  the  phosphate-accepting  residue,  whilst  the 
other  is  required  in  a  structural  capacity  to  enhance  the  peptide-kinase  interaction.  To  test 
this  possibility,  the  assay  was  repeated  with  Aar-S2  and  Aar-S3,  but  this  time  an  8-fold 
increase  in  peptide  concentration  was  used.  If  ope  of  the  serine  residues  is  required  to 
optimise  the  enzyme-substrate  binding,  then  a  large  increase  in  peptide  concentration  might 
be  able  to  overcome  the  block,  whilst  an  increase  in  peptide  concentration  should  have  little 
effect  on  the  peptide  whose  substitution  represents  the  phosphate-accepting  residue.  For 
this  experiment,  the  assay  time  was  increased  from  10  minutes  to  30  minutes  as  an 
additional  aid  to  enhance  the  kinetics  of  the  reaction.  The  repeated  assay  is  included  in 
figure  3.11  to  allow  a  direct  comparison  of  the  two  peptide  concentrations.  Whilst  the 
phosphorylation  of  both  the  Aar-SP1  control  and  Aar-S2  increased  by  greater  than  400%, 
the  phosphorylation  of  Aar-S3  increased  only  by  about  50%,  relative  to  the  control.  This 
suggests  that  the  substituted  serine  residue  in  Aar-S3  is  the  phosphate  acceptor,  and  that  the 
substituted  serine  in  Aar-S2  is  required  for  the  optimum  substrate  recognition  site.  This 
proposes  a  recognition  site  for  Aark  of  S-X-J-X-T(Phos),  with  the  highlighted  serine  being 
the  phosphate  acceptor. 
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Figure  3.11  Aark  phosphorylation  of  shortened  Aar  peptides 
The  ability  of  Aark  to  phosphorylate  Aar  peptides  with  alanine  or  phenylalanine  substitutions, 
plus  the  original  Aar-P  1  (P  1),  was  tested  in  an  in  vitro  kinase  assay.  Grey  columns  represent 
activity  towards  400gM  peptides;  black  columns  represent  activity  towards  3.2mM  peptides 
in  an  extended,  30  minute,  assay  (only  selected  peptides  were  repeated  at  3.2mM,  see  text  for 
details).  The  results  of  a  single  assay,  performed  in  triplicate  are  shown,  +/-  SEM. 
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A  genetic  interaction  between  GskA  and  Aardvark  has  previously  been  established 
(Grimson  et  al.,  2000).  It  was  originally  the  aim  of  this  work  to  determine  whether  that 
interaction  is  a  direct  one,  i.  e.  does  GskA  phosphorylate  Aar?  That  question  still  remains 
unanswered,  but  in  addressing  this  question,  a  novel  priming-dependent  Ser/Thr  kinase  that 
phosphorylates  Aar  in  vitro  was  discovered. 
3.11.1  GSK-3  will  phosphorylate  an  N-terminal  ß-catenin  peptide  in  vitro 
In  vitro  GSK-3  kinase  assays,  utilising  peptide  substrates,  have  previously  been  described 
(Ginger  et  al.,  2000;  Ryves  et  al.,  1998;  Wang  et  al.,  1994).  However,  the  use  of  ß-catenin 
peptides  in  GSK-3  assays  has  not  been  reported.  The  data  presented  here  shows  that  GSK-3 
will  phosphorylate  an  N-terminal  ß-catenin  peptide  in  vitro  and,  furthermore,  this 
phosphorylation  requires  the  peptide  to  be  primed  on  Ser-45.  The  K.  value  for  this 
interaction  was  established  as  85µM.  This  figure  falls  within  the  range  of  values  previously 
reported  for  GSK-3  peptide  substrates. 
3.11.2  Is  Aar  a  GSK-3  substrate? 
Peptides  based  on  the  putative  GSK-3  phosphorylation  sites  of  Aardvark  were  synthesised 
commercially,  with  and  without  a  priming  phosphate.  These  peptides  were  not  substrates 
for  GSK-3  in  vitro.  However,  the  possibility  that  GskA,  but  not  GSK-3,  would 
phosphorylate  at  these  sites  in  vitro  still  remained.  To  address  this,  FPLC-purified 
Dictyostelium  cell  extracts  with  high  levels  of  GskA  activity  were  tested  for  activity 
towards  the  Aar  peptides.  Activity  was  observed,  but  the  specific  GSK-3  inhibitor,  SB- 
415286 
,  reduced  the  activity  by  only  about  20%.  This  suggested  that  the  activity  in  the 
extracts  was  not  due  to  GskA. 
94 These  experiments,  however,  can  not  exclude  the  possibility  that  GskA  phosphorylates  Aar 
protein  in  vivo.  Additional  potential  GSK-3  phosphorylation  sites  are  also  present  in  the 
Aar  sequence,  within  the  Arm  domain  and  also  within  the  N-terminus.  Like  the  N-terminal 
sites  of  ß-catenin,  the  GSK-3  sites  in  Arm  repeat  number  two  of  Aar  contain  multiple 
residues  that  could  be  phosphorylated  by  GskA.  Further  peptide  synthesis  and  kinase  assays 
would  be  required  to  establish  whether  these  are  genuine  GSK-3  phosphorylation  sites. 
3.11.3  Aark  phosphorylates  Aar  in  vitro 
The  discovery  that  a  kinase  other  than  GskA  (named  Aark)  was  able  to  phosphorylate  Aar 
peptides  in  vitro  was  unexpected  and  further  characterisation  work  was  performed. 
The  charge-separated  fraction  containing  the  peak  of  Aark  activity  was  subjected  to  further 
FPLC  purification.  This  time  separation  was  performed  on  the  basis  of  size,  and  it  was 
established  that  Aark  has  an  apparent  molecular  weight  of  30-35kDa.  In  addition  to 
estimating  the  size  of  Aark,  the  K.  value  for  its  interaction  with  Aar-P1  was  calculated  to 
be  365µM.  This  figure  may  be  high  compared  to  other  kinase-substrate  interactions,  but 
several  reasons  for  this  could  exist.  If  Aark  phosphorylates  Aar  in  vivo,  it  may  be  that 
scaffold  proteins  and/or  other  additional  factors  are  required.  This  would  bring  the  kinase 
and  substrate  into  close  proximity  and  reduce  the  effective  Km.  Also,  the  conformation  of 
Aar  in  vivo,  compared  with  that  of  the  Aar  peptides,  may  be  such  that  the  phosphate- 
accepting  residues  are  better  presented  to  the  kinase. 
Having  established  the  size  of  Aark  and  a  K.  value  for  its  interaction  with  Aar-P1,  the 
focus  shifted  towards  the  identification  of  the  kinase.  Several  approaches  were  taken.  The 
preference  for  phosphate-primed  substrates,  and  the  lack  of  inhibition  by  SB-415286, 
suggested  that  Aark  might  be  Casein  Kinase  1.  The  casein  kinase  1  (CK1)  family  are  the 
95 only  kinase  family,  other  than  the  GSK-3  family,  that  are  known  to  show  a  preference  for 
phosphate-primed  substrates  and  some  family  members  are  35kDa.  The  notion  that  Aark 
could  be  CK1  is  further  enhanced  by  the  finding  that  CKlct  phosphorylates  ß-catenin,  at 
Ser-45,  in  vitro  (Amit  et  al.,  2002,  Liu  et  al.,  2002). 
3.11.4  Is  Aark  Casein  Kinase  1? 
Two  parallel  approaches  were  taken  to  establish  whether  Aark  could  be  CK1.  The  CK1 
specific  inhibitor  CKI-7  was  used  in  an  attempt  to  block  Aark  activity  towards  Aar-P1  and 
purified  CK1  was  used  in  an  attempt  to  phosphorylate  Aar-P1  in  vitro. 
The  CK1  inhibitor,  CKI-7,  reduced  CK1  activity  towards  its  synthetic  peptide  substrate 
CKI-P  by  approximately  80%  and  reduced  Aark  activity  towards  Aar-P1  by  45%. 
However,  the  manufacturers  quote  an  IC50  value  of  9.5µM  for  CKI-7  interaction  with  CK1, 
but  80%  inhibition  was  observed  with  10µM  CKI-7.  If  the  correct  IC50  value  for  CKI-7 
inhibition  of  CK1  was  calculated  for  these  conditions  and  added  to  Aark,  it  may  be  that 
little  inhibition  is  observed.  In  other  words,  the  45%  inhibition  seen  in  this  assay  may  have 
been  non-specific  inhibition  associated  with  the  high  concentration  of  inhibitor  used. 
Furthermore,  purified  CK1  failed  to  phosphorylate  either  the  unprimed  (Aar-UP)  or  primed 
(Aar-P1)  peptides  in  vitro.  This  suggests  that  Aark  is  not  to  a  CK1.  However,  the  CK1 
isoform  used  in  these  assays  was  CK1S,  whereas  the  CK1  isoform  that  has  been  shown  to 
phosphorylate  (3-catenin  is  CK1a.  The  two  isoforms  will  phosphorylate  some,  but  not  all, 
of  the  same  substrates  in  vitro.  CK18  is  the  only  isoform  of  CK1  that  is  commercially 
available,  which  puts  limitations  on  the  experiments.  However,  only  one  CK1  has  been 
identified  in  Dictyostelium  and  this  has  been  shown  to  have  a  molecular  weight  of  49kDa 
(Moreno-Bueno  et  al.,  2000),  which  is  much  larger  than  the  apparent  size  of  Aark. 
96 The  strongest  argument  against  Aark  being  CK1  comes  from  an  examination  of  the 
substrate  recognition  site.  A  closer  inspection  of  the  amino  acids  that  surround  the  Aark 
recognition  site  of  Aar  reveals  conservation  with  the  CKI-P  peptide.  This  conservation  is 
X-X-G-L,  at  +1  to  the  phosphate-accepting  serine/threonine  residue.  However,  the  Aar-P1 
peptide  is  terminated  after  X-X,  and  therefore  an  extended  Aar  peptide  containing  the 
conserved  Gly  and  Leu  residues  may  be  phosphorylated  by  CK1  in  vitro,  and  CK1 
phosphorylation  of  Aar  could  be  of  in  vivo  relevance. 
3.11.5  Aark's  recognition  site 
The  recognition  site  of  Aark  was  determined.  Peptides  containing  single  amino  acid 
substitutions  that  produced  non-phosphorylatable  residues  were  synthesised  commercially. 
The  ability  of  Aark  to  phosphorylate  each  of  these  was  tested.  Initial  results  showed  that 
two  different  substitutions  abolished  Aark  phosphorylation.  The  block  caused  by  one  of  the 
substitutions  could  be  overcome  by  increasing  the  concentration  of  the  peptide  and  the 
incubation  time  of  the  assay.  This  led  to  the  determination  of  Aark's  phosphorylation  site  as 
S-X-J-X-T(Phos),  with  the  highlighted  Ser  residue  being  the  phosphate  acceptor.  It  would 
be  interesting  to  observe  the  effects  of  expressing  a  mutant  Aar  protein  which  contains 
amino  acid  substitutions  at  this  site,  and  to  observe  the  effects  in  wild  type  cells  and  the  aar 
null  mutant. 
3.11.6  A  GSK-3-like  kinase  is  prgsent  in  Dictyostelium 
If  the  evidence  presented  thus  far  argues  against  Aark  being  GSK-3  or  CK1,  what  is  the 
identity  of  Aark?  The  gskA  null  mutant  shows  no  significant  activity  towards  the  GSM 
substrate  in  vitro  (Ryves  et  al.,  1998).  However,  a  kinase  that  shows  greatest  homology 
with  the  GSK-3  family  has  been  discovered  in  the  Dictyostelium  genomic  database.  This 
97 kinase  has  been  named  GLK,  for  GSK-3-like  kinase.  An  examination  of  the  GLK  amino 
acid  sequence  shows  complete  conservation  of  the  Arg-96,  Arg-180,  Lys-205  residues 
which  have  been  shown  to  be  essential  for  the  binding  of  GSK-3(3  to  phosphate-primed 
substrates  (Dajani  et  at.,  2001,  Harwood,  2001).  However,  the  GLK  sequence  is  not 
conserved  at  the  Axin-binding  site  of  GSK-3ß.  It  has  a  Val-267G1y  and  a  Glu-268Arg 
substitution.  These  exact  substitutions  have  been  shown  to  abolish  Axin-binding  in  GSK-30 
and  have  multiple  effects  on  GskA  in  Dictyostelium  (Fraser  et  at.,  2002).  Aark  may  be 
GLK,  but  further  analysis  is  needed.  However,  if  Aark  is  GLK,  then  it  would  be  expected  to 
phosphorylate  Aar  in  an  Axin-independent  manner. 
Addition:  Both  GSK-3  and  GskA  are  unable  to  phosphorylate  Aar  at  the  putative  N- 
terminal  GSK-3  sites  in  vitro.  This  does  not  preclude  that  the  two  proteins  do  not  interact  in 
vivo;  the  protein  may  be  a  much  better  substrate  for  the  kinase  than  the  peptides. 
Alternatively,  the  phosphorylation  of  Aar  by  GskA  may  require  interaction  with  scaffold 
proteins,  for  example,  or  other  additional  activating  factors.  However,  it  may  also  be  that 
Aar  is  not  a  substrate  for  GskA  at  all.  The  evidence  for  a  genetic  interaction  between  the 
two  proteins  has  already  been  established  (Grimson  et  al,  2000;  Fraser  et  al,  2002),  but  this 
interaction  may  prove  to  be  indirect.  Either  way,  the  interaction  would  appear  to  be 
unconventional  in  comparison  with  that  of  GSK-3  and  (3-catenin,  but  this  is  not  unique.  The 
interaction  between  GSK-3  and  the  (3-catenin  homologue  WRM-1  in  C.  elegans,  for 
example,  is  a  positive  one  (see  Korswagen  2002),  unlike  that  seen  in  flies  and  mammals. 
Further  potential  GSK-3  phosphorylation  sites  do  exist  within  the  Aar  sequence.  These  sites 
are  present  within  the  second  armadillo  repeat  of  the  protein  and  align  with  putative  GSK-3 
phosphorylation  sites  within  the  second  armadillo  repeat  of  ß-catenin  (Yost  et  al,  1996). 
Furthermore,  complete  loss  of  the  N-terminal  GSK-3  sites  of  ß-catenin  does  not  lead  to 
total  loss  of  GSK-3  phosphorylation,  suggesting  that  the  protein  is  indeed  phosphorylated  at 
98 additional  sites.  Phosphate-primed  and  unprimed  peptides  based  on  the  sequence  of  these 
second  sites  in  Aar  have  been  synthesised.  The  phosphate-primed  and  not  the  unprimed 
peptide  has  recently  been  demonstrated  to  be  a  substrate  for  both  GSK-3  and  GskA  in  vitro 
(W.  J.  Ryves,  pers.  commun.  ).  It  has  yet  to  be  established  whether  an  interaction  occurs 
between  GskA  and  Aar  in  vivo,  but  it  would  appear  that  any  interaction  is  unconventional, 
but  may  turn  out  to  be  a  universal  mechanism  for  ß-catenin  regulation. 
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99 4.1  Introduction 
It  has  previously  been  established  that,  like  its  mammalian  counterpart,  Aar  plays  important 
roles  in  both  adhesion  and  signalling  processes  within  the  cell.  Aark  has  been  discovered  as 
a  kinase  that  will  phosphorylate  Aar  at  a  defined  site  in  vitro,  but  is  this  phosphorylation  of 
Aar  actually  significant  to  the  protein's  function? 
In  order  to  answer  this  question,  but  also  to  increase  the  understanding  of  the  role  that  Aar 
plays  in  both  adhesion  and  signalling  in  Dictyostelium,  a  series  of  DNA  constructs  for  the 
expression  of  Aar  and  Aar  deletion  mutants  were  created.  The  full-length  aar  cDNA,  or 
deletions  encoding  N-terminal  or  C-terminal  Aar  truncations  were  cloned  into  a  modified 
version  of  the  pDXA-3C  vector  (Manstein  et  al.,  1995).  The  pDXA  vector  is  an 
extrachromosomal,  high  copy  number  plasmid,  which  expresses  transgenes  from  the 
constitutively-expressed  actin15  promoter.  This  vector  was  previously  modified  to  allow 
for  translation  from  the  aar  initiator  codon  (Grimson  et  al.,  2000). 
aar  and  each  of  its  deletion  derivatives  were  also  fused  to  a  sequence  encoding  a  C- 
terminal  green  fluorescent  protein  (GFP)  `tag'  so  that  the  localisation  of  the  proteins  could 
be  followed  in  living  cells.  Figure  4.1  highlights  the  features  of  the  modified  pDXA-3C 
sion  vector. 
Actin  15 
2,265b 
Actin  8 
promoter  terminator 
;  ure  4.1  The  9.335Kb  pDXA-aar-gfp  expression  vector 
e  861bp  Amp'  gene  allows  for  selection  in  bacteria,  whilst  the  831bp  Neo'  gene  allows 
positive  selection  of  eukaryotic  transformants.  The  vector  also  contains  a  Dietvosteliurn 
gin  of  replication,  for  extrachromosomal  replication. 
100 Aar  is  required  in  both  a  signalling  and  adhesion  capacity  within  the  Dictyostelium  cell. 
Thus,  multiple  phenotypes  are  associated  with  the  loss  of  Aar.  These  include  the  collapse  of 
fruiting  bodies  and  ectopic  stalk  formation  -  both  associated  with  the  loss  of  adherens 
junctions;  a  reduction  of  pspA  gene  expression,  both  during  development  and  in  isolated 
cells;  and  a  reduction  of  spore  and  stalk  cell  production  in  monolayer  culture  (Coates,  1999; 
Coates  et  al.,  2002;  Grimson  et  al.,  2000). 
The  two  simplest  assays  were  chosen  as  independent  indicators  of  Aar  function.  A 
comparison  of  the  morphology  of  mature  fruiting  bodies  was  chosen  as  a  marker  for 
adhesion,  whilst  the  expression  of  the  prespore  marker  gene  pspA  in  isolated  cells  was 
chosen  as  a  marker  for  signalling  activity. 
4.2  Aar-GFP  is  functional  in  the  both  the  aar  mutant  and  wild  type  Dictyostelium  with 
respect  to  development 
To  test  that  the  GFP  fusion  had  no  effect  on  Aar  function  within  the  cell,  both  aar  mutant 
and  wild  type  Dictyostelium  were  transformed  with  pDXA-aar-gfp.  Transformants  were 
starved  for  24  hours  and  the  morphology  of  the  resulting  fruiting  bodies  examined  by  light 
microscopy. 
Upon  starvation,  aar  mutant  cells  will  aggregate,  but  produce  fruiting  bodies  that  differ 
from  those  of  wild  type  cells.  Stalks  appear  thinner  and  weaker  than  in  wild  type  structures, 
and  the  majority  of  fruiting  bodies  collapse  onto  the  substratum  (Coates,  1999;  Grimson  et 
al.,  2000).  These  collapsed  fruiting  bodies  are  often  seen  to  reculminate  from  within  the 
fallen  fruiting  body.  In  addition,  aar  null  mutants  form  ectopic  stalk  structures  (Coates  et 
al.,  2002).  Over-expression  of  aar  in  the  aar  mutant  partially  rescues  the  collapse,  but 
fruiting  bodies  remain  weaker  than  wild  type  ones  (Coates,  1999). 
101 Transmission  electron  microscopy  (TEM)  of  cross  sections  of  fruiting  bodies  of  the  aar 
mutant  revealed  a  loss  of  actin  fibres  at  the  adherens  junctions  (Grimson  et  al.,  2000).  This 
suggests  that  Aar  is  necessary  for  the  formation  of  Dictyostelium  adherens  junctions,  which 
itself  may  be  a  necessary  process  in  the  creation  of  a  rigid  fruiting  body.  Conversely,  TEM 
of  aar  mutants  over-expressing  aar  revealed  the  adherens  junctions  to  possess  abnormally 
high  levels  of  actin  filaments,  leading  to  a  buckling  of  the  membrane.  Thus  the  collapse  of 
structures  in  the  aar  mutant  could  be  explained  by  the  total  absence  of  adherens  junctions, 
whilst  the  weakness  of  the  aar  over-expressing  culminants  could  be  explained  by  an  excess 
of  adherens  junctions.  In  short,  loss  or  over-expression  of  Aar  upsets  the  balance  of  a 
highly  regulated  adhesion  process. 
If  over-expression  of  aar  affects  fruiting  body  morphology  by  causing  a  disruption  to 
regulated  cell-cell  adhesion,  the  effect  should  also  occur  in  wild  type  cells.  This  is  indeed 
the  case.  Over-expression  of  aar  in  wild  type  Dictyostelium,  causes  the  stalks  of  culminants 
to  become  twisted,  leading,  in  some  instances  to  a  collapse  of  the  structures,  as  seen  with 
the  aar  mutant  (Coates,  1999). 
In  order  to  show  that  the  C-terminal  GFP  fusion  does  not  affect  the  function  of  Aar,  both 
aar  mutant  and  wild  type  cells  were  transformed  with  the  full-length  pDXA-aar-gfp 
expression  construct.  Cells  were  starved,  and  allowed  to  develop  on  nitrocellulose  filters. 
After  24  hours,  their  morphology  was  examined  by  light  microscopy.  Transforming  aar 
mutant  cells  with  pDXA-aar-gfp  rescued  the  collapse  of  many  fruiting  bodies,  but  some 
collapse  was  also  seen  (figure  4.2b).  Expression  in  wild  type  cells  led  to  contortion  of  the 
stalk  tube,  smaller  spore  heads  and  instability  and  often  collapse  of  the  fruiting  body  (figure 
4.2d).  Both  of  these  observations  are  consistent  with  the  phenotypes  of  aar  overexpression. 
102 (b) 
(c)  (d) 
Figure  4.2  Cells  transformed  with  pDXA-aar-gfp  display  the  aar 
overexpression  phenotype  in  both  aar-  and  wild  type  cells 
(a)  aar-  Dictyostelium.  Most  culminants  have  collapsed  onto  the  substratum. 
(b)  aar-  Dictyostelium  overexpressing  aar-gfp.  Expression  of  aar-gfp  partially 
rescues  the  collapsed  fruting  body  phenotype  but  also  leaves  culminants  unstable. 
(c)  Wild  type  Dictyostelium 
(d)  Wild  type  Dictyostelium  overexpressing  aar-gfp.  Note  the  twisted  stalk  tubes, 
denoted  by  the  red  arrows,  and  the  collapsed  fruiting  body  (blue  arrow)  in  the 
aar  overexpressors.  Scale  bar  represents  0.5mm. 
x.:. 
103 4.3  Rescue  of  the  aar  mutant  phenotype  by  N-terminal  and  C-terminal  Aar-GFP 
deletions 
Each  of  the  deletion  constructs  were  transformed  into  the  aar  mutant,  and  expression  was 
determined  by  northern  analysis,  utilising  an  aar  cDNA  probe  (figure  4.3).  Maps  of  the  Aar 
deletions  are  also  included  in  the  figure.  In  addition,  western  blot  analysis  was  used  to 
detect  expression  of  the  mutant  proteins  by  way  of  their  C-terminal  GFP  tags  (figure  4.3a). 
Two  independent  clones  of  each  deletion  mutant  were  starved  and  allowed  to  develop  on 
nitrocellulose  filters.  As  with  the  full-length  mutants,  morphology  was  examined  after  24 
hours  by  light  microscopy.  The  pictures  shown  are  representative  of  both  clones  tested. 
N-terminal  deletions:  the  expression  of  AN201  Aar-GFP  and  AN258  Aar-GFP  (loss  of  the 
N-terminus  and  loss  of  the  N-terminus  plus  the  region  containing  the  Aark  phosphorylation 
sites,  respectively)  led  to  the  same  developmental  phenotype  as  expression  of  full-length 
Aar-GFP  (figure  4.4).  This  suggests  that  the  N-terminus  of  Aar,  up  to  and  including  the 
Aark  sites,  is  not  required  for  rescue  of  the  aar  fruiting  body  morphology.  However, 
AN371  and  AN587  mutants  (loss  of  the  putative  a-catenin  binding  site  and  loss  of  the  first 
7  arm  repeats,  respectively)  resemble  the  aar  mutant  (figure  4.4). 
C-terminal  deletions:  the  morphology  of  all  three  of  the  C-terminal  deletion  mutants  of 
Aar  resembled  the  aar  mutant  (figure  4.5).  This  suggests  that  the  C-terminus  of  Aar  is  not 
essential  for  developmental  rescue. 
The  minimum  sequence  of  Aar  that  will  rescue  the  mutant  morphology,  from  these  results, 
is  therefore  the  AN258  mutation 
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Figure  4.3  Detecting  expression  of  Aar-GFP  deletions  by  northern  analysis 
(a)  Nomenclature  of  N-terminal  and  C-terminal  Aar-GFP  deletions. 
ANxxx  =  deletion  of  Aar  from  the  N-terminus  as  far  as  amino  acid  xxx 
ACxxx  =  deletion  of  Aar  from  the  C-terminus  as  far  as  amino  acid  xxx 
Black  ovals  and  red  star  mark  the  Aark  phosphorylation  and  putative 
a-catenin  binding  sites,  respectively. 
(b)  Northern  analysis  of  Aar-GFP  deletion  mutants,  expressed  in  aar- 
cells.  Top  panel  shows  our  expression,  whilst  the  bottom  panel  shows 
the  ubiquitously-expressed  1g7  message,  shown  here  as  a  loading 
control.  FL  =  full-length. 
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Sample  Size  (kda) 
Positope  53 
aar-  N/A 
FL  113 
AN201  90 
AN258  84 
AN371  70 
AN587  46 
AC623  94 
AC288  60 
AC201  52 
(c) 
Figure  4.3a  Detection  of  aar-GFP  deletion  mutants  in  cell  lysates 
(a)  Western  blot  analysis  was  used  to  detect  the  expression  of  the  Aar-GFP 
deletion  mutants  in  Dictvostelium  cell  lysates.  +=  positope  positive 
control  protein;  FL  =  full-length  Aar-GFP. 
(b)  Coomassie  blue  staining  was  used  to  compare  loadings 
(c)  The  blot  in  (a)  was  subjected  to  a  greater  period  of  exposure  in  order  to  detect 
bands  of  weaker  intensity.  Only  the  first  6  lanes  are  shown. 
(d)  Table  of  predicted  sizes  for  each  Aar  deletion  mutant,  as  determined  by 
their  amino  acid  sequences. 
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LL  add Figure  4.4  Development  of  N-terminal  Aar-GFP  deletion  mutants 
Two  independent  clones  of  each  mutant  were  developed  on  nitrocellulose 
filters  for  24h.  Note  that  whilst  FL,  AN201  and  AN258  all  partially  rescue 
the  aar-  phenotype,  AN371  and  AN587  mutants  display  the  aar-  phenotype. 
Scale  bar  represents  0.5mm. 
106 Figure  4.5  Development  of  C-terminal  Aar-GFP  deletion  mutants 
Two  independent  clones  of  each  mutant  were  developed  on  nitrocellulose 
filters  for  24h.  Note  that  all  three  mutants  display  the  aar-  phenotype. 
Scale  bar  represents  0.5mm. 
107 4.4pspA  expression  in  the  Aar-GFP  deletion  mutants  (aar-  background) 
The  loss  of  aar  leads  to  both  a  delay  and  a  reduction  in  the  levels  of  expression  of  the  pre- 
spore  gene  pspA  during  development  (Coates,  1999).  These  observed  effects  are 
exaggerated  in  isolated  cells  (Grimson  et  al.,  2000).  Over-expression  of  aar  in  the  aar 
mutant  rescues  this  reduction,  leading  to  higher  levels  of  expression  than  in  wild  type  cells. 
The  ability  of  each  of  the  deletion  mutants  to  rescue  pspA  signalling  in  the  aar  mutant  was 
examined  in  isolated  cells.  Cells  were  starved  by  shaking  at  low  density  in  KK2  buffer  for 
6-8h,  before  shaking  with  1mM  cAMP  for  a  further  15  hours  to  induce  pspA  signalling.  The 
experiment  was  repeated  with  independent  clones  and  comparable  results  were  obtained. 
N-terminal  deletions:  loss  of  the  N-terminus  of  Aar  (ON201)  had  no  effect  on  the  ability 
of  Aar  to  rescue  the  null  phenotype  (figure  4.6).  However,  the  level  of  pspA  expression  in 
the  AN258  mutant  was  close  to  that  of  the  aar  mutant,  whilst  the  AN371  and  AN587 
mutants  appeared  to  show  reduced  levels  of  pspA  expression  (figure  4.6b  and  c).  This 
shows  the  region  of  Aar  containing  the  Aark  phosphorylation  sites  to  be  necessary  for  the 
full  rescue  of  pspA  signalling,  suggesting  a  requirement  for  Aark  phosphorylation. 
C-terminal  deletions:  loss  of  the  final  three  Arm  repeats  of  Aar  (AC623)  appeared  to 
increase  the  protein's  ability  to  rescue  pspA  signalling  over  and  above  that  of  the  full-length 
protein  (figure  4.6).  This  suggests  that  not  only  is  the  C-terminus  of  Aar  not  required  for 
full  pspA  rescue,  but  it  may  actually  be  inhibitory  to  Aar  signalling  function  when  the 
protein  is  over-expressed.  The  AC288  and  AC210  mutants  showed  pspA  expression  levels 
that  were  lower  than  those  of  the  aar  mutant,  but  this  will  be  discussed  in  section  4.7. 
108 Figure  4.6  Northern  analysis  of  pspA  expression  in  aar  deletion  mutants 
(a)  A  reminder  of  the  Aar-GFP  deletions. 
(b)  Northern  analysis  of  pspA  expression  in  aar  deletion  mutants,  expressed 
in  an  aar-  background.  Top  panel  represents  pspA  expression.  The  bottom 
panel  represents  Ig7  expression,  included  for  comparison  of  loadings.  WT 
=  wild  type;  FL  =  full-length. 
(c)  A  repeat  of  the  northern  analysis  in  (b),  performed  with  independent  clones. 
(d)  Table  of  statistics  based  upon  the  densitometry  readings  for  each  northern 
(calculated  using  Quantity  One  software).  Each  pspA  figure  was  normalised 
to  Ig7  levels,  before  being  expressed  as  a  percentage  of  FL  expression.  SD  = 
standard  deviation. 
1094 4.5  Development  of  Aar-GFP  deletions  in  wild  type  cells 
Each  of  the  deletion  constructs  were  transformed  into  wild  type  cells  and  expression 
determined  by  northern  analysis,  probing  for  aar  as  in  section  4.3  (figure  4.7). 
Two  independent  clones  of  each  mutant  were  starved  and  developed  on  nitrocellulose 
filters  for  24  hours,  before  examining  the  morphology  of  the  fruiting  bodies.  The  pictures 
are  representative  of  both  clones 
N-terminal  deletions:  loss  of  the  N-terminus  of  Aar  (AN201)  and  loss  of  the  Aark 
phosphorylation  sites  (AN258)  still  gave  the  characteristic  aar  over-expression  phenotype 
(figure  4.8).  Stalk  tubes  were  twisted,  spore  heads  smaller,  and  many  fruiting  bodies 
collapsed  onto  the  substratum.  The  AN371  and  AN587  mutants  (loss  of  the  putative  a- 
catenin  binding  site  and  loss  of  the  first  seven  arm  repeats,  respectively)  both  displayed 
wild  type  morphology  (figure  4.8).  These  observations  are  comparible  to  the  results  of 
expression  of  the  same  deletions  in  the  aar  mutant.  This  suggests  that  the  region  of  Aar 
between  the  N-terminus  of  . 
N258  and  AN371  Aar-GFP  is  important  for  protein  function, 
and.  This  would  be  consistent  with  a-catenin  binding  at  the  predicted  site. 
C-terminal  deletions:  wild-type  cells  over-expressing  the  C-terminal  Aar  truncations, 
AC288  &  AC210  showed  no  visible  phenotype;  that  is,  development  appeared  normal  in 
comparison  with  that  of  wild  type  cells  (figure  4.9). 
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Figure  4.7  Detecting  expression  of  aar  deletions  by  northern  analysis 
(a)  A  reminder  of  the  Aar-GFP  deletions 
(b)  Northern  analysis  of  Aar-GFP  deletions.  The  top  panel  represents  aar 
expression,  whilst  the  bottom  panel  represents  the  28s  rRNA  hand  (shown 
as  a  loading  control).  WT  =  wild  type;  FL  =  full-length. Figure  4.8  Development  of  N-terminal  Aar-GFP  deletion  mutants 
Two  independent  clones  of  each  mutant  were  developed  on  nitrocellulose 
filters  for  24h.  Note  that  whilst  AN201  and  AN258  display  the  aar  over- 
expression  phenotype,  AN371  and  AN587  appear  wild  type.  WT  =  wild 
type;  FL  =  full-length.  Scale  bar  represents  0.5mm. 
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Figure  4.9  Development  of  C-terminal  Aar-GFP  deletion  mutants 
Two  independent  clones  of  each  mutant  were  developed  on  nitrocellulose 
filters  for  24h. 
OC288  and  AC210  developed  with  wild  type 
morphology.  WT  =  wild  type;  FL  =  full-length.  Scale  bar  represents 
0.5mm. 
113 4.6  pspA  expression  in  the  Aar-GFP  deletion  mutants  (wild  type  background) 
Over-expresssion  of  aar  in  isolated  wild  type  cells  leads  to  an  increase  in  the  expression  of 
pspA  (Grimson  et  al.,  2000) 
pspA  expression  was  examined  in  isolated  cells  of  wild  type  Dictyostelium  expressing  the 
Aar-GFP  deletions.  Cells  were  shaken  at  low  density  as  before,  and  treated  with  1  mM 
CAMP  to  induce  pspA  expression.  The  experiment  was  repeated,  using  independent  clones. 
The  results  between  the  two  experiments  varied;  some  results  were  reproducible  and  others 
were  not.  These  are  discussed  below. 
N-terminal  deletions:  the  effect  of  the  AN201  and  AN258  truncations  (deletion  of  the  N- 
terminus  and  deletion  of  the  Aark  phosphorylation  sites,  respectively)  on  pspA  expression 
differed  little  from  the  expression  of  full-length  aar  in  one  northern  (figure  4.10c),  yet 
showed  dominant  negative  effects  in  the  other  (figure  4.10b).  The  effects  of  expression  of 
AN371  and  AN587  however,  were  more  reproducible.  The  former  showed  a  drastic 
reduction  in  pspA  levels,  whilst  expression  of  the  latter  had  little  effect  in  both  northerns. 
C-terminal  deletions:  expression  of  the  AC623  mutants  appeared  to  have  little  effect  on 
pspA  levels  in  both  experiments,  whilst  expression  of  both  the  AC288  and  AC210  mutants 
caused  a  drastic  reduction  in  pspA  expression  levels. 
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m Figure  4.10  Northern  analysis  of  pspA  expression  in  aar  deletion  mutants 
(a)  A  reminder  of  the  Aar-GFP  deletions. 
(b)  Northern  analysis  of  pspA  expression  in  aar  deletion  mutants,  expressed 
in  a  wild-type  background.  Top  panel  represents  pspA  expression.  The  bottom 
panel  represents  the  28s  rRNA  band,  included  for  comparison  of  loading.  WT 
=  wild  type;  FL  =  full-length. 
(c)  A  repeat  of  the  northern  analysis  in  (b),  performed  with  independent  clones. 
(d)  Table  of  statistics  based  upon  the  densitometry  readings  for  each  northern 
(calculated  using  Quantity  One  software).  Each  pspA  figure  was  normalised 
to  Ig7  levels,  before  being  expressed  as  a  percentage  of  wild  type  expression 
levels.  SD  =  standard  deviation. 
1154 4.7  Discussion 
4.7.1  Aar  and  cell  adhesion 
The  expression  of  N-terminal  and  C-terminal  Aar-GFP  deletions  affects  adhesion  and 
signalling  processes  in  both  the  aar  mutant  and  wild  type  Dictyostelium.  To  summarise  the 
adhesion  effects,  table  4.1  lists  the  morphology  of  the  deletion  mutants,  whilst  table  4.2 
summarises  the  signalling  effects  by  listing  the  pspA  expression  levels. 
Mutant  Effect  in  aar  mutant  cells  Effect  in  wild  type  cells 
FL  rescue/aar  over-expression  phenotype  aar  over-expression  phenotype 
AN201  rescue/aar  over-expression  phenotype  aar  over-expression  phenotype 
AN258  rescue/aar  over-expression  phenotype  aar  over-expression  phenotype 
AN371  aar-'phenotype  wild  type 
AN587  aar-  phenotype  wild  type 
AC623  aar-  phenotype  N/A 
AC288  aar-  phenotype  wild  type 
AC210  aar-  phenotype  wild  type 
Table  4.1  Summary  of  morphological  phenotypes 
The  resulting  morphology  of  expression  of  each  deletion  mutant  in  both  the  aar  mutant  and 
wild  type  cells  are  included. 
Loss  of  the  N-terminus  has  no  effect  on  the  ability  of  Aar  to  rescue  the  aar  mutant  fruiting 
body  morphology,  nor  its  ability  to  cause  the  over-expression  phenotype.  The  same  is  true 
of  further  deletion  to  remove  the  Aark  phosphorylation  sites.  Deletion  of  the  putative  a- 
catenin  binding  sites  does,  however,  affect  both  of  these  processes.  This  supports  the  idea 
that  amino  acids  301-331  of  Aar  contain  a  binding  site  for  a-catenin.  In  support  of  this,  a 
vinculin/cx-catenin-like  protein  has  recently  been  identified  in  Dictyostelium  (T.  Soldati, 
116 pers.  commun).  If  Aar  functions  like  ß-catenin  in  the  formation  of  adherens  junctions,  then 
cadherin  binding  would  be  expected  in  the  C-terminus  of  Aar.  Deletion  of  the  final  3  arm 
repeats  of  Aar  created  a  protein  that  was  unable  to  rescue  the  aar  mutant,  and  therefore 
further  deletions  were  also  unable  to  rescue.  The  last  three  Arm  repeats  are  therefore 
important  for  Aar  function  and  it  is  possible  that  they  could  contain  a  binding  site  for  a 
cadherin-like  molecule,  although  as  yet  no  such  protein  has  been  identified  in 
Dictyostelium. 
In  terms  of  overexpression  phenotypes,  deletions  with  loss  of  the  N-terminus  of  Aar, 
including  the  Aark  phosphorylation  sites,  acted  like  full-length  Aar.  These  results  are 
consistent  with  the  aar  mutant  rescue  experiments,  which  suggest  that  the  N-terminus  up  to 
and  including  the  Aark  phosphorylation  sites  are  not  required  for  Aar's  role  in  adhesion. 
Loss  of  the  putative  ct-catenin  binding  site  and  further  deletion  from  the  N-terminus 
prevented  the  over-expression  phenotype,  again  supporting  the  aar  mutant  data.  Deletion  of 
the  final  three  Arm  repeats  caused  a  phenotype  that  was  partially  reminiscent  of  the 
overexpression  phenotype.  However,  this  truncated  protein  fails  to  function  properly  in  the 
aar  null  mutant,  suggesting  that  a  different  mechanism  is  acting.  The  observed  phenotype 
may  be  explained  by  a  reduction  in  the  number  of  adherens  junctions.  The  truncated  protein 
may  bind  a-catenin,  but  not  a  Dictyostelium  cadherin.  This  would  mean  that  it  would 
compete  with  the  endogenous  Aar  protein  for  a-catenin.  But,  as  it  would  be  unable  to  bind 
cadherin  it  would  not  lead  to  more  recruitment  of  actin  to  the  adherens  junctions,  and  hence 
this  is  not  an  overexpression  phenotype.  Instead  this  would  prevent  the  correct  formation  of 
the  adherens  junctions  through  competition  for  one  of  the  constituent  proteins. 
Using  these  results,  a  minimum  length  of  the  protein  that  is  required  for  Aar's  adhesion 
function  can  be  defined;  both  from  the  aar-  and  wild  type  data  (figure  4.11). 
117 (a) 
NC 
FL 
AN201 
AN259 
AN371 
AN587 
(b) 
N  C 
FL 
AN201 
AN258 
AN371 
AN587 
t 
Figure  4.11  Summary  of  the  morphology  analysis  of  deletion  mutants  in  both 
aar-  and  Ax2  backgrounds. 
(a)  aar  mutant  background:  schematic  of  Aar  deletions.  FL  =  full-length.  The 
shaded  region  of  the  protein  denotes  the  minimum  length  of  protein  that  rescues/ 
gives  the  over-expression  phenotype  in  the  aar  mutant,  with  respect  to  morphology. 
This  is  determined  by  grouping  all  of  deletions  that  fail  to  rescue. 
(b)  Wild  type  background:  the  shaded  region  of  the  protein  denotes  the  minimum 
length  of  the  protein  that  is  required  to  give  an  aar  over-expression  phenotype  in 
wild  type  cells,  with  respect  to  morphology.  The  mutants  were  grouped  as  in  (a). 
118 4.7.2  Aar  and  cell  signalling 
A  summary  of  the  effects  of  expression  of  N-terminal  and  C-terminal  Aar  deletions  on 
pspA  expression  in  isolated  aar  mutant  cells  is  listed  in  table  4.2. 
Mutant  pspA  in  aar  mutant  cells 
Untransformed  Low 
FL  High 
AN201  High 
AN258  Low 
AN371  Lower  than  aar- 
AN587  Lower  than  aar- 
AC623  Higher  than  FL 
AC288  Lower  than  aar- 
AC210  Lower  than  aar- 
Table  4.2  Summary  of  pspA  expression  levels  in  Aar-GFP  deletion  mutants 
pspA  expression  levels  in  each  deletion  mutant  are  summarised  in  relationship  to  each 
other,  to  make  them  easier  to  interpret. 
Expression  of  full-length  Aar-GFP  increases  pspA  expression  levels  in  the  aar  mutant. 
Deletion  of  the  N-terminus  (ON201)  did  not  prevent  the  increase  and,  in  fact,  led  to  greater 
levels  of  pspA  expression.  Deletion  of  the  Aark  phosphorylation  sites  (AN258)  made  a 
protein  that  was  no  longer  able  to  rescue  pspA  expression.  Further  N-terminal  deletions 
(AN371  and  AN587),  not  only  failed  to  rescue  pspA  signalling,  but  also  reduced  levels  to 
below  those  observed  with  the  aar  mutant.  These  dominant  negative  effects  on  pspA 
expression,  in  the  absence  of  Aar,  suggest  that  a  second  Aar-like  protein  could  be  involved, 
or  at  least  partially  compensates  in  the  aar  mutant.  This  idea  is  further  supported  by  the  fact 
that  pspA  expression  is  not  entirely  lost  in  the  aar  mutant. 
119 Figure  4.12  defines  the  minimum  length  of  the  protein  that  is  required  for  Aar  function, 
with  respect  to  pspA  expression.  This  shows  that  the  region  of  the  protein  containing  the 
Aark  phosphorylation  sites  is  required  for  full  pspA  expression.  This  hints  that  Aark 
phosphorylation  of  Aar  may  occur  in  vivo  and,  furthermore,  may  be  required  for  pspA 
expression. 
A  reduction  in  the  expression  levels  of  pspA  was  associated  with  several  of  the  Aar-GFP 
deletions  when  expressed  in  the  aar  null  mutant.  This  could  be  an  overexpression  artefact. 
If  Aar  were  to  bind  both  negative  and  positive  regulators  of  a  the  pspA  signalling  pathway, 
overexpression  of  certain  deletion  mutants  could  sequester  out  just  the  negative  regulator, 
which  would  lead  to  an  overload  of  the  pathway.  Conversely,  the  opposite  could  be  true, 
and  expression  of  certain  deletion  mutants  could  be  leading  to  inhibition  of  the  pathway  by 
way  of  competing  out  a  co-regulator  of  pspA  expression.  This  second  scenario  could  be 
explained  by  involvement  of  a  second  Dictyostelium  catenin  molecule  in  the  pspA 
signalling  pathway.  In  support  of  this,  antisera  raised  to  amino  acids  5-304  of  human 
plakoglobin  recognises  a  69  kDa  protein  in  aar-  whole  cell  lysates  (Coates,  1999). 
Antiserum  raised  to  the  C-terminus  of  human  plakoglobin  does  not  cross-react  with  this 
protein,  named  DdPlako.  In  wild  type  cells,  Aar  may  be  the  sole  GskA  downstream  target 
in  the  pspA  signalling  pathway  of  wild  type  cells  but,  in  the  absence  of  Aar,  a  DdPlako 
could  replace  Aar  in  the  pspA  signalling  pathway.  Such  cross-talk  would  not  be  unique  to 
the  Dictyostelium  pathway.  The  functions  of  (3-catenin  and  plakoglobin  are  not  mutually 
exclusive.  As  examples,  over-expression  of  plakoglobin  induces  axes  duplication  in 
Xenopus  (Karnovsky  and  Klymkowsky,  1995)  whilst  ß-catenin  localises  to  the 
desmosomes  in  plakoglobin  null-mutant  mice  (Bierkamp  et  al.,  1999). 
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Figure  4.12  Summary  of  the  pspA  northern  analysis  of  aar  deletion  mutants  in 
the  aar  mutant  background. 
(a)  Schematic  of  Aar  deletions.  FL  =  full-length.  The  shaded  region  of  the 
protein  is  the  minimum  length  required  for  full  rescue  of  pspA  signalling  in  the  aar 
null  mutant.  The  minimum  length  was  determined  by  overlapping  the  mimum 
N-terminal  deletion  that  still  gives  full  rescue,  with  the  minimum  C-terminal 
deletion  that  still  gives  full  rescue.  As  the  AC210  mutant  showed  higher  levels  of 
pspA  expression  than  the  full-length  protein,  the  last  3  Arm  repeats  were  deemed  to 
be  in  some  way  inhibitory.  (The  data  for  Ax2  mutants  is  excluded  from  this  analysis, 
as  results  were  not  sufficiently  reproducible). 
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ý-  AC288 Evidence  for  cross-talk  already  exists  in  Dictyostelium  also.  Firstly,  the  over-expression  of 
Aar  partially  rescues  the  gskA  null  morphological  phenotype,  via  a  reduction  of  ecrB 
expression  (Coates,  1999).  Normally,  Aar  doesn't  affect  ecmB  expression  or  stalk  cell  fate. 
aar  expression  peaks  in  the  latter  stages  of  development,  whereas  the  GskA-mediated 
prestalkB:  prespore  cell  fate  decision  is  made  much  earlier,  at  the  mound  stage  (Harwood  et 
al.,  1995).  This  suggests  that  the  involvement  of  Aar  in  the  GskA/prestalkB  pathway  is  an 
over-expression  artefact.  Secondly,  the  over-expression  of  GskA  in  the  aar  mutant  does 
not  rescue  the  pspA  signalling  defect  (Grimson  et  al.,  2000),  but  over-expression  of  an 
Axin-binding  mutant  of  GskA  (GskA  G/R)  does  (Fraser  et  al.,  2002).  One  possibility  is  that 
GskA  could  lie  downstream  of  Aar  in  the  pspA  signalling  pathway,  but  given  all  the 
evidence  that  seems  unlikely.  No  Axin-like  protein  has  been  discovered  in  Dictyostelium  to 
date,  but  the  fact  that  there  is  a  phenotype  associated  with  the  expression  of  GskA  G/R  in 
Dictyostelium,  it  seems  attractive  to  think  that  one  may  exist.  Loss  of  binding  to  an  Axin- 
like  protein  could  allow  GskA  to  interact  with  other  substrates,  which  could  include 
DdPlako. 
Aark  phosphorylation  of  Aar  could  be  required  for  Aar  binding  to  this  possible  Axin-like 
protein.  GskA  phosphorylation  could  then  be  required  for  activation  of  Aar.  In  this 
hypothesis,  binding  of  cAMP  to  the  cAR3  receptor  may  lead  to  activation  of  GskA  and,  in 
a  multistep  process,  GskA  and  Aark  phosphorylation  would  be  required  for  activation  of 
Aar.  This  activation  would  promote  pspA  expression.  However,  if  the  interaction  between 
fYOMs  E((IO  S 
GskA  and  this  possible  Axin-like  protein  was  lost,  then  GskA  would  become  re  us 
and  may  activate  other  factors,  which  could  include  DdPlako. 
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Overexpression  of  Aardvark 
122 5.1  Introduction 
Aark  has  been  identified  as  a  kinase  that  phosphorylates  Aar  at  a  defined  site  in  vitro. 
Deletion  of  a  short  region  of  Aar  that  contains  the  site  of  Aark  phosphorylation  creates  a 
protein  that  is  no  longer  able  to  mediate  pspA  expression.  Further  N-terminal  and  C- 
terminal  deletions  of  Aar  have  identified  regions  of  the  protein  that  are  required  for  the 
correct  morphology  of  the  fruiting  body.  These  sites  are  assumed  to  be  binding  sites  that 
mediate  the  formation  of  adherens  junctions.  It  was  the  aim  at  the  outset  of  this  chapter  to 
examine  the  subcellular  localisation  of  full-length  Aar,  and  also  its  deletions,  to  further 
investigate  the  function  of  these  possible  interactions. 
5.2  Aar-GFP  cannot  be  visualised  in  living  cells 
As  a  control,  unfused  GFP  was  expressed  from  the  actin  15  promoter  in  aar  mutant  cells 
and  examined  by  confocal  microscopy.  The  GFP  protein  showed  a  diffuse  pattern  of 
fluorescence,  suggesting  no  restriction  of  the  GFP  protein  within  the  cell.  As  seen  in  many 
other  cases,  there  was  a  slight  enrichment  in  the  nucleus  (figure  5.1a).  In  contrast, 
examination  of  aar-  Aar-GFP  cells  by  confocal  microscopy  showed  only  background  levels 
of  fluorescence  (figure  5.1b).  Fixed  wild  type  cells  stained  with  anti-Aar  antisera  showed 
that  endogenous  Aar  has  a  diffuse  pattern  of  staining  throughout  the  cytoplasm  (figure 
5.1c). 
Several  possible  explanations  exist  to  explain  why  the  over-expressed  protein  cannot  be 
detected.  One  reason  could  be  that  the  transgene  is  not  expressed.  Northern  analysis  was 
used  to  address  this  question  (figure  5.1d).  Total  RNA  was  isolated  from  both  aar  mutant 
cells  and  aar  mutant  cells  transformed  with  pDXA-aar-gfp.  Aar  cDNA  was  used  to  probe 
the  blot,  and  demonstrated  the  prescence  of  the  transgene  in  transformed  cells  only. 
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Figure  5.1  Expression  of  a  full-length  GFP-tagged  version  of  Aar 
(a) Confocal  microscopy  image  of  aar-  cells  transformed  with  GFP  alone  (false- 
coloured  green) 
(b)  Confocal  microscopy  image  of  aar-  cells  transformed  with  pDXA-aar-gfp 
(false-coloured  green) 
(c)  Anti-Aar  anti-sera  staining  of  wild  type  Dictyostelium  (false-coloured  red) 
The  scale  bars  in  (a),  (b)  and  (c)  represent  10µm. 
(d)  Northern  analysis  to  detect  the  expression  of  Aar-GFP.  A=  aar-  cells, 
AG  =  aar-  cells  transformed  with  pDXA-aar-gfp 
Top  panel  shows  aar-gfp  expression,  whilst  the  bottom  panel  shows  expression 
of  the  ubiquitously-expressed  Ig7  for  comparison  of  loadings. 
124 5.3  Expression  of  Aar-V5-His 
As  the  aar-gfp  mRNA  was  present,  then  it  is  possible  that  it  was  not  translated.  The  use  of 
anti-GFP  antisera  to  detect  the  fusion  protein  failed  due  to  the  high  level  of  non-specificity 
shown  by  the  antisera  towards  whole  cell  lysates  (data  not  shown).  The  GFP  sequence  of 
pDXA-aar-gfp  was  removed  and  replaced  with  a  double  tag  comprising  the  V5  epitope  and 
6x  His  residues,  making  pDXA-aar-V5-his  (figure  5.2).  The  V5  epitope  facilitates  easy 
detection  of  the  protein,  which  could  be  purified  via  its  6x  His  tag  on  immobilised  cobalt 
resin  (TalonTM,  BD  Clontech).  The  presence  of  this  fusion  protein  in  aar  mutant  cells  was 
detected  by  western  analysis.  Figure  5.3a  shows  the  presence  of  Aar-V5-His,  present  in  the 
transformed  cell  lysate  (AV),  but  absent  in  the  untransformed  aar-  cell  lysate  (A). 
Aar-V5-His  is  predicted  to  have  a  molecular  weight  of  88kDa.  However,  a  second 
methionine  residue,  i.  e.,  another  putative  translational  start  site,  exists  at  the  end  of  the 
additional  N-terminal  sequence  that  Aar  posseses  compared  with  ß-catenin.  The  western 
blot  analysis  in  figure  5.3  reveals  that  the  cell  must  translate  this  additional  sequence  in 
vivo,  as  the  size  of  Aar-V5-His  appears  to  be  approximately  88kDa.  In  addition  to  detecting 
the  protein,  the  ability  of  Aar-V5-His  to  induce  higher  levels  of  pspA  expression  was 
demonstrated  by  northern  analysis  (figure  5.3b),  showing  that  this  fusion  protein  is 
functional,  at  least  with  respect  to  pspA  signalling. 
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Figure  5.2  The  8.675Kb  pDXA-aar-V5-his  expression  vector 
The  861bp  Amp`  gene  allows  for  selection  in  bacteria,  whilst  the  831hp  Neo`  gene  allows 
for  positive  selection  of  eukaryotic  transformants.  The  Dictvostelium  origin  of  replication  is 
also  present  for  extrachromosomal  expression. 
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Figure  5.3  Expression  of  pDXA-aar-V5-his  in  the  aar  mutant 
(a)  Expression  of  Aar-V5-His  can  he  detected  in  oar-  cells  by  Urstern  blot 
analysis:  P=  positope  positive  control  protein  (53kDa),  A=  oar-  cell  lysate, 
AV  =  aar-  Aar-V5-His  cell  lysate.  Aar-V5-His  has  a  predicted  moleular 
weight  of  88kDa. 
(b)  Northern  analysis  of  aar-  Aar-V5-His  transformants  shows  that  the  protein 
is  functional,  as  determined  by  an  increase  in  ppspA  expression.  A=  oar-  cells, 
AV=  nur-  Aar-V5-His  cells.  Top  panel  shows  pupA  expression.  Bottom  panel 
shows  expression  of  the  ubiquitously-expressed  /g7.  included  for  comparison 
of  loadings. 
126 5.4  Aar-GFP  is  destabilised  within  the  cell 
Detection  of  unfused  GFP  by  confocal  microscopy  demonstrated  that  the  cells  can  translate 
the  message  and  synthesise  the  protein.  Likewise,  the  use  of  the  V5-His  tag  demonstrated 
that  the  aar  sequence  can  also  be  translated  and  the  protein  synthesised.  This  makes  it  very 
unlikely  that  the  Aar-GFP  protein  is  not  being  synthesised  within  the  cell. 
If  Aar-GFP  protein  is  synthesised  by  the  cell,  then  why  could  no  fluorescence  be  detected? 
One  explanation  centres  around  the  intrinsic  fluorescence  of  the  GFP  protein.  The  GFP 
molecule  is  made  up  of  238  amino  acids  arranged  in  one  single  polypeptide  that  is  non- 
fluorescent.  Fluorescence  is  emitted  from  an  intrinsic  chromophore  formed  by  cyclisisation 
and  oxidation  of  three  adjacent  amino  acids  (Ser-65,  Tyr-66,  Gly-67)  (Cody  et  al.,  1993). 
From  the  synthesis  of  the  polypeptide  to  completion  of  the  final  fluorophore  takes 
approximately  4  hours  at  22°C  in  vitro  (Cody  et  al.,  1993).  This  presents  two  ways  in  which 
Aar-GFP  fluorescence  could  be  prevented.  Firstly,  the  correct  folding  of  GFP  is  of 
paramount  importance  to  its  fluorescence.  In  other  words,  any  attachment  to  the  protein  that 
interferes  with  the  protein's  folding  may  either  reduce  or  abolish  fluorescence.  It  may  be 
that  the  Aar-GFP  fusion  protein  folds  in  such  a  way  as  to  hinder  the  cyclisation  and 
oxidation  of  amino  acids  65-67  of  GFP,  thus  affecting  fluorescence.  The  successful  GFP 
`tagging'  of  armadillo  repeat-containing  proteins,  however,  has  been  described  many  times, 
which  makes  errors  in  folding  an  unlikely  reason  for  the  lack  of  fluorescence. 
The  second,  and  more  likely  scenario  is  that  Aar  is  under  tight  post-translational  control 
within  the  cell,  such  that  the  turnover  of  the  protein  is  high.  In  mammalian  cells,  ß-catenin 
is  targeted  for  breakdown  via  the  proteasome  following  GSK-3  phosphorylation.  It  is  only 
upon  Wnt  stimulation  of  the  cell  that  ß-catenin  is  allowed  to  accumulate  and  induce 
expression  of  downstream  genes.  Aar-GFP  may  be  subject  to  a  similar  mechanism  of 
127 control  in  Dictyostelium.  This  would  mean  that  although  Aar-GFP  is  expressed  at  high 
levels,  each  individual  molecule  is  not  present  for  a  sufficient  amount  of  time  to  produce 
the  fluorophore  and  hence  fluoresce.  If  this  were  the  case,  then  western  blot  analysis  should 
detect  the  protein.  However,  the  poor  specificity  of  the  antisera  when  tested  against 
Dictyostelium  whole  cell  lysates  made  this  difficult. 
5.5  Is  Aar-GFP  under  developmental  regulation? 
Both  aar  mutant  and  wild  type  cells  expressing  Aar-GFP  were  starved  and  allowed  to 
develop  for  24  hours.  The  resulting  fruiting  bodies  were  examined  by  epifluorescence  UV 
microscopy.  The  level  of  fluorescence  in  Aar-GFP  over-expressing  cells  was  comparable  to 
that  of  untransformed  cells  (figures  5.4a  &  c).  Fluorescence  could  however,  be  detected  in 
fruiting  bodies  of  cells  transformed  with  gfp  alone  (figure  5.4b).  This  suggests  that  even  if 
Aar-GFP  is  under  developmental  regulation,  the  levels  of  protein  are  insufficient  to  be 
detected  by  these  methods. 
5.6  Expression  of  Aar-GFP  in  fbxA-  Dictyostelium 
As  discussed  in  chapter  1,  following  GSK-3  phosphorylation,  the  F-box  protein  ßTrcp 
binds  ß-catenin,  thus  targeting  it  for  breakdown  via  the  proteosome.  At  least  one 
Dictyostelium  ßTrcp  homologue,  FbxA,  exists.  pDXA-aar-gfp  (and  pDXA-aar-V5-his  as  a 
positive  control)  were  transformed  into  Dictyostelium  cells  null  for  JbxA.  As  with  the  aar 
mutant,  Aar-GFP  could  not  be  detected  by  confocal  microscopy  (figure  5.5b).  Northern 
analysis  confirmed  that  the  message  was  present  (figure  5.5c).  The  presence  of  Aar-V5-his 
was  confirmed  by  western  blot  analysis  (figure  5.5d),  which  was  consistent  with  the 
findings  in  the  aar  mutant.  If  Aar-GFP  is  subject  to  degradation  within  the  cell,  it  would 
appear  that  it  is  via  an  FbxA-independent  mechanism. 
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Figure  5.4  Development  of  Aar-GFP  transformants 
Cells  were  developed  on  nitrocellulose  filters  for  24h,  and  viewed 
under  a  UV  dissecting  microscope. 
(a)  Untransformed  cells 
(b)  Cells  transformed  with  gfp  alone 
(c)  Cells  transformed  with  pDXA-aar-gfp 
Scale  bar  represents  0.5mm 
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Figure  5.5  Detection  of  overexpressed  Aar  infbxA-  cells 
(a)  Confocal  image  ofjbxA-  cells  transformed  with  gfp  alone 
(b)  Confocal  image  of  fbxA-  cells  transformed  with  pDXA-aar-gfp 
Scale  bars  in  (a)  and  (b)  represent  10µm 
(c)  Northern  analysis  to  detect  aar-gfp  message,  F  =JbxA-  cells, 
FG  =JbxA-  cells  transformed  with  pDXA-aar-gfp.  Top  panel  shows  aar 
expression,  whilst  the  bottom  panel  shows  levels  of  the  28s  rRNA  subunit, 
shown  for  comparison  of  loadings. 
(d)  Western  analysis  to  detect  Aar-V5-his  (predicted  molecular  weight  of 
88kDa)  in  fbxA-  cells.  P=  positope  positive  control  protein  (53kDa); 
F  =JbxA-  cell  lysate;  FV  =  fbxA-  Aar-V5-his  cell  lysate. 
130 
PF  FV 5.7  Inhibition  of  GskA  by  treatment  with  lithium  chloride 
If  Aar-GFP  is  broken  down  within  cells,  it  would  appear  not  to  be  via  the  F-box  protein 
FbxA.  This  does  not  preclude  that  Aar-GFP  is  degraded  following  the  binding  of  another  F- 
box  protein,  as  multiple  F-box  proteins  exist  in  mammals,  flies  and  plants  and  so  more 
would  be  predicted  to  exist  in  Dictyostelium  (see  Kipreos  and  Pagano,  2000) 
To  address  the  question  of  whether  GskA  activity  leads  to  Aar-GFP  degradation,  lithium 
chloride  (LiCl)  treatment  was  used  to  inhibit  the  kinase.  aar  mutant  cells  containing  either 
GFP  alone  or  Aar-GFP  were  treated  with  10mM  lithium  chloride  and  viewed  after  30 
minutes  by  confocal  microscopy. 
Treatment  of  GFP-only  transformants  caused  the  cells  to  become  more  rounded,  and  also 
appeared  to  increase  their  fluorescence  (figure  5.6).  However,  no  difference  in  fluorescence 
was  observed  between  the  treated  and  untreated  Aar-GFP  transformants.  This  would 
suggest  that  inhibition  of  GskA  does  not  stabilise  Aar-GFP.  This  is  also  consistent  with 
previous  observations  that  GskA  appears  to  act  positively  on  Aar  (Fraser  et  al.,  2002; 
Grimson  et  al.,  2000).  On  two  independent  occasions,  however,  a  very  small  number  (less 
than  1:  100)  of  Aar-GFP  fluorescent  cells  were  detected  (figure  5.7).  The  fluorescence 
within  these  cells  was  very  diffuse,  but  was  absent  from  a  subcellular  compartment  with  the 
appearance  of  the  nucleus.  Upon  treatment  of  these  cells  with  lithium  chloride  the 
fluorescence  pattern  changed,  from  diffuse  to  a  more  concentrated  pattern,  in  the 
subcellular  compartment  that  appears  to  be  the  nucleus.  The  same  effect  was  not  observed 
with  sodium  chloride  controls  or  with  treatment  with  IMPase  inhibitors.  This  would  suggest 
that  this  effect  is  due  to  the  inhibition  of  GskA,  and  not  the  alternative  LiCI  target  within 
the  cell,  which  is  IMPase.  Unfortunately,  it  was  not  possible  to  repeat  this  experiment 
further,  as  no  fluorescent  cells  have  since  been  detected. 
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Figure  5.6  Inhibition  of  GskA  by  treatment  with  lithium  chloride 
Treatment  of  aar-  cells  transformed  with  pDXA-aar-gfp  with  50mM  LiCI 
for  30  minutes  failed  to  restore  fluorescence. 
(a)  aar-  GFP  only  cells  -  note  the  increase  in  roundedness  and  fluorescence 
after  treatment  with  LiC1. 
(b)  aar-  Aar-GFP  cells 
Scale  bar  represents  IO  tm 
132 
(aý  -  L1CI 
(b)  -  LiCI Figure  5.7  Nuclear  translocation  of  Aar-GFP 
Confocal  microscopy  was  used  to  detect  fluorescence  of  Aar-GFP  cells. 
Untreated  cells,  cells  treated  with  NaCl  and  cells  treated  with  the  IMPase 
inhibitor  all  showed  a  diffuse  fluorescence  pattern,  with  exclusion  from 
what  would  appear  to  be  the  nucleus.  Treatment  with  LiCl,  led  to  the 
translocation  of  Aar-GFP  to  the  nucleus.  Scale  bars  represent  10µm. 
133 5.8  Proteasome  inhibition 
The  ubiquitin-proteasome  pathway  is  responsible  for  the  degradation  of  the  vast  majority  of 
both  short  and  long-lived  proteins  synthesised  within  the  cell.  Therefore,  if  Aar-GFP 
becomes  degraded  shortly  after  synthesis,  it  is  highly  likely  that  the  proteasome  is involved. 
MG-132  is  a  potent,  reversible,  cell-permeable  proteasome  inhibitor  (Tsubuki  et  at.,  1996). 
The  use  of  MG-132  to  inhibit  the  proteasome  in  Dictyostelium  has  previously  been 
described  (Pukatzki  et  al.,  2000).  If  Aar-GFP  is  degraded  via  the  ubiquitin-proteasome 
pathway,  then  treatment  of  transformants  with  MG-132  would  be  expected  to  produce 
fluorescence. 
aar  mutant  cells  transformed  with  pDXA-aar-gfp  were  treated  with  MG-  132  for  6  hours,  to 
allow  the  protein  to  accumulate  and  the  GFP  fluorophore  to  form.  In  addition  to  Aar-GFP 
transformants,  GFP  only  controls  were  also  treated.  Cells  were  viewed  after  6  hours  by 
confocal  microscopy  and  cell  lysates  were  produced  for  western  blot  analysis  with  anti- 
ubiquitin  antisera.  Successful  inhibition  of  the  proteasome  leads  to  a  build  up  of 
ubiquitinated  proteins  within  the  cell,  seen  as  a  smear  on  a  western  blot.  Whilst  the 
successful  inhibition  of  the  proteasome  was  observed  (figure  5.8c),  no  fluorescence  was 
detected  in  the  Aar-GFP  transformants  (figure  5.8b).  This  would  suggest  that  the  sequence 
of  Aar  responsible  for  preventing  fluorescence  -  the  `destabilisation  motif'  -  leads  to  a 
conformation  of  the  fusion  protein  that  prevents  the  production  of  the  GFP  fluorophore. 
Alternatively,  this  sequence  contains  a  degradation  motif,  responsible  for  targetting  Aar- 
GFP  for  breakdown  independently  of  the  ubiquitin-proteasome  pathway. 
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Figure  5.8  Treatment  of  cells  with  the  proteasome  inhibitor  MG-132 
Confocal  microscopy  was  used  to  detect  Aar-GFP 
(a)  aar-  cells  transformed  with  GFP  alone 
(b)  aar-  cells  transformed  with  pDXA-aar-gfp 
Scale  bar  represents  10µM 
(c)  MG-  132-treated  aar-  Aar-GFP  cell  lysates,  probed  with  anti-ubiquitin 
antibody.  -=  untreated,  +=  treated  for  6h  with  100µM  MG-132 
(d)  Coomassie  blue  staining  of  a  duplicate  of  the  gel  used  in  (c),  to 
demonstrate  equal  loading. 
135 5.9  Aar-GFP  deletions  in  aar  mutant  cells 
Direct  evidence  for  Aar-GFP  destabilisation  remains  elusive.  However,  if  this  is  an  active 
mechanism,  it  should  be  possible  to  identify  a  part  of  Aar  that  is  responsible  for  protein 
destabilisation.  To  test  this,  confocal  microscopy  was  used  to  examine  the  N-terminal  and 
C-terminal  Aar  deletions  (see  chapter  4)  at  the  subcellular  level.  Deletion  mutants  in  both 
aar  mutant  and  wild  type  backgrounds  were  examined. 
N-terminal  deletions:  in  aar  mutant  cells,  no  fluorescence  was  detectable  with  the  AN201, 
AN258  and  AN371  mutants  (loss  of  the  N-terminus,  loss  of  the  Aark  phosphorylation  sites 
and  loss  of  the  putative  a-catenin  binding  site,  respectively)  (figure  5.9).  However,  the 
AN587  mutants  (loss  of  arm  repeats  1-7)  displayed  fluorescence  comparable  to  the  levels  of 
the  GFP-only  transformants,  which  was  present  throughout  the  cell. 
C-terminal  deletions:  whilst  the  AC623  mutants  (deletion  of  the  final  3  arm  repeats)  failed 
to  fluoresce,  both  the  AC288  and  AC210  mutants  showed  high  levels  of  fluorescence 
(figure  5.10),  which,  again,  was  present  throughout  the  cell. 
136 Figure  5.9  N-terminal  deletions  of  Aar-GFP  in  the  aar  mutant 
Confocal  microscopy  was  used  to  detect  fluorescence.  The  most  C-terminal 
fragment  of  Aar  (AN587)  displayed  GFP  fluorescence.  GFP  =  aar-  cells 
transformed  with  gfp  alone.  FL  =  aar-  cells  transformed  with  full-length 
pDXA-aar-gfp.  Scale  bars  represent  10µm. 
137 Figure  5.10  C-terminal  deletions  of  Aar-GFP  in  the  aar  mutant 
Confocal  microscopy  was  used  to  detect  fluorescence.  Deletion  of  the 
final  3  arm  repeats  (AC623)  had  no  effect  on  fluorescence,  but  further 
deletion  of  the  C-terminus  (AC288  and  OC210)  led  to  levels  of 
fluorescence  comparable  with  control  cells.  GFP  =  aar-  cells 
transformed  with  gfp  alone.  Scale  bars  represent  10µm. 
138 5.10  Aar-GFP  deletions  in  wild  type  cells 
The  same  deletions  as  used  in  section  5.9  were  also  examined  in  wild  type  Dictyostelium,  to 
see  if  endogenous  Aar  has  any  effect  on  the  localisation  of  the  truncated  proteins.  As  the 
anti-Aar  antisera  used  in  figure  5.1c  was  no  longer  available,  the  GFP  tags  were  relied  upon 
for  further  localisation  studies. 
N-terminal  deletions:  as  with  the  aar  mutant  cells,  no  fluorescence  was  detectable  in  the 
ON201,  AN258  and  AN371  mutants  (loss  of  the  N-terminus,  loss  of  the  Aark 
phosphorylation  sites  and  loss  of  the  putative  a-catenin  binding  site,  respectively)  (figure 
5.11).  However,  the  AN587  mutants  (loss  of  arm  repeats  1-7)  again  displayed  fluorescence 
comparable  to  the  levels  of  the  GFP-only  transformants. 
C-terminal  deletions:  whilst  the  AC623  mutants  (deletion  of  the  final  3  arm  repeats)  failed 
to  fluoresce,  both  the  AC288  and  AC210  mutants  showed  high  levels  of  fluorescence 
(figure  5.12).  Again,  this  was  consistent  with  the  results  seen  in  the  aar  mutant.  With  the 
AC288  mutants,  both  diffuse  cytoplasmic  fluorescence  and  a  punctate  pattern  of 
fluorescence  were  observed  (figure  5.12). 
By  aligning  the  deletion  sequences  and  comparing  those  which  fluoresced,  the  boundaries 
of  the  minimum  sequence  that  abolishes  Aar-GFP  fluorescence  was  determined  (figure 
5.13).  This  sequence  makes  up  the  putative  `destabilisation  motif'  of  Aar. 
139 Figure  5.11  N-terminal  deletions  of  Aar-GFP  in  wild  type  cells 
Confocal  microscopy  was  used  to  detect  fluorescence.  The  most  C-terminal 
fragment  of  aar  (AN587)  displayed  GFP  fluorescence.  GFP  =  car-  cells 
transformed  with  g  fp  alone.  FL  =  aar-  cells  transformed  with  full-length 
pDXA-aar-gfp.  Scale  bars  represent  104m. 
140 Figure  5.12  C-terminal  deletions  of  Aar-GFP  in  wild  type  cells 
Confocal  microscopy  was  used  to  detect  fluorescence.  Deletion  of  the  final 
three  arm  repeats  (AC623)  had  no  effect  on  fluorescence,  but  further  deletion 
of  the  C-terminus  (AC288  and  AC2  10)  led  to  levels  of  fluorescence  comparable 
with  control  cells.  GFP  =  aar-  cells  transformed  with  GFP  alone.  Scale  bars 
represent  10µm. 
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Figure  5.13  Defining  the  minimum  sequence  required  for  Aar  destabilisation 
(a)  Full-length  Aar  and  each  deletion  have  been  aligned.  Those  that  fail  to  fluoresce 
have  been  shaded  out.  This  allows  the  boundaries  of  the  destabilisation  sequence  to 
be  defined  (broken  red  lines). 
(b)  Amino  acid  sequence  of  the  'destabilisation  motif  of  Aar. 
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__w 5.11  Discussion 
One  of  the  crucial  aims  of  the  work  presented  in  this  chapter  was  to  express  full-length  Aar 
protein,  with  a  C-terminal  GFP  fusion,  and  examine  its  subcellular  localisation.  In  trying  to 
do  this,  a  putative  Aar  destabilisation  motif  was  mapped. 
The  initial  finding  that  no  fluorescence  could  be  detected  upon  transformation  of  cells  with 
pDXA-aar-gfp,  suggested  that  either  the  gene  or  the  protein  was  not  present.  Northern 
analysis  confirmed  both  the  presence  of  the  construct  and  expression  of  the  gene.  In 
addition,  the  protein  was  detected  by  western  blot,  albeit  at  low  levels.  This  leaves  several 
possible  explanations  as  to  why  a  GFP  fusion  protein  could  be  expressed,  yet  fluorescence 
not  be  detected.  Each  explanation  is  individually  addressed  below. 
"  The  GFP  polypeptide  is  not  being  synthesised  correctly,  i.  e.  there  are  mutations  in  the 
DNA  construct  which  lead  to  a  truncated  protein.  The  entire  length  of  the  aar-gfp  gene 
was  sequenced  commercially,  and  the  use  of  DNA  analysis  software  showed  that  no 
mutations  were  present.  There  is  no  reason  to  believe  that  the  sequence  of  the  transgene 
does  not  correctly  encode  for  an  Aar-GFP  fusion. 
"A  part  of  the  aar-gfp  mRNA  sequence  inhibits  its  own  translation.  Several  factors  argue 
against  this  being  the  case.  Firstly,  the  Aar  over-expression  morphology  is  observed 
when  cells  containing  pDXA-aar-gfp  are  allowed  to  develop.  Secondly,  the  detection  of 
Aar-V5-his  by  western  blot  and  the  detection  of  GFP  alone  by  confocal  microscopy 
proves  that  both  the  aar  and  gfp  sequences  can  be  translated.  There  is  no  reason  why 
the  combination  of  aar  with  gfp  should  lead  to  a  great  reduction  in  the  levels  of  protein 
that  are  synthesised  within  the  cell. 
"  As  the  evidence  presented  so  far  suggests  that  Aar-GFP  is,  in  fact,  synthesised  by  the 
ribosomes  at  the  normal  rate,  then  another  explanation  is  that  the  GFP  protein  is 
incorrectly  folded  due  to  the  Aar  fusion.  The  intrinsic  fluorescence  of  GFP  relies  on  the 
143 correct  folding  of  the  238  amino  acid  polypeptide.  Following  correct  folding,  three 
adjacent  amino  acids  (Ser-65,  Tyr-66,  Gly-67)  become  cyclisised  and  oxidised  to  form 
the  fluorophore.  This  process  takes  up  to  4  hours  in  vitro.  The  possibility  of  incorrect 
GFP  folding  cannot  be  ruled  out  from  the  evidence  presented  in  this  chapter.  However, 
successful  GFP  tagging  of  other  arm  repeat-containing  proteins  has  previously  been 
reported  (Giannini  et  al.,  2000;  Miller  and  Moon,  1997;  Mimori-Kiyosue  et  al.,  2000; 
Oda  and  Tsukita,  1999). 
"  Degradation  of  Aar-GFP  is  the  remaining  explanation  for  a  lack  of  fluorescence  in 
transformed  cells.  Several  reasons  for  this  may  exist.  Firstly,  the  structure  of  the  Arm 
repeats  is  a-helical.  It  may  be  that  some  of  the  deletions  disrupt  the  secondary  structure 
of  Aar  in  such  a  way  as  to  compromise  the  protein's  folding.  This  could  lead  to  the 
protein  become  degraded.  The  secondary  structure  of  the  protein  may  possibly  not  be 
compromised.  In  which  case,  either  an  insufficient  level  of  Aar-GFP  within  the  cell,  or 
a  turnover  rate  high  enough  to  leave  GFP  with  insufficient  time  to  fold  correctly,  would 
prevent  fluorescence.  0-catenin  is  under  tight  post-translational  regulation,  targeted  for 
breakdown  via  the  proteasome,  following  GSK-3  phosphorylation  and  binding  of  the  F- 
box  protein,  (3Trcp.  Expression  of  Aar-GFP  in  a  strain  null  for  the  Dictyostelium  F-box 
protein,  FbxA,  failed  to  produce  fluorescence.  Other  Dictyostelium  F-box  proteins  may 
exist,  and  so  this  method  of  degradation  cannot  be  ruled  out.  Inhibition  of  GskA,  the 
Dictyostelium  GSK-3  homologue  also  failed  to  yield  Aar-GFP  fluorescence.  However, 
some  evidence  has  been  presented  which  suggests  that  the  inhibition  of  GskA  may  lead 
to  a  change  in  the  subcellular  localisation  of  Aar-GFP  (see  chapter  6  for  further 
discussion). 
One  unexpected  finding  was  the  punctate  pattern  of  fluorescence  observed  when  the  AC288 
mutant  was  expressed  in  a  wild  type  background.  This  may  be  have  simply  been  an  over- 
expression  artefact.  The  spots  may  represent  aggregates  of  the  fusion  protein,  formed  due  to 
144 the  high  levels  of  protein  within  the  cell,  or  they  could  represent  the  fusion  protein 
localising  to  the  lysosomes,  as  part  of  a  degradation  pathway,  again  brought  about  by  the 
high  levels  of  protein  present  within  the  cell. 
Two  plant  (3-catenin  homologues  exist  in  Arabidopsis  thaliana,  Arabidillo-1  and 
Arabidillo-2  (for  `Arabidopsis  Armadillo').  Interestingly,  no  fluorescence  is  detected  when 
C-terminal  GFP  fusions  of  either  are  over-expressed  in  Arabidopsis  (J.  C.  Coates,  pers. 
commun.  )  Both  of  these  proteins  contain  F-box  motifs  at  their  N-terminus.  This  would 
suggest  these  proteins  do  not  require  binding  of  an  F-box  protein  to  be  targeted  by  the  E3 
ubiquitin  ligase.  On  closer  inspection  of  the  amino  acid  sequence,  an  N-terminal  F-box 
domain  can  also  be  found  in  Aar.  However,  the  AN371  truncation  lacks  the  F-box  motif, 
yet  does  not  fluoresce.  It  may  be  that  both  the  F-box  domain  and  another  site  are  required 
for  targetting  to  the  E3  ubiquitin  ligase.  Whatever  the  case,  elucidation  of  the  mechanism  of 
Aar  destabilisation  should  provide  further  insight  into  the  regulation  of  this  important  class 
of  molecule. 
145 Chapter  6 
Discussion 
146 6.1  Aims  of  work 
It  was  the  aim  of  this  thesis  to  answer  the  following  questions: 
"  Does  GskA  directly  phosphorylate  Aar? 
"  What  physiological  roles  can  be  assigned  to  the  various  features  of  the  Aar  sequence? 
"  What  does  the  subcellular  localisation  of  Aar  reveal  about  Aar  protein  function? 
6.2  Does  GskA  directly  phosphorylate  Aar? 
The  studies  presented  in  this  thesis  failed  to  demonstrate  that  GskA  directly  phosphorylates 
Aar.  Peptides  based  upon  the  putative  N-terminal  GSK-3  phosphorylation  sites  of  Aar 
turned  out  not  to  be  substrates  for  GSK-3  or  GskA  in  vitro.  It  may  be  that  these  sites 
become  better  substrates  when  presented  to  the  kinase  as  part  of  the  whole  protein,  or  it 
may  be  that  other  proteins  need  to  be  in  association  in  order  for  GskA  to  phosphorylate  Aar 
in  vivo.  However,  recent  evidence  suggests  that  Aar  is  a  substrate  for  GskA,  but  that  it  is 
phosphorylated  at  alternative  sites  to  those  in  the  N-terminus  (W.  J.  Ryves,  unpublished 
data). 
Whilst  investigating  the  phosphorylation  of  Aar  by  GskA,  a  novel,  priming-dependent, 
serine/threonine  protein  kinase,  which  phosphorylates  Aar  at  the  putative  N-terminal  GSK- 
3  sites  in  vitro,  has  been  discovered.  This  kinase  was  subsequently  named  Aark,  for 
Aardvark  kinase.  Aark  has  an  apparent  molecular  weight  of  30-35kDa.  The  K.  value  for  its 
interaction  with  Aar-P1  was  calculated  at  365µM.  This  figure  is  high,  but  it  may  be  that 
scaffold  proteins  and/or  other  additional  factors  are  required  for  Aark  phosphorylation  of 
Aar  in  vivo.  Although  Aark  phosphorylates  Aar  in  vitro,  it  cannot  be  concluded  that  Aark 
phosphorylates  Aar  in  vivo,  and  the  high  Km  value  does  not  support  this.  However,  deletion 
of  a  small  region  of  Aar  containing  the  Aark  phosphorylation  sites  effects  the  physiological 
function  of  the  protein  (see  section  6.4).  This  suggests  that  Aark  phosphorylation  may  be 
147 required  for  proper  Aar  function.  Creating  a  knockout  of  Aark  in  Dictyostelium  would 
provide  a  simple  route  to  determining  this. 
Due  to  the  priming-dependency  of  Aark,  CK1  was  a  potential  candidate.  However,  CKI  did 
not  phosphorylate  the  Aar  peptides  tested  in  vitro,  and  the  size  of  Aark  differs  greatly  from 
that  of  CK1  isolated  from  Dictyostelium.  A  closer  examination  of  the  Aar  amino  acid 
sequence  surrounding  the  Aark  recognition  site  shows  conservation  with  the  CK  1  peptide 
substrate  CKI-P.  This  conservation  is  missing  from  Aar-P1,  suggesting  that  Aar  may  be  a 
substrate  for  CK1  in  vivo,  but  that  Aar-P1  is  not.  The  phosphorylation  site  of  Aark  was 
determined:  S-X-S-X-T(Phos),  with  the  Ser  residue  in  bold  being  the  phosphate  acceptor. 
This  site  differs  from  both  the  recognition  site  of  GSK-3  and  that  of  CK  1.  Therefore  Aark 
represents  a  novel  serine/threonine  protein  kinase,  which  shows  a  preference  for  phosphate- 
primed  substrates. 
A  GSK-3-like  kinase  (GLK)  has  been  discovered  in  the  Dictyostelium  genomic  database 
and  shows  conservation  of  the  Arg-96,  Arg-180,  Lys-205  residues  which  determine  the 
priming-dependency  of  GSK-3  substrates  (Dajani  et  al.,  2001;  Harwood,  2001).  The 
cloning  of  GLK  may  provide  a  short  route  to  the  identification  of  Aark.  GLK  does  not 
show  conservation  of  the  Axin-binding  domain,  so  if  Aark  is  GLK,  then  it  would  be 
expected  to  phosphorylate  Aar  in  an  Axin-independent  manner.  It  is  important  to  note  that 
only  circumstantial  evidence  exists  to  support  the  presence  of  an  Axin-like  protein  in 
Dictyostelium,  as  none  have  been  discovered  to  date. 
This  work  has  shown  that  Aark  is  able  to  phosphorylate  Aar  peptides  in  vitro.  This  does  not 
mean  that  Aar  is  necessarily  a  substrate  for  Aark  in  vivo.  Of  course,  if  GLK  does  turn  out  to 
in  fact  be  Aark,  then  it  will  be  relatively  simple  to  determine  whether  the  interaction  of 
Aark  with  Aar  is  a  true  one.  A  simple  way  to  show  this  would  be  to  take  cell  extracts  of 
148 GLK  mutants  and  test  them  for  kinase  activity  towards  Aar  in  the  in  vitro  kinase  assay,  as 
in  section  3.5  of  this  thesis.  Expression  of  an  Aar  protein  with  mutated  Aark 
phosphorylation  sites  may  be  expected  to  exhibit  a  similar  phenotype  to  the  GLK  null 
mutant,  if  Aark  is  GLK  and  Aar  lies  downstream  of  the  latter. 
Another  way  to  investigate  whether  a  physiological  role  can  be  assigned  to  the 
phosphorylation  of  Aar  by  Aark,  is  to  express  deletion  mutants  of  Aar,  some  of  which  lack 
the  Aark  phosphorylation  sites.  This  approach  was  taken  since  it  had  the  added  advantage 
of  being  able  to  potentially  assign  functions  to  other  regions  of  the  protein  in  addition  to  the 
Aark  phosphorylation  sites. 
6.3  What  physiological  roles  can  be  assigned  to  the  various  features  of  the  Aar 
sequence? 
A  number  of  N-terminal  and  C-terminal  deletions  of  Aar-GFP  were  made  and  expressed  in 
both  the  aar  null  mutant  and  wild  type  cells.  Expression  of  these  truncated  proteins  was 
determined  by  both  northern  and  western  analyses.  The  levels  of  mRNA  detected  for  each 
of  the  mutants  varied  considerably,  and  coincidently  some  of  the  higher  expressors  had 
more  drastic  phenotypes  than  the  lower  expressions.  This  is  coincidental,  since  the  western 
analysis  showed  that  the  protein  levels  did  not  reflect  the  mRNA  levels  detected.  It  would 
thus  appear  from  this  work,  that  Aar  is  subject  to  post-translational  control,  and  that  certain 
deletion  mutants  are  able  to  evade  this  control  (see  section  6.4). 
Cell-cell  adhesion 
Deletion  of  the  putative  a-catenin  binding  site  prevents  both  the  rescue  of  the  aar  null 
mutant  morphology  and  the  Aar  over-expression  phenotype.  This  suggests  that  this  region 
of  the  protein  is  important  for  the  adhesive  function  of  Aar.  This  is  consistent  with  amino 
acids  301-331  of  Aar  being  the  binding  site  for  a-catenin  and  an  cc-catenin/vinculin-like 
149 protein  has  recently  been  cloned  in  Dictyostelium  (T.  Soldati,  pers.  commun).  For  the  role 
of  Aar  in  the  formation  of  adherens  junctions  to  be  like  that  of  its  mammalian  counterpart,  a 
site  for  the  binding  of  the  C-terminus  of  cadherin  would  also  be  needed.  Deletion  of  the 
final  three  Arm  repeats  of  Aar  created  a  protein  that  was  unable  to  rescue  the  aar  mutant, 
and  hence  further  deletions  were  also  unable  to  rescue.  It  could  be  that  the  last  three  Arm 
repeats  are  required  to  bind  to  a  cadherin-like  molecule,  although  no  such  protein  has 
identified  in  Dictyostelium  to  date.  The  two  sites  could  be  used  as  bait  to  identify  these 
respective  binding  proteins  in  a  yeast  two-hybrid  screen. 
Cell  signalling 
Deletion  of  the  region  of  Aar  containing  the  Aark  phosphorylation  sites  made  a  protein  that 
was  no  longer  able  to  rescue  pspA  expression.  Further  N-terminal  deletions  not  only  failed 
to  rescue  pspA  signalling,  but  also  reduced  levels  to  below  those  observed  with  the  aar 
mutant.  Some  dominant  negative  effects  were  also  observed  in  wild  type  cells,  once  the 
Aark  phosphorylation  sites  had  been  removed  from  Aar,  but  these  results  were  unclear. 
Dominant  negative  effects  on  pspA  expression,  in  the  absence  of  Aar,  suggest  that  a  second 
Aar-like  protein  could  be  involved,  or  at  least  can  partially  compensate  in  the  aar  mutant. 
This  idea  is  further  supported  by  the  fact  that  pspA  expression  is  not  entirely  lost  in  the  aar 
mutant.  A  plakoglobin  homologue  has  been  discovered  in  Dictyostelium,  and  would  be  a 
good  candidate  for  this  second  Aar-like  protein. 
As  loss  of  the  region  of  Aar  containing  the  Aark  phosphorylation  sites  prevents  Aar  rescue 
of  pspA  signalling  in  the  aar  mutant,  suggesting  that  these  sites  may  be  required  for  Aar 
function  in  vivo.  GskA  activity  is  also  known  to  be  required  for  pspA  expression,  and  it 
may  be  that  Aark  phosphorylation  is  required  for  the  GskA-Aar  interaction.  The  second  site 
of  Aar  that  was  discovered  to  be  important  for  pspA  expression  may  be  required  for  the 
150 binding  of  Aar  to  a  transcription  factor,  or  maybe  a  transporter  protein,  which  would  direct 
Aar  to  or  from  the  nucleus. 
To  gain  a  greater  insight  into  what  each  of  the  regions  of  the  protein  that  are  now  deemed 
important  for  Aar  function,  localisation  studies  were  pursued. 
6.4  What  does  the  subcellular  localisation  of  Aar  reveal  about  Aar  protein  function? 
In  order  to  examine  the  subcellular  localisation  of  Aar,  a  C-terminal  GFP  fusion  was  added 
to  the  protein,  before  expression  in  both  the  aar  mutant  and  wild  type  cells.  This  work  led 
to  the  observation  that  Aar  may  contain  a  destabilisation  motif  within  its  Arm  domain. 
Following  transformation  of  cells  with  pDXA-aar-gfp,  no  fluorescence  could  be  detected. 
This  suggested  that  either  the  gene  or  the  protein  were  absent.  Northern  analysis  confirmed 
both  the  presence  of  the  DNA  construct  and  expression  of  the  gene,  leaving  four  possible 
explanations  as  to  the  lack  of  fluorescence: 
"  Incorrect  synthesis  of  the  polypeptide. 
"  Failure  to  translate  the  mRNA  sequence. 
"  Incorrect  folding  of  the  fusion  protein. 
"  Degradation  of  the  fusion  protein. 
Sequence  data  showed  that  there  was  no  reason  to  believe  that  the  Aar-GFP  polypeptide 
was  being  incorrectly  synthesised.  An  over-expression  phenotype  was  associated  with  the 
expression  of  pDXA-aar-gfp,  Aar-V5-His  could  be  detected  by  western  blot  and 
fluorescence  of  GFP  alone  could  be  detected.  This  shows  that  the  cell  is  able  to  translate 
both  the  aar  and  gfp  sequences  and  so  there  should  be  no  reason  why  a  fusion  of  the  two 
can  not  be  translated.  The  possibility  of  incorrect  GFP  folding  cannot  be  ruled  out  from  the 
151 evidence  presented  in  chapter  5,  but  successful  GFP  tagging  of  other  Arm  repeat-containing 
proteins  has  previously  been  reported,  suggesting  that  Aar  folding  does  not  affect  the 
fluorescence  of  GFP  (Giannini  et  al.,  2000;  Miller  and  Moon,  1997;  Mimori-Kiyosue  et  al., 
2000;  Oda  and  Tsukita,  1999). 
The  most  probable  explanation  for  the  lack  of  fluorescence  associated  with  Aar-GFP 
transformants  is  degradation.  Either  an  insufficient  level  of  Aar-GFP  within  the  cell,  or  a 
turnover  rate  high  enough  to  leave  GFP  with  insufficient  time  to  fold  correctly,  would 
prevent  fluorescence.  This  would  be  analogous  to  (3-catenin  degradation  in  resting 
mammalian  cells,  where  the  F-box  protein  ßTrcp  binds  following  GSK-3  phosphorylation. 
In  the  case  of  Aar,  however,  there  is  no  evidence  for  the  involvement  of  a  3Trcp  protein  or 
proteasome-mediated  degradation  as  yet. 
Treatment  of  cells  with  lithium  chloride  to  inhibit  GskA  failed  to  induce  fluorescence  in 
Aar-GFP  transformants.  However,  in  a  small  number  of  transformants  that  showed 
fluorescence,  the  inhibition  of  GskA  led  to  the  redistribution  of  Aar-GFP  within  the  cell. 
The  localisation  of  the  protein  changed  from  a  general  cytoplasmic  distribution  to  a  high 
enrichment  in  the  nucleus.  All  of  the  evidence  to  date  suggests  that  the  interaction  between 
GskA  and  Aar  is  a  positive  one  (Fraser  et  at.,  2002;  Grimson  et  al.,  2000).  If  inhibition  of 
GskA  causes  the  accumulation  of  Aar  in  the  nucleus,  then  how  does  GskA  function  to 
mediate  pspA  expression?  A  simple  hypothesis  would  be  that  Aar  functions  to  export  a 
repressor  of  pspA  expression  from  the  nucleus.  Nuclear  export  is  also  though  to  regulate  the 
repressive  function  of  the  C.  elegans  TCF  homologue  POP-1  (see  Korswagen,  2002).  In 
Dictyostelium,  GskA  phosphorylation  of  Aar  would  be  required  for  nuclear  export.  This  is 
consistent  with  the  previous  observed  role  of  GSK-3  phosphorylation  in  the  nuclear  export 
of  cyclin  D,  NF-AT  and  DdStatA  (Alt  et  at.,  2000;  Antos  et  at.,  2002;  Ginger  et  al.,  2000). 
In  addition,  evidence  for  an  Armadillo/Pangolin  derepression  mechanism  required  for  the 
152 expression  of  Wg  target  genes  in  Drosophila  has  emerged  (Chan  and  Struhl,  2002).  This  is 
in  contrast  to  the  widely  accepted  belief  that  upon  activation  of  Wnt  signalling, 
Armadillo/(3-catenin  enters  the  nucleus  and  binds  with  Pan/TCF  transcription  factors  to 
activate  expression  of  target  genes. 
In  conclusion,  many,  but  not  all,  properties  of  Aar  function  and  regulation  are  homologous 
to  those  of  ß-catenin  in  animal  cells.  Interestingly,  upon  initial  analysis  of  Aar,  its  function 
appeared  very  different  from  ß-catenin  in  the  canonical  pathway.  However,  it  is  becoming 
apparent  that  the  current  understanding  of  this  pathway  may  be  deficient.  The  observations 
described  in  this  thesis  offer  an  alternative  means  to  study  what  could  be  a  universal 
system. 
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